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Abstract 
 
Under oxidative stress condition, telomerase catalytic subunit can shuttle from the 
nucleus and localises within mitochondria. hTERT can improve mitochondrial functions 
and contribute to a decreased oxidative stress suggesting an entirely new function of 
telomerase in protecting mitochondria and cells under stress. However, there are still 
many questions about the mechanism and what factors influence the protective function 
of telomerase. 
In this study we investigated the kinetic exclusion of hTERT, the catalytic subunit of 
telomerase, in various cell lines under different oxidative stress conditions. We also 
used organelle specific hTERT localisation vectors to model hTERT localisation and 
investigated a correlation between hTERT location, nuclear DNA damage and ROS 
production. We found that cells excluded endogenous hTERT from the nucleus in a 
heterogeneous fashion independently of the cell types. Importantly, nuclear DNA 
damage showed a significant correlation with the localisation of hTERT. Cells where 
hTERT remained in the nucleus displayed high DNA damage while cells which 
excluded hTERT from the nucleus displayed no or very low DNA damage. Our results 
from specific hTERT localisation vectors specified that mitochondrial localisation of 
hTERT protects the nucleus from DNA damage and did not showed any sign of  
apoptosis induction while nuclear localisation of hTERT correlated with higher amounts 
of DNA damage and apoptosis. Moreover, mitochondrial localisation of hTERT 
decreased mitochondrial ROS generation levels directly after both endogenous and 
exogenous stress which we interpret as the  reason for the prevention of nuclear DNA 
damage.  
Additionally, we analysed whether p53 status might influence the protective function of 
telomerase. Our results in an isogenic cell pair of glioblastoma cells showed that p53 
status does not prominently influence the protective function of mitochondrial hTERT 
under low stress condition. However, nuclear hTERT of cells which contained inactive 
p53 displayed a significantly higher nuclear DNA damage than cells which contained an 
active p53 and this became more pronounced when stress levels were increased. We 
hypothesise that telomerase localisation might possibly interact with p53 when a cancer 
cell is under stress condition. However, the molecular mechanism for that is unknown.  
Our results demonstrate a novel link between mitochondrial localisation of hTERT, 
decrease of mitochondrial ROS generation and the protective capacity of hTERT to 
nuclear DNA from damage after stress treatments.    
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Chapter 1 
Introduction 
 
1.1 Telomerase 
Telomerase, a ribonucleoprotein complex, is a unique reverse transcriptase which has a 
canonical function to maintain telomere length by adding specific nucleotide repeat 
sequence onto the telomeres. However, evidence suggests that telomerase has additional 
physiological functions. Telomerase has been related to DNA damage response and 
repair, apoptosis resistance and changes in chromatin structure and gene expression 
(Smith et al., 2002, Sharma et al., 2003, Masutomi et al, 2005, Choi et al., 2008, Park et 
al., 2009a). Ectopic expression of telomerase in normal human cells leads to the 
extension of lifespan (Bodnar et al., 1998). Inhibition of telomerase in telomerase 
positive cancer cells can lead cell to death (Saretzki et al., 2001, Wong et al., 2002; 
Zhang et al., 2003; Rubio et al., 2004; Cong and Shay, 2008). Moreover, hTERT, the 
catalytic subunit of telomerase, can shuttle from the nucleus to the mitochondria upon 
oxidative stress and drug treatment (Santos et al., 2004, 2006; Ahmed et al., 2008; 
Haendeler et al., 2003, 2004, 2009; Indran et al., 2010).  hTERT has been demonstrated 
to bind and protect mitochondrial DNA against UV-induced depletion and increase the 
respiratory chain activity specially complex I (Haendeler et al., 2009). Previous 
experiments of our group have shown that mitochondrial DNA (mtDNA) in hTERT 
over-expressing fibroblasts is better protected against the oxidative DNA damage. 
hTERT is excluded from the nucleus and protects mitochondria under oxidative stress 
condition. hTERT over-expressing fibroblasts show a lower mitochondrial superoxide 
generation, less mitochondrial DNA damage, less mitochondrial mass/mtDNA copy 
number and higher mitochondrial membrane potential under stress conditions (Ahmed 
et al., 2008). Thus, localisation of hTERT in mitochondria seems to correlate to 
mitochondrial protection. However, a disadvantage of the general over-expression of 
hTERT in those cells is that the protein shuttles dynamically. 
 
1.2 The history of telomerase discovery 
Telomerase was first discovered in an in vitro study by Carol Greider and Elizabeth 
Blackburn in 1985. They were using a biochemical assays in Tetrahymena  thermophila 
cell-free extracts and discovered a telomere-specific terminal transferase activity that 
was subsequently named telomerase (Greider and Blackburn, 1985).  In their 
2 
experiments, Greider and Blackburn showed that the terminal transferase was sensitive 
to proteinase K,  micrococcal nuclease, and Rnase A and that a 159 nucleotides RNA 
subunit co-purified with telomerase activity over five fractionation steps (Greider and 
Blackburn, 1985, Greider and Blackburn, 1987). This experiment provided strong 
biochemical evidence that the terminal transferase was a cellular ribonucleoprotein 
reverse transcriptase.  
In human cells, telomerase activity was first identified by Gregg Morin in 1989 (Morin, 
1989).  He analysed nucleus and cytoplasm extracted from Hela and found a repeating 
pattern of 6 nucleotides which sequenced as TTAGGG as found at human telomeres. 
His experiments also showed that human telomerase can synthesise only 65-70 
repeating nucleotide sequences under optimal assay conditions while Tetrahymena 
enzyme could synthesise up to 8000 nucleotides as reported by Blackburn and 
colleagues in 1989 (Morin, 1989). In 1995, Feng  and co-workers identified the RNA 
component of human telomerase (hTR) in normal somatic cells, germline tissues and 
tumor cell lines (Feng et al., 1995). The template region of 11 nucleotides (5'-
CUAACCCUAAC) that they found is complementary with human telomere sequence 
(TTAGGG)n. They confirmed their findings by transfecting Hela cells with an 
antisense of hTR sequence. The results showed loss of telomeric DNA in Hela and cells 
began to die after 23 to 26 doublings.   
The telomerase catalytic protein subunit was first identified in 1996 through genetic 
screens in yeast (Lendvay et al., 1996) and biochemical purification of Euplotes 
aediculatus telomerase (Lingner and Cech, 1996). The E. aediculatus protein was found 
to be a homolog of the yeast protein and sequence comparison with prototypical RTs 
revealed an evolutionarily-conserved reverse transcriptase domain in both proteins. 
Substitution of residues within the reverse transcriptase motifs of the yeast protein 
caused telomere shortening and cellular senescence, indicating that the RT domain was 
required for telomere synthesis in vivo (Lingner et al., 1997).  
Human telomerase catalytic subunit gene was independently identified by two research 
groups (Kilian et al., 1997; Nakamura et al., 1997). Nakamura and co-workers reported 
a conserved telomerase catalytic subunit gene in human cells. Blast search information 
(GeneBank AA281296) and cDNA cloned from adenovirus transfected-human 
embryonic kidney cells were used to construct the hTERT motif. The expression of the 
hTERT gene  was identified in 6 telomerase-positive immortal cell lines (Nakamura et 
al., 1997). In the same year, Kilian and co-workers identified a 4 kb long human 
catalytic subunit gene in colon cancer cell line. By using this sequence, RT-PCR of 
3 
mRNA confirmed the expression of this discovered catalytic subunit gene 
corresponding with high telomerase activity in several telomerase-positive and tumor 
cell lines.  
 
1.3 Telomerase activity and its’ biological function 
Telomerase activity is varying in different human cells and tissues. Telomerase is active 
during early embryonic development but it is switched off in the majority of cells 
starting at 20 weeks of gestation in the human embryo (Ulaner et al., 1998; Geserick 
and Blasco, 2006). In embryonic stem cell, decrease of the expression of telomerase 
activity during differentiation is because of the deacetylation of histone H3 and H4 in 
the promoter region of hTERT and H3 at the hTR promoter resulting in downregulation 
of telomerase gene expression (Saretzki et al., 2008). Telomerase has been 
progressively repressed through differentiation in the majority of  human adult tissues 
while some cell types such as lymphocytes, endothelial cells and  adult stem cells retain 
a certain level of telomerase activity. Rare events of telomerase expression in human 
fibroblasts have been reported. Masutomi and co-workers found a small quantity of 
telomerase activity in two primary presenescent human fibroblasts (BJ-fibroblast and 
WI-38 fibroblasts) that exhibited hTERT activity in S-phase and noted that telomere 
shortening on its own cannot trigger senescence and cells need the bimodal action of 
hTERT depletion and telomere shortening (Masutomi et al., 2003). However, 
telomerase activity remains inactive in most other somatic cells.  
Telomerase activity and telomere maintenance are prerequisites for cellular immortality.  
Telomerase activity has been detected in 90% of all human malignancies (Shay and 
Bacchetti, 1997). Over-expression of hTERT is sufficient to counteract telomere 
shortening and extend cellular lifespan in  human diploid fibroblasts (Bodnar et al., 
1998; McSharry et al., 2001). Over expression of hTERT in two human embryonic stem 
cell lines resulted in enhancement of cellular pluripotency and suppression of cellular in 
vitro differentiation while downregulation counteracted pluripotency and proliferation 
(Yang et al., 2008).  All of these results indicate an important function of telomerase 
activity in telomerase positive cells. 
 
1.4  The hTERT gene and its transcription 
Regulation of telomerase occurs at several different levels (Cong et al., 2002; and Vega 
et al., 2003). The correlation between the expression of hTERT mRNA and telomerase 
activity indicates the transcriptional regulation of the hTERT gene. As shown in figure 
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1.1, the hTERT gene is located on chromosome band 5p15.33 in human diploid cells 
and it is approximately 2Mb away from the telomeres (Leem et al., 2002). The hTERT 
gene is composed of 16 exons and 15 introns extending over 35kb and all the splice 
junctions at exon/intron boundaries conform to GT/AG sequence except for the last 
intron (Cong et al.,1999). The sequence of the hTERT promoter contains a core region 
extending from 330 bp upstream of the hTERT ATG to 37 bp of the gene. The core 
region does not contain TATA or CAAT boxes but contains binding sites for several 
transcription factors (Cong et al., 1999). hTERT transcriptional activity is regulated by 
transcription factors like  SP1 (Kyo et al., 2000), c-Myc (Greenberg et al., 1999), and 
also by the papillomavirus E6 protein (Klingelhutz et al., 1996). Hoffmeyer and 
colleagues reported recently that Wnt/-catenin binds to the transcription start site 
(TSS) and regulates TERT expression in embryonic and adult mouse stem cells as well 
as human carcinoma cells (Hoffmeyer et al., 2012).  
There are many factors that have been shown to repress the expression of TERT 
including E2F, histone deacetylases, and Rb family of proteins (Cong et al., 2002; and 
Takakura et al., 2001). Mad1 and p53 were identified as negative regulators of hTERT 
transcription (Xu et al., 2001; Kanaya et al., 2000).  
Only the full length hTERT transcript is associated with telomerase activity (Cong et 
al., 2002). However, The hTERT gene is also differentially spliced. Several hTERT 
transcripts have been detected in human cells including α variant variant and 
alternative combination of α and variants. All of the various transcripts are expressed 
during fetal development in a tissue-dependent and gestational age-dependent manner 
(Ulaner et al., 1998). Also this alternative splicing of hTERT mRNA takes place and 
seems to be related to some diseases such as skin cancer (melanoma) (Lincz et al., 
2008) and kidney cancer (malignant renal tumour) (Fan et al., 2005). Changes of 
hTERT alternative splicing patterns were found in gastric carcinogenesis and can be 
used for the diagnosis of gastric cancer or percancerous lesions (Xu et al., 2009). 
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Figure 1.1 Gene organisation of the hTERT gene. hTERT consists of 16 exons and 
15 introns located on the short arm of chromosome 5 (5p15.33) (Cong et al., 2002).  
 
 
1.5 Post-translational modification of hTERT 
hTERT is found throughout the nucleoplasm in S phase, but is concentrated in nucleoli 
in the remaining phases of the cell cycle (Wong et al., 2002; and Yang et al., 2002). 
PinX1p, an inhibitor of telomerase, regulates telomerase by sequestering TERT into the 
nucleolus, thus preventing the association of TERT with the RNA subunit (Lin and 
Blackburn, 2004). ADP-ribosylation of hTERT by PARPs (Poly (ADP-ribose) 
polymerases) regulates telomerase activity (Ghosh and Bhattacharya, 2005). Akt kinase 
and protein kinase C enhance human telomerase activity through phosphorylation of the 
hTERT subunit (Li et al., 1998; Kharbanda et al., 2000, Kang et al., 2006). Moreover, 
phosphorylation of TERT by Akt and/or PKCα is necessary for nuclear translocation 
(Jagadeesh and Banerjee, 2006). Under H2O2  stress condition (Haendeler et al., 2003) 
and possibly others stresses such as hyperoxia (Ahmed et al., 2008), Src kinase 
phosphorylates hTERT at tyrosine 707 and stimulates hTERT to translocate from the 
nucleus into cytoplasm via nuclear pores in a CRM1/Ran-GTPase dependent manner. 
Moreover, hTERT can be translocated into mitochondria under stress condition (Ahmed 
et al., 2008; Haendeler et al., 2009; Indran et al., 2011; Sharma et al., 2012). Therefore, 
intracellular shuttling is an important mechanism to regulate telomerase since the 
absence of telomerase in the nucleus can lead to telomere shortening (Ahmed et al., 
2008). The oxidative stress can induce dramatic changes in hTERT localisation which 
are related to telomere independent functions of telomerase in mitochondria as 
described in 1.15.  
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1.6 Canonical function of telomerase  
Telomerase is a unique reverse transcriptase which has a canonical function to maintain 
telomere length by adding specific nucleotide repeat sequence onto the telomeres.  
Telomeres are special structures which are found at the end of eukaryote chromosomes. 
In mammals, telomeres are composed of 5-15 kb of a TTAGGG specific repetitive 
DNA sequences (Moyzis et al., 1988) with a multi protein complex. In humans, the 
protein complex is known as “shelterin” which is composed of six important proteins: 
TRF1, TRF2, hRap1, TIN2, TPP1 and POT1 (de Lange, 2005; Deng et al., 2008). These 
proteins help to form special complex structures to protect the end of a chromosome 
(Griffith et al., 1999). TRF1 and TRF2 bind to the double stranded telomeric sequence 
and fold telomere DNA back onto itself to form a large telomere loop (T-loop).  POT1 
binds to the 3’ end overhang on the telomere  and folds the DNA to bind to the double 
stranded telomeric sequence of the 5’end to form a displacement loop (D-loop) 
(Smogorzewska et al., 2000; Baumann and Cech, 2001). The structure of a telomere is 
described in figure 1.2. This three-dimensional structure can protect telomeres and 
prevent them from an inappropriate DNA repair such as exonucleolytic degradation and 
ligation of one chromosome end to another (Smogorzewska and De Lange, 2004; 
Wright and Shay, 2005; de Lange, 2006). However, during each cell division, telomere 
DNA is gradually shortening due to the oxidative stress (Von Zglinicki et al., 1995, 
Richter and Von Zglinicki, 2007) and the failure of the replication mechanism to 
replicate the last bases of the chromosome end what is called ‘‘end replication 
problem’’ (Olovnikov, 1973).  
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Figure 1.2. Telomere structure A: Telomeres cap mammalian chromosomes and are 
composed of TTAGGG repetitive sequences that terminate in a 3' single-stranded (ss) 
overhang. Telomeric DNA is complexed by the six-protein shelterin complex, 
composed of telomeric-repeat binding factor 1 (TRF1), TRF2, RAP1, TRF1-interacting 
nuclear factor 2 (TIN2), TPP1 and POT1. The TPP1–POT1 heterodimer regulates 
telomerase access to the telomeric substrate. B: The single stand overhang can invade 
the double-stranded region of the telomere to form a protective telomere (t) loop with a 
ss displacement (D) loop at the invasion site. Mammalian telomeres also transiently 
interact with a host of other factors, many of which are involved in the DNA damage 
response (from Blasco, 2005).  
 
 
This shortening of telomeres limits cells from indefinite cell division. Somatic cells 
without telomerase activity lose about 50-100 nucleotides of telomere sequence each 
time the cell divides which depends on the oxidative stress and intracellular anti-oxidant 
capacity. During cell division, on the lagging strand, DNA polymerase cannot 
continue replication all the way through the end of chromosomes because the 
semiconservative replication of DNA which processes only in the 5' to 3' direction. 
DNA polymerase  has to use a 3‘ hydroxyl group from RNA primer to start replication 
of short DNA sequences as called Okazaki fragment. After removal of RNA primers, 
DNA ligase will continue to fill up the gap between Okazaki fragments. However at the 
very end of the lagging strand in telomere region, after removed of RNA primer, DNA 
ligase can not fill up the last gap because of lagging of 3‘ hydroxyl group resulting in 
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the shortening of telomere in every time of cellular division. Once the length of the 
telomeric DNA reaches a critical level the cells will undergo replicative senescence and 
withdraw from cell cycle (Reddel, 2003). This phenomenon of normal somatic cells 
could limit cells to a fixed number of divisions which might be responsible for ageing 
on the cellular level and hence acting as a potent tumour suppressor mechanism. 
However, germ line cells, immortal cells and unicellular organisms express high levels 
of telomerase activity and thereby overcome the telomere shortening that leads to 
senescence (Shippen-Lentz and Blackburn, 1989). 
As shown in figure 1.3. telomerase synthesises telomeric sequences by recognising the 
tip of the telomeric G-rich strand with the 3’overhang of an existing telomere DNA 
repeat sequence and elongates it in the 5’-to-3’ direction. Telomerase synthesises 
telomeric sequence using the 11 nucleotode long template region of hTR and extends 
the ssDNA 3’-end (telomerase-mediated extension step) to a length that is sufficient for 
another priming event. The telomere is subsequently extended by the semi-conservative 
replication machinery (C-strand fill-in reaction) and then removed. A 5’-3’ nuclease has 
been proposed to generate the ssDNA overhang at the 3’-end of the leading strand, as 
well as catalyse the resection of the lagging strand 5’-end (5’-end resection step).  
 
 
Figure 1.3 Telomere elongation by telomerase. The 3’ end of the parental DNA stand 
is extended by the RNA-dependent DNA polymerase function of telomerase. This 
allows the incomplete daughter DNA strand that is paired with it to be extended in the 
5’ direction. The incomplete lagging strand is presumed to be completed by DNA 
polymerase α.  
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1.7 Telomere-independent functions of telomerase in cancer cells 
Telomerase activity and telomere maintenance have been considered as a pre-requisit 
for the immortality of cancer cells. However, despite the absence of net telomere 
elongation, telomerase might play an important role in cancer development. The first 
evidence which suggested a telomere independent function of telomerase and related to 
tumourigenesis was obtained in mice. Gonzales-Suarez and co-workers (Gonzales-
Suarez et al., 2001) generated a transgenic mTERT overexpressing mouse and found 
that without any significant extension of telomeres compared with the aged-matched 
wild-type mice, mTERT overexpressing mice displayed more sensitive to a chemical 
carcinogen and mitogenic effects of phorbol esters than wild-type mice. mTERT 
overexpressing mice were more susceptible to the development of neoplasias. 
Moreover, mTERT overexpressing mice expressed a significant faster wound-healing 
rate than the corresponding wild type which could reflect a proliferative advantage of 
telomerase overexpressing cells. These observations indicated a role of telomerase in 
signalling proliferation under mitogenic condition (Gonzales-Suarez et al., 2001).   
In humans, the increased of telomerase activity in already-formed tumours is viewed as 
a negative prognostic marker for cancer formation (Wesbuer et al., 2010). However, 
telomerase does not only promote tumour cell immortalisation but also expresses an 
additional function through the apoptotic pathway. Rahman and co-workers reported a 
link between p53 and telomerase activity. Constitutive over-expression of hTERT 
antagonised p53-induced apoptosis independently of its canonical function in Burkitt 
lymphoma and colon carcinoma cells (Rahman et al., 2005). Massard and co workers 
reported a pro-neoplastic function of telomerase as an endogenous inhibitor of the 
mitochondrial pathway of apoptosis. Inhibition of hTERT by siRNA could induce Bax, 
a pro apoptotic Bcl-2 family protein. This expression occurred in a p53-independent 
fashion (Massard et al., 2006). Moreover, Terrien and colleagues reported that in 
primary B lymphocytes, ectopic expression of telomerase down regulated the 
expression of BZLF1 which is the main activator for the Epstein-Barr virus (EBV) lytic 
cycle. Interestingly, hTERT positive EBV infected B cells grow significantly faster than 
hTERT negative EBV infected B cells. This ectopic expression of hTERT increased 
cellular resistance to lytic cycle induction, and also enhanced in vitro growth properties 
and proliferation of B lymphocytes. Thus hTERT might confer a cellular growth 
advantage in this circumstance (Terrin et al., 2007). Since this establishment of viral 
infection is a crucial prerequisite for Epstein-driven B cell transformation, telomerase 
may directly contribute to various EBV-related lymphoid malignancies (Maeda et al., 
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2009). Thus, telomerase enables cells with altered and unstable genomes to survive and 
induce the risk of many diseases.  
All together, telomerase does not express only its canonical function but also relates to 
other independent roles such as inhibition of apoptosis and interaction with cellular 
signalling in cancer cells which indicates the existence of independent function of 
telomerase from telomere maintenance. The mitochondrial function of telomerase is 
explained in 1.15.  
 
1.8 Telomere-independent functions of telomerase in non-cancer cells 
Beyond the clear role of telomerase in maintaining telomere length, ectopic expression 
of telomerase in normal human cells leads to the extension of cellular lifespan (Bodnar 
et al., 1998) or can promote increases the immortalisation (Kondo et al., 1998). Ectopic 
expression of  hTERT can immortalise human foreskin fibroblasts compared with their 
parental primary cells (Kampinga et al., 2004). Telomerase is also necessary for the 
long-term proliferation potential of stem cells. Sarin et al. (2005) showed an effect of 
TERT over-expression in an mTR knockout background on the proliferation of hair 
follicle stem cells. Transfection of the hTERT gene into rhesus monkey bone marrow 
stem cells can increase the population doubling up to 50 PD without any effect on 
cellular phenotypes (Gao et al., 2008). Moreover, expression of exogenous hTERT can 
bypass the  Rb and p53 pathway-dependent barriers to proliferation and immortalised 
normal human urothelial cells (Chapman et al., 2006).  
Telomerase also promotes cell growth. Telomerase modulates the expression of growth-
controlling genes and enhances cell proliferation.  TERT can induce growth-related 
proteins such as epidermal growth factor receptor (EGFR) in mammary epithelial cells 
(Smith et al., 2003) and interferes with the TGF-beta network of growth factors in 
primary murine cell lines (Geserick et al., 2006). Telomerase also associates with 
multiple regulatory proteins which might be involved in various intracellular pathways. 
It has also been shown that ectopic expression of hTERT leads to increased expression 
of genes involved in DNA damage repair and changes in the interaction of the telomeres 
with the nuclear matrix inside the cell nucleus (Sharma et al., 2003). Over-expression of 
telomerase in human oral fibroblasts resulted in enhanced nucleotide excision repair and 
DNA end joining capacity of UV damaged DNA (Shin et al., 2004). Transfection of 
hTERT gene into normal human embryonic lung cells can up-regulate the expression of 
vascular endothelial growth factor (VEGF) which is a key regulator of angiogenesis 
(Zhou et al., 2009). Telomerase modulates Wnt/-catenin signalling which is sufficient 
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to activate quiescent epidermal stem cells (Park et al., 2009a; Hoffmeyer et al., 2012).  
Moreover, TERT has shown properties of an RNA-dependent RNA polymerase when in 
a complex with the RNA component of the mitochondrial endoribonuclease RMRP and 
synthesises double stranded RNA which can be further processed into siRNAs (Maida 
et al., 2009).  
 
1.9 Telomerase and apoptosis  
Inhibition of telomerase is widely investigated in order to induce apoptosis in cancer 
cells.  The link between apoptosis and telomerase has been considered to be cause by 
the role of telomerase in telomere maintanence (Zhang et al., 1999; Herbert et al, 1999). 
However, evidence suggests that telomerase has an additional role in apoptosis 
regulation independently from telomere maintenance. The first evidence of independent 
function of telomerase in apoptosis has been reported in 2002. Fu and co-workers 
reported a novel role of telomerase in mediating the cell survival-promoting actions of 
two neurotrophic factors in developing hippocampal neurons. Telomerase activity and 
hTERT mRNA were increased by brain-derived neurotrophic factor (BDNF) and a 
secreted form of -amyloid precursor protein (sAPP) in embryonic hippocampal 
neuron. However, the increase in telomerase activity happened only during the early 
stages of cultured embryonic neurons (Fu et al., 2002). Results from the same group in 
mouse hippocampus suggested a decrease in mTERT levels during adulthood. 
Telomerase activity in mouse brain declines until it is undetectable by day 10 postnatal 
which is the period that cell death occurs. This finding indicates an important role of 
telomerase in early neuronal development stage (Klapper et al., 2001).    
Inhibition of telomerase can probably also induce telomere-independent apoptosis in 
cancer cells. Inhibition of telomerase with an antisense telomerase expression vector 
increased the susceptability to cisplatin-induced apoptotic cell death in human 
malignant glioblastomas cell lines (Kondo et al., 1998). Inhibition of telomerase in mass 
cultures of ovarian cancer cells induced cell death independent of telomere shortening 
(Saretzki et al., 2001).  
Telomerase is also related to apoptosis via a mitochondrial mechanism. Massard and 
colleagues reported a function of telomerase as an endogenous inhibitor of the 
mitochondrial pathway of apoptosis (Massard et al., 2006). Del Bufalo and colleagues 
reported an apoptosis induction by inhibiting Bcl-2 which is a regulator of telomerase 
with specific oligonucleotide in human breast carcinoma (Del Bufalo et al., 2005). 
Inhibition of Bcl-2 could repress telomerase expression which indicates a strong 
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correlation between telomerase and Bcl-2. Moreover, hTERT protects cells from 
chemical-induced apoptosis independently of its enzymatic and telomere-maintaining 
activity. Interestingly, inducing ROS generation in these cancer cells induces nuclear 
export of hTERT. Telomerase was excluded from the nucleus to the cytosol and 
attenuate mitochondrial apoptosis induced by interfering with the Bcl-2-dependent 
mitochondrial apoptosis (Del Bufalo et al., 2005). 
Taking together, telomerase may be involved in various cellular pathways which affect 
apoptosis.  
 
1.10 Telomerase and nuclear DNA damage response 
TERT has been shown to play a role in chromatin remodelling and DNA damage 
response as one of the non-canonical function (Sharma et al., 2003, Masutomi et al, 
2005, Park et al., 2009a). In mammals, cellular responses to DNA damage are mediated 
by many protein kinases including ATM (ataxia telangiectasia mutated) and ATR 
(ATM and Rad3-related) (Ljungman, 2010). ATM regulates a number of DNA damage 
response factors to response to the damage such as DNA double strand breaks by 
phosphorylate H2A.X at serine 139 and facilitates the assembly of checkpoint and DNA 
repair factors including 53BP1, MDC1⁄ NFBD1 and NBS1 to form a DNA damage 
response complex at the site of DNA double stand breaks. MDC1, which binds to the 
phosphorylated H2A.X will allow ubiquitin ligase RNF8 to bind. As shown in figure 
1.4, RNF8 ubiquitylates histones in the chromatin surrounding the damage, thereby 
recruiting BRCA1 via the RAP80 protein and 53BP1 via chromatin structure alterations 
in the vicinity of DNA damage (Huyen et. al., 2004). When assembled, this complex 
enhanced DNA double strand break repair and increased resistance to radiation (Yan 
and Jetten, 2008).  
Masutomi and co-workers reported that transient expression of hTERT in normal 
fibroblasts modulated DNA damage response (DDR).  Fibroblasts with stably 
suppressed hTERT function by RNA interference exhibited a lack of induction of ATM 
and H2A.X phosphorylation after radiation, irionotecan and etoposide (Masutomi et al, 
2005). Nitta and colleagues reported that mice with double deficient ATM and TERT 
demonstrated increased progression of ageing and had shorter lifespan compared to 
mice lacking only ATM which indicates a correlation between TERT and ATM (Nitta 
et al., 2011). 
 
 
13 
 
 
 
Figure 1.4. Formation of a DDR complex at site of DNA DSB.  A DSB induces a 
topological alteration in the DNA/chromatin that leads to the activation of ATM and the 
C-terminal tail of H2A.X becomes available for phosphorylation by ATM. 
Phosphorylation of H2A.X then triggers the assembly of a large DDR complex 
consiting of MDC1, RNF8 BRCA1, 53BP1, and DNMT (Ljungman, 2010).  
 
 
1.11 Mitochondria 
Mitochondria are the main energy generating organelles in the cell and are in addition 
considered the  major source of intracellular ROS generation. As shown in fugure 1.5, 
mitochondria are double membrane organelles located in the cytoplasm of eukaryotic 
cells (Kakkar et al., 2007).  The basic structure of a mitochondrion consists of outer 
membrane, intermembrane space, inner membrane, cristae, and matrix  in size of about 
1 μm.  The outer membrane of mitochondria is very similar to that of a eukaryotic cell 
membrane in both structure and composition (Voet et al., 2004).  
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Figure 1.5. The general organization of a mitochondrion. Mitochondria are a double 
membranous organelle found in the cytoplasm of all eukaryotic cells.  They contain the 
outer membrane and the inner membrane which is made up of proteins and 
phospholipids. The space  between the two membranes is called  the inter-membrane 
space. (Image taken from http:// amrita.vlab.co.in/) 
 
The outer membrane contains large amounts of the protein ‘porin‘ which creates 
transport pores for the diffusion of the molecules (Ryan 2005). Any large proteins that 
enter the mitochondrion must be labelled at the N-terminus and actively transported by 
the protein translocase of the outer membrane (Ryan 2005).   
The mitochondrion contains several copies of mtDNA as well as ribosomes and 
associated proteins required for mtDNA transcription and translation (Voet et al., 2004).  
The mitochondrion is the energy producing factory of the cell (Wallace 2006). The 
mechanism that converses the metabolic energy into adenosine triphosphate (ATP) 
takes place inside mitochondria.  The mechanism is known as oxidative 
phosphorylation which electron transport through the oxidative phosphorylation enables 
the pumping of protons from mitochondrial matrix into the intermembrane space, 
generating a proton motive gradient (Schultz et al., 2001).  Mitochondrial dysfunction 
has an effect to cell signalling, programmed cell death (apoptosis), control of the cell 
cycle and senescence (Wallace 2006; Kakkar et al., 2007, Passos et al., 2010). 
 
1.12 Oxidative phosphorylation  
Mitochondria are the energy producing factory of the cell that converses the metabolic 
energy into adenosine triphosphate (ATP). The process that uses energy released from 
the oxidation of glucose to produce ATP is known as oxidative phosphorylation 
(OXPHOS). This process requires the passing of electrons (via electron transport chain, 
ETC) through specific protein complexes, the OXPHOS proteins (Hansford 2002) and 
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enables the pumping of protons (H+) from the mitochondrial matrix into the 
intermembrane space which drives the production of ATP (Voet et al., 2004).   
In the process, a glycolysis step breaks down glucose to produce pyruvate, which is an 
essential component of aerobic respiration. Pyruvate will be transported into the 
mitochondria via pyruvate dehydrogenase (PDH), and converted via a series of 
reactions to acetyl CoA. This acetyl CoA is substrate for citric acid cycle (Krebs cycle) 
which provide several electron donors for electron transport chain (ETC).   
There is a series of 5 enzymes (Complex I-V) related to ETC. As shown in fugure 1.6, 
these 5 complexes are located within the mitochondrial inner membrane.  The first 
enzyme in the ETC is NADH dehydrogenase (complex I). Complex I will receive 
electrons from NADH from Krebs cycle and transfer to ubiquinone (coenzyme Q10).  
During this process 4 protons (H+) are pumped across the membrane (Hansford 2002).  
 
 
 
Figure 1.6. Oxidative phosphorylation in mitochondria Electrons donated from 
NADH and FADH2  from Krebs cycle pass down the electron transport chain with 
oxygen being the terminal acceptor at complex IV. This movement of electrons results 
in a shift of protons across the inner mitochondrial membrane and generating the energy 
for ATP synthase to produce ATP from ADP. (Protti and Singer Critical 
care 2006 10:228   doi:10.1186/cc5014) 
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The second enzyme, succinate dehydrogenase (complex II) will transfer electrons to 
Q10. This complex also has a role in the Krebs cycle (Horsefield et al., 2004).  Complex 
II oxidises succinate to fumarate and transfers these electrons to Q10.  Coenzyme Q10 
will be reduced and becomes ubiquinol.   
Ubiquinol is oxidised by mitochondrial cytochrome bc1 complex (complex III), 
resulting in the transfer of electrons and pumping of more protons.   
Complex III contains several cytochrome subunits, proteins that contain hemegroups 
and transfer electrons (Kakkar et al., 2007). Oxidation of ubiquinol allows complex III 
to transfer electrons to a mitochondrial associated protein or cytochrome c, which will 
transfer electrons to the final ETC complex, cytochrome c oxidase (complex IV). A 
series of hemegroups and metal co-factors in complex IV will utilise and transfer 
electrons to oxygen and reduce it to H2O.   
Finally the potential energy created from this step allows the pumping of protons 
(Hansford 2002).  The net pumping of protons by ETC will create a chemi-osmotic 
gradient, which allow protons through the enzyme ATP synthase (Schultz et al., 2001).  
As these protons pass back down into the matrix, a conformational change in the ‘head’ 
of ATP synthase forces ADP and Pi (in-organic phosphate) to bind, resulting in the 
production of ATP (Dimroth et al., 2000).  This ATP will transport out from 
mitochondria and be used as energy for the cell. 
However, during this process each O
2 
molecule must accept two electrons to become 
fully reduced to H
2
O. However, the process is imperfect and often only one electron is 
donated, leading to the formation of the superoxide anions. The mistake happens mostly 
at two discrete steps, complex I (NADH dehydrogenase) and Complex III (ubiquinone-
cytochrome c reductase).  
Under normal conditions complex III is the main site of ROS formation (Turrens 1997). 
Studies have shown that the rate of flow of electrons during oxidative phosphorylation 
can influence the amount of ROS produced and many treatments that affect electron 
flow produce (complex activity inhibitors) increases in ROS production (Lenaz 2001). 
The frequency of this mistake  has been reported to be about 0.1% of all oxygen 
molecules (Imlay and Fridovich 1991).  Thus the formation of this ROS is enough to 
qualify the mitochondria as the main source of cellular ROS.  
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1.13 Reactive Oxygen Species (ROS) 
ROS, also called free radicals or oxygen radicals are highly reactive small molecules 
containing unpaired electrons. These molecules can react with several organic 
molecules (nucleotides, proteins or lipids) and, in doing so, can cause considerable 
damage, impairing normal cellular function (Finkel and Holbrook 2000; Kirkinezos and 
Moraes 2001). The term Reactive oxygen species (ROS) is used to describe a variety of 
molecules including the superoxide anion (O2
•−
), hydroxyl (HO
•
), peroxyl (RO2
•
) and 
alkoxyl (RO
•
) radicals, as well as non-radical species including hydrogen peroxide 
(H2O2) (Halliwell and Cross, 1994). 
ROS can damage three kinds of organic molecules which are lipids, proteins and 
nucleotides. When reactive oxygen species react with cellular lipids, they can decrease 
membrane fluidity, influence endoperoxide generation and interact with the unsaturated 
aldehydes which are highly reactive and may act as mutagens, inactivate enzymes or 
operate as endogenous cross-linking agents (Beckman and Ames 1998).  Oxidation of 
proteins by oxygen radicals leads to formation of carbonyls, protein-protein cross-
linking, peptide fragmentation and inactivation of proteins with iron-sulfur clusters 
(Beckman and Ames 1998). Overall, any of these interactions between ROS and 
biomolecules promote cellular dysfunction.  
DNA is susceptible to the damage by ROS, especially the highly damaging hydroxyl 
radical. When ROS damage nucleotides, adduct base and sugar groups may form single- 
and double-strand breaks in the nucleotide backbone or cross-linking to other molecules 
can occur. These altered nucleotides can eventually lead to mutation, DNA 
rearrangements or problems during transcription (Beckman and Ames 1998). The main 
products of oxidative DNA base damage are thymine glycol (Wang, Kreutzer and 
Essigmann, 1998) and 7,8-dihydro-8-oxo-2’-deoxyguanosine (8-oxodG) (De Bont and 
van Larebeke, 2004).  
Thymine gycol has a low mutagenicity, while 8-oxodG has the ability, albeit with low 
frequency to cause G-T transversions upon replication (Alexeyev, 2009). 
It is also important to point out that telomere dependent replicative senescence is also 
influenced by cellular stress, in that telomere attrition is affected by the level of 
oxidative stress in the cell (von Zglinicki et al., 1995).   
 
18 
       
 
 
Figure 1.7. Involvement of ETC in PQ
2+
 -dependent H2O2 generation in brain 
mitochondria Complex III on ETC has the ability to transfer electrons to participate in 
mechanisms of H2O2 production by PQ
2+  
(Castello et al., 2007) 
 
 
In addition to the naturally occuring ROS generated by OXPHOS, mitochondrial ROS 
production can be modulated by the use of reagents, specific conditions  and irradiation. 
The example of a chemical which can activate mitochondrial ROS production is 
paraquat (Ali et al., 1996; Castello et. Al., 2007; Shibata et. Al., 2010).  
As shown in figure 1.7, paraquat (PQ
2+
) is a bipyridyl group (1,1‘ –dimethyl-4,4‘ –
bipyridylium) herbicide, the prototype toxin known to exert injurious effect through 
oxidative stress and bears a structural similarity to parkinson disease toxicant, 1-methyl-
4-pheynlpyridinium (Mohammadi-Bardbori and Ghazi-Khansari, 2008). It is widely 
accepted that PQ
2+
 -induced generation of ROS arises from a number of cellular 
sources.  However, mitochondria are a principle cellular site of PQ
2+
 -induced H2O2 
production. Electron from Complex II and complex III in the electron transport chain 
can be transfered to a PQ
2+ 
molecule and is proposed to participate in mechanisms of 
H2O2 production by PQ
2+
( Castello et. al., 2007). 
 
1.14  p53 
One important gene which is affected by ROS is p53. Among the tumour suppressor 
genes, p53, a guardian of the genome, is a DNA-binding protein which acts as a 
transcription factor to control the expression of proteins involved in the cell cycle.  p53 
was first identified in 1979 in association with simian virus 40 (SV40) large T-antigen. 
Wei et al reported in 2006 that a combination of bio-informatic and ChIP based 
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informationsuggested that the number of genes containing p53 binding sites may vary 
between 500 and 1600 (Wei et al., 2006). Genes involved in the responses of cell-cycle 
arrest and apoptosis are largely attributed to p53. Once cells are undergoing stress, p53 
mediates a series of cellular outcomes that vary from cell cycle arrest to DNA-repair 
and senescence or apoptosis. The up regulation of p53 occurs at the post-translational 
level (phosphorylation, tetramerisation), and is achieved through stabilisation of the 
protein (Choisy-Rossi et al., 1999). The key role played by p53 in tumour suppression is 
underscored by the frequent inactivation of this gene by various mutations as found in 
many in human cancer types (Martins et al., 2006). This p53 inactivation occurs in 
around 50% all tumours and might contribute to better cancer cell survival because the 
cells do not arrest even with a high load of DNA damage (Hollstein et al., 1994). How 
p53 shows its anticancer function seems to differ according to the tumour type. For 
example, restoring p53 function in p53-deficient lymphomas could induce apoptosis 
(Ventura et al., 2007). In contrast, p53 reactivation in hepatocarcinoma cells induces 
growth arrest and cellular senescence (Xue et al., 2007). It is not clear which features of 
cancer cells determine whether its response to p53 activation is apoptosis or senescence 
but both outcomes are associated with tumour regression.  
 
1.15 Activation of p53  
A variety of stress signals lead to p53 activation. DNA damage is the first type of stress 
found to activate p53 (Lane, 1992). DNA damage signalling is triggered by a variety of 
exogenous and endogenous events that might compromise the genome integrity by 
altering the structure of DNA which generates mutations, and/or by causing double 
strand breaks (DSB). The exogenous damage might be caused by UV radiation, ionizing 
radiations or chemical mutagenic compounds. However, endogenous DNA damage 
derives from normal cellular processes such as metabolism. DNA damage signals can 
activate p53 through Ser/Thr kinases which mediate p53 phosphorylations (Lambert et 
al., 1998). ATM and ATR, the two DNA damage sensor kinases and their respective 
downstream kinases Chk1 and Chk2, can phosphorylate p53 at different sites. ATM and 
Chk2 act in response to ionizing radiation and DSBs leading to phosphorylation of p53 
at Ser15, Thr 18, and Ser20. However, ATR and Chk1 which seems to response to UV 
damage and hypoxia can phosphorylate p53 at Ser15 and Ser37 while Chk1 itself can 
phosphorylates p53 at Ser6, Ser9 and Ser20 (Banin et al., 1998; Chehab et al., 1999; 
Hammond et al., 2002). In response to stress, p53 may also contribute to a constitutive 
chronic stress such as the generation of cellular ROS. Persistent activation of p53 
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enhances ROS production via pathways involving p38MAPK and transforming growth-
factor-β (TGFb), which in turn contributes to DNA damage formation and further 
activation of p53, forming a positive feedback loop that stabilizes p53-mediated cellular 
reactions (Chen et al. 2003; Bragado et al. 2007; Passos et al. 2010, see also chapter 
1.19). 
 
1.16 p53 and cellular senescence 
Several lines of evidence support the idea of p53 mediate the induction of senescence, a 
program leading to irreversible arrest of cell growth accompanied by a characteristic set 
of phenotypic changes in the cell. Senescence can be triggered by shortening of 
telomeres due to proliferation (replicative senescence) or by other exogenous or 
endogenous acute and chronic stress signals (telomere-independent or premature 
senescence). Many reports have revealed the importance of DNA-damage response 
(DDR) in initiating both replicative and premature senescence. A common signal is the 
occurrence of double strand breaks caused by telomere erosion, replication stresses or 
by oncogene activation (Bartkova et al., 2006; Di Micco et al., 2006; Hemann and 
Narita, 2007). In models of cellular senescence induced by DNA damaging agents 
causing double strand breaks, ATR/ATM mediates the activation of cell-cycle 
checkpoints via CHK1/CHK2 and p53 with the participation of p21, p16 and Rb 
(Itahana et al., 2004). p21 is a crucial transcription target in mediating p53-induced 
senescence (Brown et al., 1997). pRb activation via the CDK inhibitor p21 could 
represent a p53-mediated senescence since disruption of p21 by homologous 
recombination is able to bypass senescence in human diploid fibroblasts (Brown et al., 
1997). However, disruption of p21 fails to bypass senescence in mouse cells (Pantoja 
and Serrano, 1999). Furthermore, human cells can undergo senescence without activity 
of pRb or its family members which points to alternative, pRb-independent routes of 
p53-mediated senescence (Smogorzewska and de Lange, 2002). 
 
1.17 p53 and apoptosis 
The main role of p53 is to prevent the outgrowth of damaged or stressed cells that may 
develop into tumor cells. This can be achieved by eliminating cells through apoptosis.  
The best known transcriptional targets of p53 include a large number of pro-apoptotic 
genes that can be divided into categories depending on their specific functions (Wei et 
al., 2006). Genes related to apoptosis are generally classified into the extrinsic and 
intrinsic apoptotic pathways. Only intrinsic pathway relates to p53. The extrinsic 
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apoptotic pathway engages death-receptors belonging to the TNF-receptor family and 
leads to the induction of a cascade of caspases which induce apoptosis (Attardi et al., 
2000). The intrinsic pathway is activated in response to different signals such as DNA 
damage, oncogenic signalling or hypoxia and is associated with mitochondrial 
depolarization and  release of cytochrome C from the mitochondrial as well as caspase 
activation (Cory and Adams, 2002).  
 
 
Figure 1.8 Extrinsic and intrinsic pathways for apoptosis. (Aslan et al., 2008) 
 
For this intrinsic pathway, p53 can contribute to several p53-regulated genes such as 
Bax, Noxa and PUMA (Miyashita and Reed, 1995). Bax was the first identified p53-
regulated pro-apoptotic Bcl-2 family member (Miyashita and Reed, 1995). Loss of Bax 
accounts for nearly half of the accelerated tumour growth which resulted from the loss 
of p53 in brain tumour (Schmitt et al., 2002). Bax is also responsible for nearly half of 
p53-dependent apoptosis induced by 5-FU in colorectal cancer cells (Zhang et al., 
2000). In contrast, Bax is dispensable for the apoptosis induced by γ-irradiation in 
thymocytes and intestinal epithelial cells (Bouvard et al., 2000). PUMA and Noxa are 
activated in a p53-dependent manner following DNA damage (Nakano and Vousden, 
2001; Yu et al., 2001). PUMA mediates apoptosis induced by p53 in response to 
hypoxia, DNA damaging agents, and endoplasmic reticulum stress in human colorectal 
cancer cells (Yu et al., 2003). The absence of Noxa resulted in resistance to X-ray-
induced apoptosis in the small intestinal crypts in vivo (Shibue et al., 2003; Villunger et 
al., 2003). Moreover, under genotoxic, hypoxic, and oxidative stresses, the p53 protein 
can translocate to mitochondria (Marchenko et al., 2000). This translocation is 
dependent on Mdm2 (Marchenko et al., 2007; Pei et al., 2012). At the mitochondria, 
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p53 has been found to interact with the Bcl-xL and Bcl-2 protective proteins (Mihara et 
al., 2003).  
There is a crosstalk among p53 functions at the mitochondria and its transcriptional 
activity, in fact upon stress-induced-stabilisation and activation within the nucleus, p53 
induces the transcription of Puma and this one is able to release cytoplasmic p53 from 
the inhibitory interaction with Bcl-xL, thus allowing it to directly activate Bax (Chipuk 
et al., 2005). p53 interacts also with Bad and the mitochondrial p53/Bad complex 
promotes apoptosis via activation and oligomerization of Bak (Jiang et al., 2006). 
Moreover, p53 acts directly on the pro-apoptotic Bak promoting its dissociation from 
the anti-apoptotic protein MCL1 (Leu et al., 2004). Once the inhibitory interactions 
upon Bax and Bak are relieved, they oligomerise to form a transmembrane pore for the 
release of cytochrome C from mitochondria. 
 
1.18 p53 mutations 
Various mutations at hot spots have been described to inactivate p53 in many cancer 
types (Liu et al., 2010; Ye et al., 2009; Campitelli et al., 2012). The physiological 
expression of point-mutated p53 can strongly limit the overall cellular p53 function (de 
Vries et al., 2002).‎The most common p53 mutations are missense mutations on the 
DNA binding domain which affect the full length protein so that it is incapable to bind 
DNA. There are two types of p53 DNA binding domain mutations, conformational 
mutants and contact site mutants (Willis et al., 2004). p53 is active in tetramer form 
(Friedmann et al.,1993). Since most of the mutations found in cancers are not located 
within its tetramerisation domain, most of the p53 mutants are functional for 
tetramerisation (Chene, 1998). Mutant p53 can tetramerise with wild-type p53 to form 
hetero-tetramers and drive the wild-type subunits into a mutant conformation (Milner et 
al., 1991; Brachmann et al., 1996; Ko and Prives, 1996). This dominant negative 
activity is important for inactivating the wild-type p53 allele in heterozygous tumours 
(Chene, 1998). Moreover, p53 mutants can actually alter patterns of gene expression. 
Mutant p53 can upregulate promoters of genes such as MRD-1 (Atema and Chene, 
2002) and c-myc (Frazier et al., 1998). The presence of mutated p53 reduces the ability 
of wild-type p53 in inducing p21, MDM2 and PIG3 (Willis et al., 2004). Thus mutant 
p53 exerts its dominant negative activity by abrogating functional wile-type p53. 
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1.19 Cellular senescence 
Since there is a correlation between p53 and cellular senescence as explained in 1.16, 
cellular senescence can acts as a barrier to prevent cancerous phenotypes, averting the 
accumulation of mutations and therefore plays an important role in tumour suppression 
(Ohtani et al., 2009). Most somatic cells cannot divide indefinitely. They permanently 
stop dividing after a finite number of cell divisions and enter a state known as cellular 
or replicative senescence. This limit of replication was first described by Hayflick, and 
is often termed the ‘Hayflick limit’ (Hayflick and Moorhead, 1961). Replicative 
senescence is induced by critically short telomeres, counting the number of cell 
divisions as they progressively shorten with each division (d’Adda di Fagagna et al., 
2003). Importantly, telomere shortening can be exacerbated by oxidative stress (von 
Zglinicki et al., 1995; Lu and Finkel, 2008). The telomere dependence of replicative 
senescence gained support from evidence showing that addition of hTERT (telomerase 
catalytic subunit) can immortalise human somatic cells (Bodnar et al., 1998). In addition 
to telomere shortening, cellular senescence can be induced by other multiple extrinsic 
factors such as DNA damaging agents, oxidising agents, over expression of certain 
oncogenes or lack of nutrients or growth factors as shown in figure 1.18 (Ben-Porath 
and Weinberg, 2005). This ‘extrinsic form’ of induction of senescence occurs much 
more rapidly than that induced by telomere attrition. This led to a distinction between 
‘replicative senescence’ which refers to senescence due to population doublings which 
most likely is induced by telomere erosion and ‘stress-induced premature senescence’ 
(SIPS), where senescence is induced more rapidly by exogenous factors other than loss 
of telomere segments (Dierick et al., 2002). 
 
 
 
Figure 1.9 The signals activating senescence. Multiple types of stress can induce 
cellular senescence (Ben-Porath and Weinberg, 2005). 
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1.20 Stress-Induced Premature Senescence (SIPS) 
These are several exogenous factors which can activate SIPS including external DNA 
damage using chemotherapeutic agents, irradiation, oxidative stress, damage to 
chromatin structure and oncogene activity which can cause cells to enter an immediate 
growth arrest without any measurable telomere shortening (Saretzki, 2010). Oxidative 
stress and the accumulation of intracellular reactive oxygen species (ROS) is one of the 
signals playing an important role in this premature senescence (von Zglinicki et al., 
1995; Lu and Finkel, 2008). Internal ROS can damage cellular components through the 
oxidation of DNA, proteins and lipids (Chen et al., 1998; Sitte et al., 2000). Increase of 
intracellular ROS levels through hydrogen peroxide treatment or through the inhibition 
of ROS scavenging enzymes, such as superoxide dismutase can cause premature 
senescence (Blander et al., 2003). Oxidative stress can cause DNA damage and 
accelerate telomere shortening rates (von Zglinicki et al., 1995, Chen et al., 1998). 
Oxidative stress induces single stranded breaks in telomeric DNA (von Zglinicki et al., 
2000) and causes an impaired cellular redox state, irreparable DNA damage and 
oxidatively damaged proteins (von Zglinicki et a., 2005).   Moreover, ROS can act 
directly as  a second messenger to regulate specific signalling pathways (Saitoh et al., 
1998). It has been shown that the reduction of ambient oxygen levels does not reduce 
the fraction of p16-expressing cells in a pre-senescent population of normal fibroblasts. 
However, it is the proportion of p21-expresssing cells that is reduced (Itahana et al., 
2003). Thus this data suggests that oxidative stress might acts through DNA damage 
response and p53→p21→Rb to induce senescence (Chen et al., 1998; Ben-Porath and 
Weinberg, 2005).  
 
 
Figure 1.10 Telomere shortening and DNA damaged by ROS, which are generated by 
mitochondrial respiration, induce a DNA damage response including the formation of 
telomeric DNA damage foci. This process could activate p53 which triggers cellular 
senescence (Passos et al., 2007). 
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Moreover, a long-term activation of p21 (CDKN1A) could induce mitochondrial 
dysfunction and the production of mitochondrial ROS through a serial signalling 
GADD45-MAPK14(p38MAPK)-GRB2-TGFBR2- this 
study, MRC5 fibroblast were treated with ionizing radiation (20Gy). After irradiation, 
the number of DNA damage foci permanently increased which indicated the 
development of cells into stress-induced premature senescence. At 24 hours after 
irradiation, the level of mitochondrial superoxide (measured as mitoSOX by flow 
cytometry) and cellular peroxides (measured as DHR by flow cytometry) increased and 
remained elevated during the observation. Not only was ROS production increased, but 
mitochondria in stress-induced senescent cells also showed an increase in mitochondrial 
mass (measured by NAO fluorescence), mitochondrial uncoupling (increase 
transcription of UCP-2 and decrease of mitochondrial membrane potential (measure by 
JC-1 fluorescence) (Passos et al., 2010).  This feedback loop persists in both in vivo and 
in vitro cellular senescence. 
Oxidative stress can cause DNA damage and accelerated telomere shortening (Chen et 
al., 1998) triggers a DNA damage response and cellular senescence (Wang et al., 2009). 
This DNA damage response is characterised by the activation of ATM and ATR 
(Ljungman, 2010). The proteins are recruited to the site of damage and lead to 
phosphorylation of Ser-139 of the histone H2A.X molecules (c-H2A.X) close to the site 
of DNA damage as described previously in 1.10. The phosphorylation of histone 
H2A.X facilitates the assembly of checkpoints and DNA repair factors including 
53BP1, MDC1 and NBS1, and also promotes the activation by phosphorylation of Chk1 
and Chk2 that ultimately result in cell cycle arrest (Smogorzewska & de Lange, 2002). 
The focus size increases rapidly after formation, and remains present until damage is 
repaired. Since the signalling pathway activated by DNA damage has to be maintained 
to keep cells in a senescent state, cellular senescence can be observed as a permanently 
maintained DNA damage response state (Saretzki, 2010). Therefore, H2A.X foci can 
be used as a marker for stress induced senescence. Thus antibodies against DNA 
damage foci components, such as H2A.X or 53BP1 can be used as a marker for 
senescent cells.  
 
1.21 Telomerase shuttling  
Extra-nuclear localisation of telomerase has been described by various groups (Santos et 
al., 2006; Ahmed et al., 2008; Haendeler et al., 2009, Indran et al., 2010). The hTERT 
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protein contains a nuclear and nucleolar localisation signal as well as a nuclear export 
signal (Santos et al., 2004, 2006). Telomerase can be found in the nucleolus (and there 
are clear functions described) and can be associated with the signalling protein 14-3-3 
and nuclear exportin CRM1 that are involved in the sub-cellular shuttling of several 
proteins (Seimiya et al., 2000; Wong et al., 2002; Zhang et al., 2003).  Endogenous 
TERT can be found in the nucleus and cytoplasm of mouse hippocampal neurons, 
human cells and mouse tissues (Fu et al., 2000, Haendeler et al., 2009). This data 
suggests that sub-cellular shuttling is not an artefact of forced hTERT expression. It 
occurs naturally within cells and is dynamically regulated. This shuttling process 
depends on various factors such as cell cycle phase, DNA damage and oxidative stress 
(Saretzki, 2009). 
 
1.22 Mitochondrial localisation of hTERT  
Since many proteins show a capacity to shuttle between the nucleus and mitochondria, 
different models have been used to determine telomerase function in different 
subcellular fractions including over-expression of a GFP/hTERT fusion protein in 
cancer cells or hTERT over-expression in normal and tumour cells.  Recent studies 
from four different groups have shown that hTERT can shuttle from the nucleus to the 
mitochondria upon oxidative stress and drug treatment (Santos et al., 2004, 2006; 
Ahmed et al., 2008; Haendeler et al., 2003, 2004, 2009; Indran et al., 2011).  Haendeler 
and colleagues found that hTERT is phosphorylated at tyrosine 707 in a Src kinase-
dependent manner and excluded from the nucleus after oxidative stress (Haendeler et 
al., 2003).  They also showed that nuclear export of endogenous hTERT occurs in 
endothelial cells approaching senescence due to increased oxidative stress, whereas 
treatment with antioxidants was able to reverse this process (Haendeler et al., 2004). 
Santos and co-workers have described a specific mitochondrial targeting signal (MTS) 
at the N-terminus of hTERT (Santos et al., 2004). The transportation of hTERT to the 
mitochondria seems to be an induced, directed and naturally occurring process.. Santos 
and colleagues reported that mitochondrially localised hTERT increased mitochondrial 
DNA damage and apoptosis after H2O2 treatment and suggested a potential role of iron 
metabolism (Santos et al., 2004). This result is different from the report of Ahmed and 
co-workers in 2008 that fibroblasts over-expressing hTERT do not maintain telomere 
length under oxidative stress but exclude hTERT from nucleus and protect 
mitochondria. The accumulation of TERT in mitochondria diminishes mitochondrial 
superoxide production and intracellular ROS under increased chronic oxidative stress 
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condition compared to parental fibroblasts under the same conditions. They also showed 
that hTERT over-expression in human fibroblasts protected mtDNA from DNA damage 
upon acute (H2O2 treatment) and chronic (hyperoxia) oxidative stress. The frequency of 
apoptosis after treatment with H2O2 and etoposide also was substantially lower in 
hTERT over-expressing cells compared to parental or vector-transfected fibroblasts. 
(Ahmed et al., 2008).  
 In 2009,  Haendeler and coworkers reported that TERT is transported into the 
mitochondrial matrix by using translocase of outer membrane (TOM) and translocase of 
inner membrane (TIM), binds to mitochondrial DNA coding regions for ND1 and ND2 
and increases complex I respiratory efficiency. They also showed that binding of TERT 
to the mitochondrial DNA can protect the mitochondria against ethidium bromide 
damage induction and increases overall respiratory chain activity which increases 
mitochondrial respiratory efficiency.  Moreover, inhibition of hTERT expression using 
siRNA in endothelial cells (Ahmed et al., 2008) and shRNA in HEK293 (Haendeler et 
al., 2009) also shows increase of oxidative stress. They also demonstrated that heart 
mitochondria from TERT knockout mice had a less efficient respiration in comparison 
to wild type mice. However, the same effect could not be shown in liver cells. At the 
same time they have demonstrated a positive correlation between mitochondrially 
localised hTERT and apoptosis resistance as well as an increase in mitochondrial ROS 
generation after hTERT ablation (Haendeler et al., 2009). In 2010, Indran and 
coworkers reported that hTERT is localised at the inner as well as outer mitochondrial 
membrane fraction in transient hTERT transfection of Hela cells. Hela cells transfected 
with a vector containing hTERT display a significant lower basal and mitochondrial 
ROS levels compare to wildtype Hela cells and Hela cells transfected with the control 
vector after H2O2 treatment.  siRNA-mediated gene silencing in transiently hTERT 
overexpressing Hela cells increased the level of ROS generation (Indran et al., 2010). 
Moreover, they also reported an enhancement of glutathione antioxidant defence 
capacity in Hela and hTERT overexpressing MRC5. hTERT overexpressing Hela 
showed inhibition of cytosolic acidification, blocking of mitochondrial translocation of 
Bax, the drop in transmembrane protential and the release of cytochrome C to the 
cytosol (Indran et al., 2011). Thus, from independent model systems, three independent 
groups have demonstrated a protective effect of hTERT to the mitochondria.  
Previously, Santos and colleagues had described a specific mitochondrial import 
sequence and reported that mitochondrially localised hTERT increased mitochondrial 
DNA damage and apoptosis after H2O2 treatment (Santos et al., 2004, 2006). However, 
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new results from her group demonstrate a protective function of hTERT to 
mitochondria. Kovalenko and colleagues reported that cell with mutated hTERT protein 
blocking the translocation of hTERT to mitochondria produce high levels of 
mitochondrial reactive oxygen species   (Kovalenko et al., 2010b). Sharma and co-
workers reported in 2011 that absence of hTERT from mitochondria resulted in 
increased ROS production, mtDNA damage, mitochondria distension and 
autophagosomes complex (Sharma et al., 2012). The new data from J. Santos’s group 
confirm the protective properties of telomerase in mitochondria found by others. 
Ahmed and co-workers reported that oxidative stress causes 80–90% of all hTERT to 
enter the mitochondria (Ahmed et al., 2008), with the remaining telomerase in the 
nucleus being unable to maintain telomere length under conditions of chronic hyperoxia 
(40% oxygen) (Ahmed et al., 2008). Furthermore, Haendeler and colleagues have 
analysed the distribution of telomerase activity in three cellular subfractions of HEK 
293 cells. They found that cells show around 60% of telomerase activity within the 
nucleus, 20% in the mitochondria and 20% in the remaining cytoplasm before oxidative 
stress (Haendeler et. al., 2009). Thus, localisation of hTERT in mitochondria is 
increased under cellular stress condition.   
G Saretzki’s group also showed that shifting of hTERT over-expressing cells back from 
hyperoxia to normoxia can reverse the nuclear exclusion of telomerase (Ahmed et al., 
2008). Interestingly, Santos’ group constructed a mutant hTERT with a disrupted 
nuclear export signal (NES) of hTERT which renders it nuclear and unable to shuttle to 
mitochondria. Transfected into primary human foreskin fibroblasts (NHF) these NES-
hTERT showed premature senescence and where refractory to immortalisation and that 
overexpression of this NES-hTERT protein in primary fibroblast was associated with 
telomere-based cellular senescence, multinucleated cells and the activation of DDR 
genes ATM, Chk2 and p53 (Kovalenko et al., 2010a). This localisation of a mutated 
hTERT protein in the nucleus increased DNA damage in both telomeric and extra-
telomeric sites. The mutated hTERT also impaired the mitochondria. Cells expressing 
this mutant protein produce high levels of mitochondrial reactive oxygen species   
(Kovalenko et al., 2010b). This observation corresponds well with the beneficial role of 
shuttling TERT to mitochondria as described by Ahmed (Ahmed et al., 2008) and 
Haendeler (Haendeler et al., 2009).  
Thus, the nuclear exclusion and shuttling capacity of hTERT to mitochondria could 
present an important physiological mechanism in human cells that are positive for 
telomerase such as lymphocytes, endothelial cells and stem cells. It could mean that 
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telomerase that protects telomeres under normal growth conditions shifts its protective 
function towards mitochondria under conditions of increased oxidative stress (Saretzki, 
2009).  
Nuclear exclusion might be a novel regulatory mechanism for mitochondrial protection 
of the telomerase catalytic subunit. There is data suggesting that the mitochondrial 
function might co-exist with the telomeric function and 20–30% of telomerase has been 
found outside the nucleus and partially within mitochondria already under normal basal 
conditions in various cell types (Ahmed et al., 2008; Haendeler et al., 2009; Indran et 
al., 2010).  
 
 
 
Figure 1.11  Schematic representation of known telomerase localisations and 
respective functions (Saretzki, 2009).  
 
Although telomerase requires both catalytic subunit and RNA component in telomere 
elongation, hTR is not present in mitochondria and mitochondrial hTERT can work 
independently from hTR (Maida et al., 2009, Sharma et al., 2011). This data might 
suggest the hypothesis of a protective effect of hTERT to the mitochondria 
independently of its RNA component. Whereas hTERT can bind to mitochondrial 
nucleic acid and mitochondrial tRNA (Sharma et al., 2011), it is not entirely clear via 
what mechanisms hTERT protects mitochondrial DNA. One possible mechanism could 
be the decrease of mitochondrial ROS generation by improved coupling or more 
effective respiration, direct binding to and protection of mtDNA, improved DNA repair 
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or an accelerated degradation of mitochondria harbouring damaged DNA (Saretzki, 
2009).  
The functions of telomerase in different subcellular location is summarised in Figure 
1.8.  The demonstration of telomere-independent function of telomerase in protection of 
mitochondria under stress condition describes a new function of telomerase independent 
of the canonical function on telomere maintenance. However, there are still many 
questions about what factors influence this telomere-independent function of 
telomerase.  
 
 
Aims   
 
The aims of this project were: 
Aim 1: Has mitochondrial localisation of telomerase effect on nuclear DNA 
damage? 
Previous experiments of our group have shown that mitochondria in hTERT over-
expressing fibroblasts seem to be better protected. hTERT is excluded from the nucleus 
and protects mitochondria under oxidative stress conditions (Ahmed et al., 2008). 
hTERT over-expressing fibroblasts showed lower production of oxidative stress, less 
mitochondrial DNA damage, less mitochondrial mass/mtDNA copy number and high 
mitochondrial membrane potential (Ahmed et al., 2008).  Moreover, mitochondrial ROS 
are also known to be responsible for nuclear DNA damage (Passos et al., 2010). 
Therefore the aim was to analyse whether ROS reduction due to mitochondrial hTERT 
localisation might also help to reduce DNA damage in the nucleus.  
However, general hTERT overexpression made it difficult to analyse where the protein 
is localised under specific conditions. To analyse whether there exists a direct 
correlation between physical location of hTERT in the mitochondria and its protective 
function, we used specific shooter vectors (Invitrogen) that deliver proteins specifically 
to various cellular locations. Various cell lines were transfected with hTERT-containing 
shooter vectors which include localisation signals specific for the mitochondria or the 
nucleus (further on called mitoTERT and nuclTERT). Cells were double stained with 
H2A.X and myc-tag. H2A.X was used because it is a sensitive marker for detecting 
DNA double-strand breaks (DSBs) in cells. DNA damage foci were compared under 
normal and stress condition between mitochondrial and nuclear TERT containing 
shooter vector. These experiments should uncover whether localisation of telomerase 
affects nuclear DNA damage after stress treatment. As stressors hydrogen peroxide and 
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x-irradiation were used. This experiment should also demonstrate whether 
mitochondrial localisation of hTERT alone is sufficient and necessary to protect nuclear 
DNA under normal and stress condition compared to the situation when only nuclear 
hTERT is present. 
 
 Aim 2: Is physical localisation of telomerase in mitochondria necessary and 
sufficient for decrease of mitochondrial superoxide after exogenous stress? 
The aim was to analyse whether the reason for the protection of nuclear DNA after 
exogenous stress is the localisation of telomerase in mitochondria. The same 
transfection of hTERT-expressing shooter vectors to the mitochondria and nucleus were 
performed in various cell types. Hydrogen peroxide and irradiation were used as an 
exogenous stress in this experiment. Cells transfected with mitoTERT and nuclTERT 
vectors were compared regarding their mitochondrial superoxide level under normal and 
exogenous stress conditions induced by hydrogen peroxide and x-irradiation. This 
experiment should show whether the reduction of mitochondrial superoxide by hTERT 
localisation in mitochondria would has a direct effect on the nuclear DNA protection by 
reducing the number of damage foci.  
 
Aim 3: Does p53 status influence the protective function of hTERT? 
For this aim we analysed whether there is an effect of p53 function on the protective 
function of the telomerase catalytic subunit. We hypothesised that function of p53 
protein might influence the protection of hTERT and might influence the level of 
nuclear hTERT exclusion. In order to achieve that an isogenic cell pair of glioblastoma 
cells were used to analyse whether the p53 status might play any role for the correlation 
between mitochondrial protection of hTERT and DNA damage. The glioblastoma cell 
line U87 which contains active wild type p53 was compared with a U87 clone (further 
called UP96) transfected with a mutated p53 allele (Saretzki et al., 1999). Again, the 
isogenic cell pair was transfected with mito-hTERT and nucl-hTERT vectors and 
treated with irradiation. Cells were double stained with H2A.X and myc-tag and their 
DNA damage foci under normal and exogenous stress condition will be compared for 
both cell lines. The mitochondrial superoxide levels were correlated to nuclear DNA 
damage. This experiment will show whether p53 status might have an effect to the 
protective function of hTERT. In addition, we analysed the co-localisation between 
hTERT and DNA damage for nucl-hTERT transfected U87 and UP96 cells using Telo-
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Fish. This experiment should clarify whether the sites of nuclear damage are different 
for cells with active or inactive p53.  
 
Aim 4: Is physical localisation of telomerase in mitochondria necessary and 
sufficient for decrease of mitochondrial superoxide and nuclear DNA damage after 
endogenously induced stress? 
The aim was to demonstrate whether the protective capacity of telomerase occurs not 
only after exogenous stress but also after endogenously generated oxidative stress. We 
used paraquat as an endogenous stress inducer to investigate the protective function of 
telomerase when it localises in the mitochondria. Paraquat is a chemical which can 
activate mitochondrial ROS production  by influencing  oxidative phosphorylation of 
mitochondria  by an impairment of mitochondrial complexes resulting in inhibition of 
electron transport with subsequent increased production of superoxide anions (Boelsterli 
and Lim, 2007). An isogenic cell pair (MRC-5 and MRC-5/hTERT) was used and cells 
transfected with mitoTERT and nuclTERT shooter vectors. Cells were double stained 
with H2A.X and myc-tag and their DNA damage foci correlated to mitochondrial 
superoxide level untreated and after paraquat treatment. This experiment should clarify 
whether the protective capacity of telomerase works not only after exogenous stress but 
also protects a cell from endogenous stress via reduction of mitochondrial superoxide 
level. 
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Chapter 2 
Materials and Methods 
 
2.1 Materials 
 
2.1.1 Cell lines 
MRC5 (Human embryonic lung fibroblast); ECACC (Salisbury,UK) 
hTERT overexpressing MRC5 (MRC5-hTERT); retroviral transfection of MRC-5 
fibroblasts with pLCP-hTERT (Clontech) (Ahmed et al., 2008) 
SV40-transformed MRC-5 (SV40-MRC5) American Type Culture Collection (ATCC), 
Rockville, MD  
Hela (human cervix adenocarcinoma); American Type Culture Collection (ATCC), 
Rockville, MD  
MCF7 (human breast adenocarcinoma); American Type Culture Collection (ATCC), 
Rockville, MD  
U87 (glioblastoma astrocytoma); American Type Culture Collection (ATCC), 
Rockville, MD  
UP96 (mutated p53-glioblastoma astrocytoma); Wtp53 U87 cells were transfected by 
electroporation with the vector pC53-SCX3 which expresses a p53 cDNA point-
mutated at codon 143 (resulting in alanine-valine substitution) under the control of the 
CMV promoter/enhancer (Saretzki et al., 1999). Transfected cells were selected using 
G-418 sulfate (Calbiochem) in a concentration of 500 g/ml. 
 
2.1.2 Antibody, restriction enzymes and molecular probes 
Primary antibodies       manufacturer/distributor 
Anti-Telomerase catalytic subunit (hTERT) (Rabbit)    Rockland 
Anti-Myc-Tag antibody (Mouse)      ABCAM 
Anti-Myc-Tag (Rabbit)           Cell Signaling 
Anti-Phospho-Histone H2A.X (mouse monoclonal IgG)   Invitrogen 
Anti-Histone H2A.X Antibody (Rabbit)          Cell Signaling 
Anti-COX II (Goat polyclonal)           Santa Cruz 
Anti-p53              Cell Signaling 
Anti-Phospho-p53 (Ser 15)           Cell Signaling 
Anti- Tubulin                  ABCAM 
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Secondary antibodies 
Alexa Fluor® 594 goat anti-mouse IgG (H+L) A-11005    Molecular probes/Invitrogen 
Alexa Fluor® 594 goat anti-rabbit IgG (H+L)A-11012      Molecular probes/Invitrogen 
Alexa Fluor® 488 goat anti-mouse IgG (H+L) A-11029    Molecular probes/Invitrogen 
Alexa Fluor® 488 goat anti-rabbit IgG (H+L) A-11008     Molecular probes/Invitrogen 
Alexa Fluor® 405 goat anti-mouse IgG (H+L) A-31553    Molecular probes/Invitrogen 
Alexa Fluor® 405 goat anti-rabbit IgG (H+L) A-31556     Molecular probes/Invitrogen 
Alexa Fluor® 488 donkey anti-goat IgG (H+L) A-11055  Molecular probes/Invitrogen 
Restriction enzymes for digest (HindIII and EcoRI)      Sigma-Aldrich 
 
Molecular probes 
MitoSOX™ Red mitochondrial superoxide indicator       Invitrogen 
Dihydrorhodamine 123 (DHR)       Invitrogen 
Cy-3-labelled telomere specific (C3TA3) 3        Panagene, Korea 
peptide nucleic acid (PNA) probe 
  
2.1.3 Buffers, Solution, Media  
30% Acrylamide/ Bis-Acrylamide 37.5:1 Severn Biotech LTD, UK 
BioRad Protein Assay Bio-Rad, Germany 
Blue/Orange Loading Dye (6x) Promega, UK 
Bovine serum albumin Sigma-Aldrich, Germany 
Crystal UV ploidy 
(DAPI solution) 
DMEM (Dulbecco’s  modified Eagle’s medium) 
DMEM with supplements 
 
 
DMSO 
ECL solution 
FBS, F9665, HYBI-MAX
®
 
Fish skin gelatin (G7765) 
G-418 sulfate  
Hybridisation buffer  
Partec GmbH, Germany 
 
PAA Laboratories GmbH, Austria 
DMEM supplemented with 10 % 
FCS (Sigma), 1 % L-Glutamine, 1 % 
Penicillin/ Streptomycin  
Sigma-Aldrich, Germany 
Amersham, UK 
Sigma-Aldrich, Germany 
Sigma-Aldrich, Germany 
Sigma-Aldrich, Germany 
PAA Laboratories GmbH, Austria 
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Hybridisation mix for Telomere-FISH      
 
 
 
 
 
Hydrogen Peroxide (H2O2) 
L-Glytamine 
Laemmli sample buffer (2x), 
Lysis Reagent (CHAPS buffer) 
 
Magnesiumchloride buffer pH7.0  
for Telomere-FISH       
 
MEM (Eagle’s minimal essential medium) 
Non-essential amino acid 100X  
2.5µl 1M Tris pH 7.2 (1mM), 21.4µl 
Magnesium chloride buffer, 175µl 
Formamide deionized, 5µl PNA 
probe (25µg/ml from Panagene, 
Korea), 12.5µl Blocking reagent 
(from Roche),  33.6µl Water 
Sigma-Aldrich, Germany 
PAA Laboratories GmbH, Austria 
Sigma-Aldrich, Germany 
Telo TAGGG Telomerase PCR Elisa 
Kit Roche, USA 
25mM Magnesiumchloride,  
9mM Citric acid,82mM Sodium  
hydrogen phosphate 
Gibco, Invitrogen, UK  
Gibco, Invitrogen, UK  
Penicillin-Streptomycin  100X Calbiochem 
Paraformaldehyde (PFA) Sigma-Aldrich, Germany 
PBS 10x                                            Gibco, Invitrogen, UK 
PBG 
 
PBG-triton 
  0.5 % BSA,  0.2 % fish skin 
gelatin(Sigma)  in PBS 
 0.5%BSA, 0.5% Triton X100, 0.2% 
Fish skin gelatin in PBS 
PFA (4%) 
Resolving buffer (4x) 
0.4g PFA, 10 ml 1x PBS 
0.4% SDS, 1.5 M Tris-HCl, pH 8.8 
Restriction enzymes Hind III and EcoR1 
Running buffer (10x) 
Sigma-Aldrich, Germany 
25 mM Tris, 192 mM glycine, 0.1 % 
SDS, pH 8.3 
SSC 
 
0.015 M Sodium Chloride,  
0.15 M Sodium Citrate  
TAE buffer (1x) for agarose gel running 0.04 M Tris acetate, 0.001 M EDTA, 
pH 8 
TBST (10x) 
 
TE buffer 
10 mM Tris, pH 7.5, 50 mM NaCl,  
0.1% Tween 20 
10 mM Tris-Cl, 50 mM Tris, 2.7 mM 
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 KCl, pH7 
Transfer buffer for Western-blotting (1x) 39 mM glycine, 20% methanol, 
 0.04% SDS, 480mM Tris base 
Trypsin  
Trypsin-EDTA  
 
Sigma-Aldrich, Germany 
 0.05% Trypsin, 0.02% EDTA (w/v) 
in water  
Wash buffer for telomere-FISH                     70ml Formamide (70%), 
                                                           1ml 1M Tris pH7.2 (10mM Tris), 
                                                           1ml BSA 10% (0,1% BSA), 
                                                           28ml water   
Western blot stripping Buffer    Pierce, USA 
 
2.1.4 Ready-to-use kits, standards  
100 bp DNA Ladder,      Invitrogen 
1 KDa DNA Ladder,      Invitrogen 
Rainbow molecular protein marker   Amersham 
EndoFree Plasmid Maxi Kit     Qiagen 
 
2.1.5 Plasmids  
Nuclear and mitochondrial shooter vectors were used in this experiment.  pShooter 
vectors containing hTERT were a kind gift from Dr. J Haendeler (University Düsseldorf 
Germany) and were constructed using pCDNA 3.1  (figure 2.2).  Invitrogen pShooter™ 
vectors containing GFP were used to verify the transfection conditions. These vectors 
are a family of vectors designed to express and target the recombinant protein to the 
desired intracellular location in mammalian cells. pShooter™ vectors are 5.5 kb 
expression vectors that express the recombinant protein as a fusion to a targeting 
sequence for the respective subcellular localisation and the c-myc epitope (Evan et al., 
1985). Fluorescence was used for GFP shooter vector. The plasmid carries protein 
sequences into a specific location of a cell upon ‘targeting sequences’ encoded within 
the sequence of a protein.  The presence of a nuclear localisation sequence from SV40 T 
antigen (Fisher-Fantuzzi and Vesco,1988) directs the protein to the nucleus, while the 
mitochondrial leader sequence isolated from subunitVIII of human cytochrome c 
oxidase (Rizzuto et al., 1992) which is removed upon translocation, directs proteins to 
the mitochondria. The mitochondrial targeting sequence (MTS) is localised at the N-
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terminus of hTERT sequence while the nuclear localisation sequence (NLS) is localised 
at the C-terminus of hTERT sequence.  
 
Table 2.1 Mitochondria and nucleus targeting signal of pShooter plasmid. 
Vector  design 
 
Location   Targeting Signal 
pCMV/myc/nuc 
(V82120 invitrogen) 
Nucleus DPKKKRKV 
 
pCMV/myc/mito 
(V82220 invitrogen) 
Mitochondria MSVLTPLLLRGLTGSARRLPVPRAKIHSL 
 
(Invitrogen, publish 09 May 2001, http://tools.invitrogen.com/content/sfs/manuals/ 
pshooter_pcmv_man.pdf ) 
 
The Invitrogen pShooter™ vectors containing GFP (figure 2.2) were also used as 
controls to exclude the effect of shooter vector transfection itself and prove the effect 
hTERT localisation in mitochondria to ROS level and nuclear DNA damage. 
 
 
 
 
Figure 2.1  pCMV/myc/mito/GFP and pCMV/myc/nuc/GFP maps (Invitrogen) 
(http://tools.invitrogen.com/content/sfs/manuals/ pshooter_pcmv_man.pdf )  
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Figure 2.2 Structure of pCMV/mito/TERT and pCMV/nuc/TERT vectors (gift 
from Dr. J Haendeler, University Düsseldorf, Germany) 
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2.1.6 Consumable items 
19 mm coverslips     VWR international, LLC, USA 
Cell culture flasks (75, 150 cm
2
)   IWAKI, Japan  
ECL
TM
 Hybond
TM
 membrane     Amersham, Pharmacia Biotech 
(PVDF membrane)    
 
 
2.1.7 Equipments 
BioRad Gel Doc2000     Bio Rad, Germany  
Fluoroskan Ascent FL     Thermo Labsystem, USA 
Ascent software 
Chemiluminescence detector system   Raytek Scientific Limited, UK  
Fluoroskan Ascent FL     Thermo Scientific  
LAS-3000       Intelligent dark box, Fujifilm 
       ImageReader LAS-3000,   
Lite Aida Image Reader Analyser 
4.13, Japan 
ND-1000 V3.2.1NanoDrop® ND-1000  ThermoFisher Scientific, USA 
UV-Vis Spectrophotometer  
Flow Cytometer     Partec GmbH, Germany 
Faxitron for X-irradiation  Faxitron MP1 (Qados, UK).,  
HEPA filtered steri-cycle carbon dioxide incubator  Thermo Forma, OH, USA  
Western Blot chambers and gel tanks   Bio-Rad, Germany 
Microscope Carl Zeiss Microscopy GmbH, 
Germany 
Zeiss Microscope AxioCam  Zeiss HRc, Carl Zeiss Micro 
Microscope GmbH, Germany 
Zeiss Microscope Axioplan    Zeiss Image Browser 
Carl Zeiss Microscopy GmbH, 
Germany 
Zeiss Microscope AxioImager Z1 Zeiss LSM, Axio Vision, Carl Zeiss 
Microscopy GmbH, Germany 
 
 
40 
2.1.8    Software  
ImageJ 1.46       ImageJ (version 1.41, freeware) 
Toronto Western Research 
Institute, Canada 
AxioVision V4.8.0.0   Zeiss LSM Image Browser, Carl 
Zeiss Microscopy GmbH, Germany 
FlowMax instrument software for FACS Partec GmbH, PAS, Muenster, 
Germany 
SIGMAPlot11 Systat Software Inc, USA  
 
 
2.2 Methods 
2.2.1 Cell culture 
All cells were stored frozen in FBS with 7% DMSO in liquid N2 and thawed prior to 
culture. Cells were cultured on 75 cm
2
 polystyrene tissue culture flasks with double 
sealed caps. Hela, MCF7, MRC5 and MRC5-hTERT were maintained in DMEM with 
high glucose and 1% L-glutamine further supplemented with 10 % FBS, 1% penicillin-
streptomycin. U87 and it’ isogenic clone UP96 were grown under MEM supplemented 
with 1% non-essential amino acid, 10% fetal calf serum, 1% glutamine, and 1% 
penicillin/streptomycin. Transfected UP96 cells were selected using G-418 sulfate  in a 
concentration of 500 g/ml. MRC5/ SV40 cells were maintained in DMEM with high 
glucose supplemented with 1% non-essential amino acid, 1% L-Glutamine, 10 % FBS 
and 1% penicillin-streptomycin. Tissue culture conditions were used as follows: at 
37
o
C, 5% CO2 in a HEPA filtered steri-cycle carbon dioxide incubator (Thermo Forma, 
OH, USA). Cells were subcultured at 85-90 % confluency and were frequently 
monitored for adherence, and signs of bacterial. All cells were tested for mycoplasma 
contamination regularly.  
To check the mycoplama contamination, cells were trypsinised and sub-cultured in a 12 
well plate overnight. Culture medium was discarded then cells were washed with PBS 
twice and fixed with 70% Ethanol, then incubated with DAPI for 5 minutes in the dark. 
DAPI solution was discarded and cells were washed with PBS  and then analysed using 
an inverse fluorescent microscope (Zeiss Microscope AxioCam, Germany).  
To subculture, cells were washed with 1X PBS and detached by adding 1X Trypsin–
EDTA (0.05% trypsin, 0.02%EDTA), 2ml for a 75 cm
2
 flask. Cells were incubated in 
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trypsin/EDTA at 37
o
C for one minute or less. Trypsinised cells were added to the 
regular medium to stop the action of trypsin. Cells were used for further experiments 
(seeding 1x10
6
 cells in 75 ml
2
 flask then sub-culture at 90% confluency) or stored in 
FBS with 7% DMSO, frozen down slowly in a Nalgene cryo-box in -80 overnight and 
then transferred to and kept under liquid N2. 
 
2.2.2 Cellular transfection: Lipofectamine 
TM
 2000 
Preparation for lipofectamine transfection: one day before transfection 0.5-2 x 10
5
 cells 
were plated to a well of a 12-well plate (with or without a coverslip) in 1 ml of regular 
DMEM medium.  Cells were cultured to be 90-95% confluent at the time of 
transfection. For a 6-well plate, 0.5-2 x 10
5
 cells were plated in 2 ml of regular DMEM 
medium.  
On the day of transfection plasmid-Lipofectamine 2000 complexes were freshly 
prepared. For a 12-well plate, 1.6 μg of plasmid was diluted in 100 μl of Opti-MEM® I 
reduced serum medium, mixed gently and incubated for 5 minutes at room temperature.  
After the 5 minute incubation, diluted plasmids were combined with the diluted 
lipofectamine 2000 (total volume was 200 μl for 12-well plate and 500 l for 6-well 
plate). All solutions were mixed gently and incubated for 20 minutes at room 
temperature to allow the DNA-lipofectamine 2000 complexes to form.  
DNA-lipofectamine complexes were added of to each well containing cells and 
medium. They were mixed gently by rocking the plate back and forth. 
Transfected cells were incubated at 37°C in a CO2 incubator for 48 hours before 
assayed for transgene expression as shown in 2.2.7-2.2.10.  
 
2.2.3 Restriction of pCMV-TERT shooter vectors 
Both mito-hTERT and nucl-hTERT were amplified in E. Coli, extracted and restricted 
as showed in figure 2.3.  1 g from each vector was mixed with 1 unit HindIII and 
incubated at 37°C for 30 minutes.  Then 2 units EcoRI were added to the mixture and 
continued  to be incubated at 37°C for 30 minutes. The restriction reaction was stopped 
by adding 0.5 M EDTA pH8 for the final concentration of 10 mM. All restricted shooter 
vectors were analysed by agarose gel electrophoresis to confirm the right size of the 
hTERT insert on the shooter vector in our plasmid preparation as shown in figure 2.3.    
The expected size of mito-hTERT is 8.92 Kb, nucl-hTERT is 8.93 Kb and   pCDNA 3.1 
is 5.44 Kb. Bands in the first and third lane showed 3 forms of DNA conformation 
which is expected as linear, circular and supercoiled plasmid DNA forms.  The 
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restriction with HindIII and EcoRI restriction enzymes is shown  in lanes 2 and 4 (fig. 
2.3) which showed the expected hTERT fragment size (3.405 Kb) and pCDNA 3.1 size 
(5.44 Kb). Results from HindIII and EcoRI restriction were compared with the 
restrictions of controls (original plasmid stock from Dr. J Haendeler (University 
Düsseldorf Germany) 
 
 
Figure 2.3 Restriction of pCMV-TERT shooter by HindIII and EcoRI pCMV 
MitoTERT (8.92 Kb) and pCMV NuclTERT (8.93 Kb) were cut by HindIII and EcoRI 
restriction enzyme compared with pCDNA 3.1 (5.44 Kb). Expected hTERT sized is 
3.405 Kb. 1 is pmito-hTERT shooter, 2 is pmito-hTERT shooter restricted by HindIII 
and EcoRI, 3 is pNUC-TERT shooter, 4 is  pNUC-TERT shooter restricted by HindIII 
and EcoRI, 5 is pCDNA3.1, 6 is p CDNA 3.1 restricted by HindIII, 7 is pmito-hTERT 
shooter original stock, 8 is a original stock pmito-hTERT shooter restricted by HindIII 
and EcoRI, 9 is pNUC-TERT shooter original stock and 10 is original stock pNUC-
TERT shooter restricted by HindIII and EcoRI.  
 
2.2.4 Oxidative treatment: hydrogen peroxide treatment (H2O2) 
Cells which were incubated at 37°C in a CO2 incubator were washed with serum-free 
culture medium, then treated as required (1 or 3 hours) at 37°C with the required 
concentration of H2O2 (100, 200, 400 or 500 M) prepared in serum free medium 
freshly from a stock solution (8.4M). After the treatment cells were washed with regular 
(FCS containing) culture medium and continued to culture for 24 hours. The reason for 
this incubation period was to avoid the direct effect of hydrogen peroxide treatment to 
influence the endogenous ROS measurement. After 24 hours, cells were washed twice 
with PBS and fixed with paraformaldehyde (4% PFA in PBS) for 10 minutes at room 
temperature. Paraformaldehyde was removed and cells were dried 3 min and then 
frozen at -80°C or immediately used for further experiments.  
 
2.2.5 X-Irradiation treatment  
X-irradiation was chosen as a second, independent damage treatment and to avoid the 
delay between H2O2 treatment and analysis of ROS using mitoSox staining and 
microscopy. Cells were incubated at 37°C in a CO2 incubator on cover slips in 12 well 
1 Kb ladder       1              2              3              4             5              6              7             8              9               10 
3 Kb 
1.5 Kb 
5 Kb 
7 Kb 
9 Kb 
43 
plates and exposed to the x-ray at the required doses (1,2,5 10 or 20 Gy). Immediately 
after the treatment, cells were washed with regular culture medium and rewashed with 
PBS. Cells were fixed with paraformaldehyde (4% PFA in PBS) for 10 minutes at room 
temperature. Paraformaldehyde was removed, cells were dried for 3 min and frozen at -
80°C or continued with for immune-fluorescence (IF) staining.  
 
2.2.6 Paraquat (PQ
2+
) treatment  
Two days after transfection cells which were incubated at 37°C in a CO2 incubator were 
washed with serum-free culture medium and treated with 400 M paraquat. Cells were 
kept with paraquat for different time periods (1-24h). After the end of the treatment (1-
24h), cells were washed with 1X PBS and fixed with paraformaldehyde (4% PFA in 
PBS) for 10 minutes at room temperature. Paraformaldehyde was removed and cells 
were frozen at -80°C or used immediately for IF staining. 
 
2.2.7 Staining of mitochondrial superoxide with mitoSOX
TM
 
For staining of mitochondrial superoxide in non-fixed cells: cells were grown on 19 mm 
circular cover slips in 12-well plates. After aspirating the medium, cells were washed 
twice with serum free medium and incubated with 5 μM mitoSox diluted in serum free 
medium. Cells were kept under 37°C and protected from light for 15 min. After 
aspiration, cells were washed twice with PBS then fixed with 1 ml 4 % PFA in PBS for 
10 min. During this step, cells were protected from light by covering with aluminium 
foil. Cells were either immediately stained or frozen at -80 ºC until required.  
 
2.2.8 Quantification of mitochondrial superoxide  
Fluorescence images were obtained using a fluorescence microscope and digital 
imaging software (AxioVision 4.8.0.0). Filters used were DAPI (emission filter 
wavelength: 345nm, excitation filter wavelength: 458nm), Texas Red (emission filter 
wavelength: 620 nm, excitation filter wavelength: 595 nm) and FITC (emission filter 
wavelength: 520 nm, excitation filter wavelength: 495) at 40X and 63X magnifications. 
For each individual experiment, at least twenty random fields were chosen. Experiments 
were repeated 3 times. The levels of mitoSox were manually quantified. 
For cytoplasmic ROS, the mitoSox signal was quantified by JAVA-based image 
processing software (Image J version 1.46, Wright Cell Imaging Facility, Toronto 
Western Research Institute, Toronto, ON, Canada, http://rsbweb.nih.gov/ij/).  Digital 
images were set into 8 bit black and white type and adjust for the clear expression of 
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ROS level. This thresholds setting was constant for the whole analysis. The cytoplasmic 
area was determined using the freehand selection function. Expression signals in the 
selected areas were evaluated using the area calculation function.  ROS levels based on 
mitoSox measurement were calculated as: 
 
The percentage of the red pixel (ROS signal) in the cytoplasmic area per total pixel 
(total cytoplasmic area) was used to discard the variation of cell size. ROS signal was 
calculated in each individual cell. Then the average percentage of at least 30 individual 
cells was taken to determine the average percentage of one experiment. ROS level of 
the population was an average from three independent experiments. 
 
2.2.9 Immunofluorescence – single staining 
Cells were grown on 19 mm circular cover slips in 12-well plates. After aspirating the 
medium, all cover slips were washed twice with PBS and fixed with 4 % PFA.  
After fixation or thawing, the washing step was repeated. Permeablising of the cells was 
carried out with 1 ml PBG-Triton for 45 minutes with slight shaking at room 
temperature. Then, 400 µl of the diluted primary antibody in PBG was applied to the 
cells. The plate was slightly shaken for one hour at room temperature. After washing 
three times with PBG for five minutes, cells were incubated with the second antibody 
(Alexa Fluor
® 
594 or 488, 1:2000 in PBG) for one hour at room temperature. After 
aspiration of the second antibody, cells were washed three times with PBS and nuclear 
staining was carried out with 400 µl of DAPI solution for 10 minutes. Afterwards, the 
washing step was repeated three times before mounting cells on slides using an anti-
fade mounting medium. Slides were sealed with nail polish and examined using a 
fluorescence microscope. 
 
2.2.10 Immunofluorescence - double staining 
After fixation or thawing, cells were washed twice with PBS and then permeablised in 
1 ml PBG-triton as for the single staining. Cells were slightly shaken at room 
temperature for 45 minutes. Then, 400 µl of the diluted first primary antibody in PBG 
was applied to the cells. The plate was slightly shaken for one hour at room 
temperature. After washing two times with PBG for five minutes, cells were incubated 
with the first secondary antibody (Alexa Fluor
® 
594 or 488, 1:2000 in PBG) for one 
hour at room temperature. After this step, cover slips were protected from light by 
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covering with aluminium foil. After aspiration of the first secondary antibody, cells 
were washed twice in PBG and then incubated with the second primary antibody for 
one hour under room temperature or overnight under 4°C. The plate was slightly shaken 
to circulate the antibody around the cover slip. Cells were washed again two times with 
1 ml PBG before incubation with the second secondary antibody (Alexa Fluor
®
, 1:2000 
in PBG) for one hour. Cells were washed three times with PBS before staining the 
nuclei with 400 µl of DAPI solution for 10 minutes. Afterwards, the washing step was 
repeated three times before mounting cells on slides using an anti-fade mounting 
medium. Slides were sealed with nail polish and examined using a fluorescence 
microscope 
 
Table 2.2 Antibody concentration used for single and double staining 
Antibody Used Concentration 
Anti-Telomerase catalytic subunit 
(hTERT)  
1:2000 
Anti-Myc-Tag antibody (ab9106) 
(Mouse)(ABCAM
®
) 
1:2000 
Anti-Myc-Tag (71D10) Rabbit mAb 
#2278 (Cell Signaling) 
1:2000 
Anti-Phospho-Histone H2A.X  1:1000 
Anti-Histone H2A.X Antibody  1:500 
anti- COX II  1:100 
Alexa Fluor® 594 goat anti-mouse IgG  1:4000 (Single staining) 
1:2000 (double staining) 
Alexa Fluor® 594 goat anti-rabbit IgG  1:4000 (Single staining) 
1:2000 (double staining) 
Alexa Fluor® 488 goat anti-mouse IgG  1:4000 (Single staining) 
1:2000 (double staining) 
Alexa Fluor® 488 goat anti-rabbit IgG  1:4000 (Single staining) 
1:2000 (double staining) 
Alexa Fluor® 405 goat anti-mouse IgG  1:4000 (Single staining) 
1:2000 (double staining) 
Alexa Fluor® 405 goat anti-rabbit IgG  1:4000 (Single staining) 
1:2000 (double staining) 
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2.2.11 Measurement of TERT exclusion rate 
For each individual cell, hTERT localisation was manually quantified by determining 
the hTERT signals inside and outside the nucleus using Image J (version 1.46, 
http://rsbweb.nih.gov/ij/). Subcellular areas were determined for nuclear and cytosolic 
regions by using freehand selection. Expression signals in the selected area were 
evaluated using area calculation function after thresholding to remove noise. Total 
hTERT signal in each individual cell means hTERT signal in nucleus area plus hTERT 
signal in cytoplasmic area of that cell. The result of each individual cell indicated a 
percentage of hTERT signal expressed in the subcellular compartment:   
 
The average percentage of nuclear and cytoplasmic localisation of hTERT from at least 
30 individual cells was taken to determine the average percentage of the subcellular 
distribution of TERT per condition (treatment and transfection). Average values from 3 
independent experiments were used to determine the distribution of hTERT in 
subcellular compartment of the whole population.   
 
2.2.12 Analysis of DNA damage  
Analysis of DNA damage response was performed using immuno-fluorescence either as 
a single staining with -H2A.X antibody or double staining of -H2A.X antibody with 
hTERT antibody. Cells were fixed, permeabilised and stained with a -H2A.X antibody 
as described before. Slides were examined using a Fluorescence microscope (Axio-Plan 
HRc and Axio-Imager Z1) and digital imaging software (AxioVision 4.8.0.0) as before.  
The number  of DNA damage foci for each individual cells was counted. The result 
from 20-40 cells per group was taken to determine the average percentage of the whole 
population.   
 
2.2.13 Determination of protein content: Bradford Assay  
A Bradford assay was performed to determine the protein concentration of the Western 
blot samples. First, cell pellets that had to be analysed were lysed with lysis buffer 
containing a mild detergent (3-[(3-Cholamidopropyl) dimethylammonio]-1-
propanesulfonate, CHAPS) on ice for 30 min. A standard curve was created with 0 to 
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5 μl of 1.4 mg/ml protein (BSA) in 800 μl of sterile water and 200 μl protein assay 
solution. Absorbance was measured at 595 nm using a fluorescence imager (Fluoroskan 
Ascent FL). 
 
2.2.14 Westernblot analysis 
30-50 μg of protein were loaded for each sample. Samples were prepared for Western 
blotting by adding equal volume of 2x Laemmli (1x final concentration). After heating 
samples to 95°C for 5 min, they were shocked on ice. Protein samples and rainbow 
molecular marker were separated on 8% SDS-polyacrylamide gels and transferred to 
PVDF membranes at 300 mV for 90 min at 4 °C. Membranes were washed in 1x TBST 
and blocked in 1x TBST plus 5% skimmed milk for 1 h at room temperature. 
Membranes were incubated overnight on a shaker at 4 °C with one of the primary 
antibodies (see table 2.3). Membranes were washed with 1x TBST and incubated with 
the specific peroxidise labelled secondary antibody (see table 2.4) for 1 hour at room 
temperature. After washing with 1x TBST, membranes were developed with ECL 
solution. The blots were exposed using the chemiluminescence software LAS 3000 of a 
chemiluminescence detector. Western Blot Stripping buffer (Thermo Scientific, USA) 
was used for stripping the membranes at 37 °C for 1 h. Membrane was re-probing with 
tubulin as a loading control. Membranes were washed in 1x TBST and blocked in 1x 
TBST plus 5% skimmed milk for 30 minutes at room temperature. Membranes were 
incubated 1 hour on a shaker at room temperature with tubulin antibody. Membranes 
were washed with 1x TBST and incubated with the secondary antibody for 1 hour at 
room temperature. After washing with 1x TBST, membranes were developed with ECL 
solution. The blots were exposed using the chemiluminescence software LAS 3000 of a 
chemiluminescence detector. 
 
Table 2.3 Primary antibodies for western blot analysis 
 
Primary Antibodies Used Concentration 
Anti-p53   (Cell Signalling Tech
®
,USA) 1:1000 
Anti-Phospho p53    
(Cell Signalling Tech
®
,USA) 
1:1000 
hTERT    (Rockland, USA) 1:500 
Anti--tubulin  (ABCam, UK) 1:2000 
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Table 2.4 Secondary Antibodies for western blot analysis 
 
Secondary antibodies Used Concentration 
hRP labelled goat anti rabbit  
(ABCam,UK) 
1:5000 
hRP labelled donkey anti rabbit  
(ABCam,UK)  
1:5000 
 
 
2.2.15 Antibody specificity 
The hTERT antibody (Rockland, USA) was tested for its specificity using Western 
blotting.  Hela, MCF7, A549 as well as MRC5 (negative control) and TERT- 
overexpressing  MRC5 (positive control) were used in this experiment. Results in figure 
3.5 show that the hTERT antibody detects a specific band at the right molecular weight 
(127 kD) which is not present in MRC5 fibroblast which don’t have any endogenous 
telomerase/TERT expression. These results correspond to those from Wu et al, (2006). 
 
Figure 2.4 Western blot analysis of cells using hTERT antibody and -tubulin. 
TERT are hTERT-overexpressing fibroblast (Positive control), A549 is a lung 
adenocarcinoma cell line, MCF7 is a human breast adenocarcinoma cell line, Hela are 
human cervical cancer cells, MRC5 are human embryonic lung fibroblasts (Negative 
control)  
 
 
2.2.16 Cellular peroxide measuring: dihydrorhodamine123 (DHR) 
Cellular peroxide level were evaluated using dihydrorhodamine123 (DHR). Cells were 
washed with 1xPBS, trypsinised and the reaction stopped with serum containing 
DMEM.  Cells were counted and centrifuged at 1800 rpm for 3 minutes at room 
temperature. Typically, 2x10
5
 cells were used per reaction.  The supernatant was 
removed by aspiration. 15l of 10mM DHR stock solution was added to 5 ml serum 
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containing DMEM, then the cell pellet was re-suspended with this 30M solution. Cells 
were incubated at 37
0
C for 30 minutes in the absence of light and centrifuged at 1800 
rpm for 3 minutes. After removing the supernatant the pellet was re-suspended in 3 ml 
of serum containing DMEM and analysed by flow cytometry.  
 
2.2.17 ROS measurement  with mitoSOX  
Mitochondrial ROS levels were evaluated using mitoSOX staining. After trypsinisation, 
cells were counted and centrifuged at 1800 rpm for 3 minutes at room temperature. The 
supernatant was removed by aspiration. Typically, 2x10
5
 cells were used per reaction. 
Cells were stained with 200 l of 5M of mitoSox for 15 min at 37 C in the absence of 
light.  After incubation, cells were centrifuged at 1800 rpm for 3 min and the 
supernatant was discarded. Cells were then resuspended in 3 ml of DMEM without 
serum and analysed by flow cytometry. 
  
2.2.18 Flow cytometry  
To evaluate the oxidative stress, free radical generation was monitored using 
dihydrorhodamine 123 (DHR) and mitoSOX staining. Cells were stained as described in 
2.2.16 and 2.2.17. Before each analysis, the flow cytometry (Partec GmbH, Germany) 
was calibrated in order to ensure accuracy and reliability by using Partec 3 M 
calibration beads (Partec). These beads are fluorescence stained and allow the 
calibration of laser, optics and stream flow. The gains for FL1 were set to 100 and those 
for FL3 to 180 in order to make different measurements comparable to each other. 
Cell populations were defined using forward and sideway scatter. Fluorescence 
channels were FL1 (green) and FL3 (red). Cells were gated in FSC/SSC, and the 
median of the gated FL1 and FL3 fluorescence peak for DHR analysis or FL3 peak for 
mitoSox analysis was used as estimates of the peroxide or mitochondrial superoxide 
concentration, respectively. All analyses were repeated at least three times. Unstained 
cells were used in order to subtract the background in the FL3 channel. At the end of 
each use the flow cytometer was cleaned with 2ml of 1% Triton X-100 and followed by 
2 ml of PBS and 2ml of water passed through the flow chamber.  
 
2.2.19 Immuno-FISH 
Immuno-FISH is a technique of fluorescence in situ hybridisation (FISH) coupled with 
an immuno-fluorescence staining. In our experiment, the detection of DNA damage 
(H2A.x) was combined with the detection of telomeres (FISH) using a telomere 
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specific peptide nucleic acid probe. Fluorescence in situ hybridisation (FISH) is a 
method of molecular cytogenetics to use fluorescent probes to detect specific sequences 
of DNA on chromosomes. FISH was carried out using a Cy-3-labelled telomere specific 
(C3TA3) 3 peptide nucleic acid (PNA) probe (Panagene, Korea). To detect the 
colocalisation between H2A.x foci with telomeres, cells were grown on 19 mm circular 
cover slips in 12-well plates. After experimental treatment procedures, all cover slips 
were washed twice with PBS and fixed with 1 ml 4 % PFA in PBS for 10 min. PFA was 
removed and cells were immediately stained. 
Before starting the staining step, cells were washed twice with PBS and then 
permeablised using 1 ml PBG-Triton for 45 minutes. The plate was slightly shaken at 
room temperature. 400 µl of the diluted H2A.x antibody in PBG was applied to the 
cover slip. The plate was slightly shaken for one hour at room temperature. After 
washing three times with PBG for five minutes cells were incubated with the second 
antibody (Alexa Fluor
®
, 1:2000 in PBG) for one hour at room temperature. After 
aspiration of the second antibody cells were washed 10 minutes three times with PBS 
and incubated with 1.3ml of fixative solution (methanol: acetic acid 3:1) for 1 hour. 
Cells were dehydrated for 2 minutes with cold ethanol solution from 70% followed with 
90% and 100% ,respectivey.  Then the cover slip was left to dry. The cover slip was 
immersed into PBS at 37
o
C for 5 minutes then denature the chromosome inside the cells 
by incubate coverslip under 4%paraformaldehyde in PBS at 37
 o
C for 2 minutes. Cells 
were dehydrated again with cold ethanol solution from 70% follow with  90% and 
100%, respectively. Then all cells was left to dry again.  
To start the hybridisation, 10µl of hybridisation mix (described in 2.1.3) was applied 
onto a clean glass slide. The cover slip was flipped onto the hybridisation solution. Air 
bubbles were pressed out to make sure that all cells were immersed into the solution.  
Following this step, cells were protected from light.  
Cells were denatured at 80°C by place the slide on the hot stainless plate leaving in the 
hot air incubator for 3 minutes, then incubated the slide in the humid chamber for 2 
hours. Cells were washed 10 miuntes three times in wash buffer (70ml Formamide 
(70%), 1ml 1M Tris pH7.2 (10mM Tris), 1ml BSA 10% (0,1% BSA) and                                                         
28ml water) and followed with washes for 5 minutes three times in TBS-Tween 0.05%. 
Cells were dehydrated again with cold ethanol solution from 70% follow with  90% and 
100%, as previously. After the cover slips were air dried, cells were washed with PBS 
for three times and nuclear staining was carried out with 400 µl of DAPI solution for 10 
minutes. Afterwards, the washing step was repeated three times before mounting the 
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cover slips on slides using an anti-fade mounting medium (vecta-shield). Slides were 
sealed with nail polish and examined using a fluorescence microscope.  
 
2.2.20 Co-localisation analysis 
After performing the immuno-FISH staining, Z-stack pictures of the stained cell were 
taken using a Leica DM5500B microscope. Co-localisation between H2A.X and PNA 
probe was analysed using Image J 1.46. Pictures in channel of the PNA probe (red 
colour as shown in 5.14B, Chapter 5) and H2A.X (green colour as shown in 5.14C, 
Chapter 5) were adjusted for the best contrast and the two channels were merged. The 
co-localisation between PNA probe and H2A.X (appeared as yellow colour as shown 
in 5.14D, Chapter 5) were counted manually in each z-stack. Every stack in the whole 
cell was analysed. At least 10 cells per group were analysed and summarised as an 
average of the number of foci per population and %TAF (percentage of H2A.X foci 
colocalising with telomere) per cell.     
 
2.2.21 Statistical Analysis  
Statistical analysis was performed to elucidate the significance between different values. 
Anova-single factor analysis was performed using Microsoft Excel, 2007, Microsoft 
Excel, 2010 and One-way ANOVA was performed using SIGMA Plot 11 (Systat 
Software Inc, USA).  
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Chapter 3 
Mitochondrial localisation of telomerase protect against nuclear DNA 
damage after exogenous stress 
 
 
3.1 Introduction  
In recent years, evidence suggests that telomerase, and particularly its catalytic subunit 
TERT, has additional physiological functions. TERT has been shown to play a role in 
chromatin remodelling and DNA damage response (Sharma et al., 2003, Masutomi et 
al, 2005, Park et al., 2009a). In mammals, cellular responses to DNA damage are 
mediated by various protein kinases including ATM (ataxia telangiectasia mutated) and 
ATR (ATM and Rad3-related) (Ljungman, 2010). Masutomi and colleagues reported 
that transient expression of hTERT in normal fibroblast modulates DNA damage 
response (DDR).  Moreover, fibroblasts with stably suppressed hTERT function by 
RNA interference or catalytic inhibition exhibited a lack of induction of ATM and 
H2A.X phosphorylation after irradiation, irionotecan or etoposide treatment (Masutomi 
et al, 2005). Nitta and colleagues confirmed an interaction between TERT and ATM in 
mouse hematopoietic stem cells (Nitta et al., 2011). ATM and TERT double deficient 
mice expressed an increase in ageing progression and had shorter lifespan compared to 
ATM-null or TERT-null mice alone.  
Reactive Oxygen Species (ROS, also called free radicals or oxygen radicals) are known 
to be one of the factors responsible for nuclear DNA damage (Passos et al., 2010). ROS 
are highly reactive small molecules containing unpaired electrons. These molecules can 
react with several organic molecules and can cause considerable damage and impair 
normal cellular function (Finkel and Holbrook 2000; Kirkinezos and Moraes 2001).  
ROS can damage nucleotides by generating adduct bases and sugar groups, single- and 
double-strand breaks in the nucleotide backbone, or cross-linking to other molecules. 
These altered nucleotides can eventually lead to mutation, DNA rearrangements or 
problems during transcription (Beckman and Ames 1998). Moreover, it is also 
important to point out that telomere dependent replicative senescence is also influenced 
by cellular stress since telomere attrition is also affected by the level of oxidative stress 
in the cell (von Zglinicki et al., 1995). Thus, reduction of ROS production might help to 
prevent DNA damage.  
Previous experiments of our group have shown that mitochondria, a major source of 
intracellular ROS generation, in hTERT over-expressing fibroblasts seem to be better 
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protected. hTERT is excluded from the nucleus and protects mitochondria under 
oxidative stress conditions (Ahmed et al., 2008). These hTERT over-expressing 
fibroblasts show lower production of oxidative stress, less mitochondrial DNA damage, 
less mitochondrial mass, less mtDNA copy number and high mitochondrial membrane 
potential. This lower ROS production might be a major reason for the protection of 
mitochondria.  
Specific aim of this chapter: To analyse whether mitochondrial localisation of TERT 
reduces DNA damage in the nucleus. First we investigate the effect of different 
subcellular shuttling of endogenous hTERT to the nuclear DNA damage under 
oxidative stress condition. Then we investigate different kinetic exclusion of 
endogenous hTERT compared between three different cell lines. To distinguish the 
exact effect of hTERT in a specific subcellular location with nuclear DNA damage, we 
used specific shooter vectors that deliver proteins specifically to various cellular 
locations. Cells were transfected with hTERT-containing shooter vectors as described in 
Chapter 2. These hTERT-containing shooter vectors include the localisation signals 
specific for the mitochondria or nucleus (further on called mito-hTERT and nucl-
hTERT).  Different cell lines were double stained with H2A.X and myc-tag fused to 
TERT protein. H2A.X was used because it is a sensitive target for detecting DNA 
double-strand breaks (DSBs) in cells and myc-tag was used to identify our exogenous 
hTERT expression. DNA damage foci were compared under normal condition and two 
exogenous stress treatments (hydrogen peroxide and irradiation). This experiment 
should show whether the reduction of mitochondrial superoxide by hTERT localisation 
in mitochondria has an indirect effect on the nuclear DNA protection by reducing the 
number of nuclear DNA damage foci.  
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3.2 Experimental procedure  
3.2.1 Correlation between cellular TERT localisation and DNA damage level  
Hela, MCF7, MRC5-hTERT and MRC5/SV40 cells have been used in this experiment. 
Subcellular shuttling of endogenous hTERT and DNA damage level of Hela, MCF7 and 
MRC5-hTERT has been investigated after treatment with 400μM hydrogen peroxide for 
3 hours. The experiments on Hela and MCF-7 were performed by a master’s student 
(Deepali Pal) while the second experiment on MCF7 and 3 independent experiments on 
MRC-hTERT cell line have been done by me. The localisation of hTERT in subcellular 
compartments has been quantified. We have classified the localisation of hTERT into 3 
categories: nuclear TERT, cytoplasmic TERT and intermediate localisation. Nuclear 
TERT was the group which showed 75%-100% of TERT signal resides within the 
nucleus, cytoplasmic TERT was the group which showed 75%-100% of TERT signal 
resides outside the nucleus and all other percentages for the class of intermediate 
localisation. For each of the 3 classes we determined the number of H2A.X foci from 
at least 30 cells per cell line per experiment. 
 
3.2.2 hTERT specific shooter vector and cellular transfection 
Hela, MCF7, MRC5, U87 and MRC5/SV40 have been used in to investigate the effect 
of specifically localised exogenous hTERT. To evaluate the transfection efficiency, 
Hela, MCF7, MRC5/SV40 and MRC5 have been transfected with specific nuclear and 
mitochondrial pShooter plasmids. The plasmid structure was described in Chapter 2. 
Initially, we intended to use MRC5 fibroblast as a model to avoid the effect of 
endogenous telomerase interfering with the result. pShooter were transfected to Hela, 
MCF7 and MRC5/SV40 by lipofectamine
TM
 2000 and transfection attempted with 
Fugene
R
 HD and lipofectamine
TM
 2000 in MRC5. Transfection efficiency of Hela was 
about 25% for mitochondrial transfection and 31% for nuclear transfection. The 
transfection efficiency of MCF7 was 20% for mitochondrial transfection and 18% for 
nuclear transfection.  Transfection efficiency for MRC5/SV40 cells was about 30%. 
However, very rare transfected MRC5 cells were detected although the experiment had 
been repeated and although we modified the transfection protocol. MRC5 transfection 
still showed a very low transfection rate. Consequently, we continued to use only Hela, 
MCF7 and U87 and use MRC5/SV40 for a model without endogenous telomerase. 
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Figure 3.1 Transfection efficiencies of mito-hTERT and nucl-hTERT into Hela, 
MCF7, MRC5 and MRC5/SV40. pShooter were transfected to Hela, MCF7 and 
MRC5/SV40 by lipofectamine
TM
 2000 and tested with Fugene
R
 HD and 
lipofectamine
TM
 2000 in MRC5. 2 days after transfection, all cells were fixed and the 
transfection efficiency was determined using Immuno-fluorescence. Cells were stained 
with primary antibody against the myc-tag (1:500) and visualised using a fluorescence 
labelled secondary antibody alexa
®
 fluor (Invitrogen). 
 
 
3.3 Results 
3.3.1 Different localisation of endogenous telomerase after stress treatment 
(H2O2) affects nuclear DNA damage 
To investigate whether the localisation of hTERT affects nuclear DNA damage, first we 
investigated the sub-cellular shuttling of hTERT protein as shown in figure 3.2-3.4. 
These experiments on Hela and MCF-7 were performed by a master’s student (Deepali 
Pal) while I repeated the MCF7 experiment and 3 independent experiments on the 
MRC5-hTERT cell line.  Figure 3.2 shows   the comparison between fractions of cells 
which represent different hTERT localisations after 3 hours of H2O2 treatment.  Hela 
and MCF7 were combined as a group of cancer cells. There was a clear heterogeneity 
for nuclear TERT exclusion between cells in each cell type. In cancer cells, there seems 
to be no difference in frequency between the nucleus, intermediate and cytoplasm 
groups; each of those contained around 30% of cells. However, MRC5-hTERT showed 
a significant higher amount of the localisation of hTERT in cytoplasm and seems lower 
in the intermediate group compared to the cancer cells after 3 hours of treatment. Thus, 
it seems that endogenous hTERT was excluded from nucleus to cytoplasm faster in 
MRC5-hTERT under oxidative stress treatment compared to the cancer cells. 
Intriguingly, when we correlated the localisation of hTERT with the number of DNA 
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damage foci, the  cytoplasmic localisation of hTERT correlated to no or a very low 
nuclear DNA damage while nuclear TERT localisation results in high nuclear damage 
as shown in figure 3.3-3.4.  
 
 
 
Figure 3.2 Comparison between fractions of cells which represent different hTERT 
localisations after 3 h of H2O2 treatment of cells. Hela and MCF7 were combined as a 
group of cancer cells since they were very similar to each other and compared to 
MRC5-hTERT which is hTERT over-expressing fibroblasts. Bars indicate means and 
standard error from 30 independent cells from each cell type. ANOVA single factor was 
used to analyse the significance between groups. 
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Figure 3.3 Representative images for the correlation between localisation of 
hTERT and DNA damage levels. Cells were treated with 400μM H2O2 for 3 hours. 
Cells were classified into three classes: nuclear TERT (N), cytoplasmic TERT (C) and 
intermediate localisation (In).  Endogenous hTERT was stained and displayed as green 
colour. Red colour represents H2A.X. The nucleus was stained with DAPI and 
displayed in blue. A:  Hela B:  MCF7and C: MRC5-hTERT. 
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Figure 3.3 shows representative images of Hela, MCF7 and MRC5-hTERT after 3 
hours of 400μM H2O2 treatment. We found that the localisation of endogenous hTERT 
correlated to the level of H2A.X foci which were used to identify nuclear DNA 
damage. It is interesting that when endogenous hTERT was excluded from nucleus to 
cytoplasm, all Hela, MCF7 and MRC5-hTERT displayed low amounts of H2A.X foci 
(arrow with C). However, when hTERT was localised in the nucleus (arrow with N), 
cells displayed a high number of H2A.X foci. All cells which showed intermediate 
hTERT exclusion (In) seemed to display an intermediate level of DNA damage foci. 
Thus, we quantified the amount of DNA damage foci correlated to the localisation of 
endogenous hTERT as shown in figure 3.4. 
Figure 3.4 was summarised from at least 30 individual cells of Hela, 2 independent 
experiments of MCF7 and 3 independent experiments of MRC5-hTERT. We found a 
correlation between the average amounts of nuclear DNA damage per nucleus with the 
different localisation of endogenous hTERT. When hTERT is excluded from nucleus 
and localised in the cellular cytoplasmic area, the three cell types showed significant 
lower amounts of DNA damage foci compared to the group where hTERT localised in 
the nucleus. A similar significantly lower amount of DNA damage was found between 
the cytoplasmic group and the group where hTERT was still inbetween nucleus and 
cytoplasm. Thus, localisation of endogenous telomerase in different cellular 
compartments relates to the different amount of nuclear DNA damage. From our three 
cell lines, cells where hTERT remains in the nucleus displayed high DNA damage 
while cells which excluded hTERT from the nucleus displayed no or very low DNA 
damage. In addition, Hela showed the highest nuclear DNA damage compared to MCF7 
and MRC5-hTERT in all categories. This might be because Hela contains an inactive 
p53. The role of the p53 status has been investigated to clarify the effect of p53 in 
Chapter 5. 
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3.3.2  Analysis of TERT exclusion kinetics 
Next we investigated the kinetic exclusion of endogenous hTERT in all three cell lines 
after treatment with 400 M H2O2. We have followed the exclusion of hTERT every 15 
minutes for 1 hour, then for 2 more hours until 3 hours, and then investigated it at 24 
hours (day1), 72 hours (day3) and 120 hours (day5) as shown in figure 3.5 and 3.6.   
 
  
 
Figure 3.4 Correlation between subcellular TERT localisation and DNA damage 
levels in 3 cell lines. Cytoplasmic TERT localisation correlates with low nuclear DNA 
damage in all 3 cell lines while nuclear TERT localisation results in high nuclear 
damage after 3 hour of 400μM H2O2 treatment. One way ANOVA was used to analysed 
the significance of differences between groups.  *p<0.05. 
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Figure 3.5 Short-term exclusion kinetics of endogenous hTERT in Hela, MCF7 and 
MRC5hTERT. All cells were treated with 400μM H2O2 and hTERT localisation was 
determined for nucleus and cytoplasm at 0 minute (untreated), every 15 minutes until 
one hour then every hour until 3 hours. Cells were fixed and analysed as described in 
Materials and Methods. Bars indicate means and standard error from at least 30 
individual cells.  
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Figure 3.6 Long-term exclusion kinetics of endogenous hTERT in Hela, MCF7 and 
MRC5/hTERT cells. All cells were treated with 400μM H2O2 and then continued to 
culture under regular medium. hTERT localisation was investigated within the nucleus 
and cytoplasm before treatment, at 3 hours, 24 hours (day1), 72 hours (day3) and 120 
hours (day5) after treatment. Cells were fixed, stained and analysed as described in 
materials and methods. Bars indicate means and standard error from at least 30 
individual cells.  
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Results in figure 3.5 represent the short-term kinetic exclusion of endogenous hTERT 
after 400μM H2O2 treatment. Before treatment (at 0 min) most of endogenous hTERT 
of MRC5-hTERT was localised in the nucleus. However, we found that about 20% of 
hTERT in Hela and MCF7 was already localised outside the nucleus. Then all three cell 
lines were treated with 400μM H2O2 and fixed (see materials and methods) every 15 
minutes until 1 hour, then every hour until 3 hours. Endogenous hTERT starts exclusion 
from the nucleus after 45-60 minutes post treatment start. At 3 hours (180 min) after 
treatment, only 30-40% of hTERT was excluded from nucleus to cytoplasm in both 
Hela and MCF7 but about 70% has been excluded in MRC5hTERT. Thus, hTERT 
seems to exclude faster in hTERT over-expressing fibroblasts. 
Results of the long-term kinetic exclusion of endogenous hTERT are shown in figure 
3.6. At 24 hours after treatment the exclusion level of hTERT in MRC5-hTERT was 
quite steady compared to the exclusion level at 3 hours after H2O2 treatment. This result 
is different from Hela and MCF7. Both cancer cells showed continuation of the 
exclusion of endogenous hTERT and reached the maximum exclusion level at 24 hours 
after treatment. Thus it seems that the exclusion of endogenous hTERT is slower in both 
cancer cell lines compared to MRC5-hTERT. This corresponds well with the higher 
fraction of cells with cytoplasmic TERT shown in figure 3.2. After 24 hours, 
cytoplasmic localisation of hTERT seems to gradually reduce in both MRC5-hTERT 
and MCF7. However, Hela showed a less obvious reduction of the cytoplasmic hTERT 
and constant until 120 hours (day5) post treatment. We hypothesise that the p53 status 
could be responsible for this difference. An experiment with an isogenic pair of 
glioblastoma cells which harbours active and inactive p53 related to the kinetic 
exclusion will been shown in chapter 5.  
 
3.3.3 Modelling telomerase locations using shooter plasmids (over-expressed 
TERT) 
In order to model the correlation found between physical location of hTERT in the 
mitochondria or nucleus with the amount of nuclear DNA damage, in the next 
experiment we used specific hTERT shooter vectors as described in Chapter 2 to deliver 
proteins specifically to various cellular locations in three cancer cell lines (Hela, MCF7 
and U87). Cells were transfected with hTERT-containing shooter vectors (vector 
structure has been shown in 2.2.3 in chapter 2) which included localisation signals 
specific for mitochondria or the nucleus (further on called mito-hTERT and nucl-
hTERT).   
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After transfection of various cell types with these hTERT expressing vectors, cells were 
treated with 2 different exogenous stresses (200 M H2O2 or 20 Gy Irradiation). The 
reason for the lower H2O2 concentration was that the transfected cells were more 
sensitive than the untransfected cells. Transfected cells showed very high DNA damage 
which might be because the cells were additionally stressed by the transfection 
procedure in addition to stress treatment. We found apoptotic cells (about 40%) after 
lipofectamine transfection. Thus, we tested the sensitivity of cells under 100 and 200 
M H2O2 treatment and finally reduced H2O2 concentration to 200 M. We also 
reduced time of treatment to be 1 hours. After stress treatment, transfected cells were 
double stained with H2A.X for DNA damage foci and myc-tag fused to the TERT 
gene/protein in the shooter plasmids which was used to identify the localisation of 
exogenous (over-expressed) hTERT. The number of DNA damage foci was compared 
in the transfected cells under normal and stress conditions between mitochondria and 
nuclear shooter vector as well as with the un-transfected/not expressing cells. The aim 
of this experiment was to analyse whether the physical localisation of hTERT in 
mitochondria or nucleus has an effect on the nuclear DNA damage.  
 
3.3.3.1  Localisation of exogenous hTERT affects nuclear DNA damage in 
Hela cells after H2O2 treatment 
In order to model the localisation of hTERT, specific localised shooter vector were used 
to investigate the direct effect of hTERT in specific cell locations. Hela cells were 
transfected with mito-hTERT or nucl-hTERT and double stained with H2A.X and 
myc-tag to investigate the effect of different physical location of hTERT in the 
mitochondria or nucleus with the amount of nuclear DNA damage.  Representative 
images of Hela transfected with mito-hTERT and nucl-hTERT under basal conditions 
and H2O2 stress treatment are shown in figures 3.7 and 3.8. The level of DNA damage 
in Hela cells without transfection and transfected with mito-hTERT or nucl-hTERT is 
shown in figure 3.9 and the conclusion has been showed in figure 3.10.  
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Figure 3.7 Double staining of Hela cells transfected with mito-hTERT shooter.  
Cells were double stained with H2A.X and myc-tag. Red colour represents DNA 
damage foci and green colour represents hTERT localisation. Nuclei were stained with 
DAPI (blue). White arrows indicate transfected cells. A is a representative image of 
cells transfected with mito-hTERT under basal condition and B is a representative 
image of cells transfected with mito-hTERT after 1 hr treatment with 200 M H2O2.  
 
 
 
 
 
Figure 3.8 Double staining of Hela cells transfected with nucl-hTERT shooter.  
Cells were double stained with H2A.X and myc-tag. Red colour represents DNA 
damage foci and green colour represents hTERT localisation. Nuclei were stained with 
DAPI (blue). White arrows indicate transfected cells. A is a representative image of 
nucl-hTERT under basal condition and B is a representative image of cells transfected 
with nucl-hTERT after 1 hr treatment with200 M H2O2.  
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Figure 3.9 DNA damage foci in Hela cells transfected with mito-hTERT, nucl-
hTERT and non transfected under normal and stress conditions. Cells were treated 
with 200 M H2O2 for 1 h, then fixed and double stained with H2A.X and myc-tag (for 
TERT identification) and damage foci number counted. A: non-transfected Hela. B: 
Hela transfected with mito-hTERT. C: Hela transfected with nucl-hTERT. Bars indicate 
mean and standard error from three independent experiments. Results have been 
compared using ANOVA-single factor * P<0.05, ** P<0.01, ns = non-significant 
difference.  
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As shown in figure 3.9, the number of DNA damage foci under normal and stress 
condition are different. DNA damage amounts were separated into 4 categories: first 
group: no-damage containing cells which did not show any DNA damage foci. This 
group was indicated as ‘0’. The second: a group with low damage which contained cells 
that showed between 1 to 20 damage foci. The third group: medium-high damage, this 
group consisted of cells which showed between 21 to 50 damage foci. The last group 
represents very high damage which means cells which showed more than 50 damage 
foci. In this category fell in particular cells with so many foci that it was not possible to 
count them separately. 
In non-transfected and transfected Hela, there was a significant difference between the 
treated and untreated groups. This demonstrates that the treatment induced indeed DNA 
damage. In addition, even under basal conditions, Hela cells had already presented a 
number of damage foci in the nucleus (figure 3.9 A). Moreover, it is interesting that 
Hela transfected with nucl-hTERT showed more nuclear DNA damage foci than the 
non-transfected and mito-hTERT transfected groups even under basal condition. (figure 
3.9 C). The quantitative comparison between groups is shown in figure 3.10.  
After Hela was treated with 200 M H2O2 for 1 hour the number of cells falling within 
the high and medium high damage group was significantly increased while the low and 
no damage groups were significantly decreased. It is interesting that the amount of high 
damage cells did not show a significant difference between treated and untreated cells in 
Hela transfected with mito-hTERT (figure 3.9 B). Importantly, Hela cells transfected 
with nucl-hTERT showed an even more pronounced increase of the high damage group 
compared to untreated and mito-hTERT transfected Hela. This experiment was repeated 
three times and nucl-hTERT Hela consistently showed the same pattern.  
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Figure 3.10 Comparison of damage foci in Hela cells transfected with both TERT 
shooter vectors under different conditions. The graph represents the percentage of 
cells which showed more than 20 damage foci. In the H2O2 positive groups, cells were 
treated with 200 M H2O2 for 1 hour. Bars indicate mean and standard error from the 
same 3 independent experiments shown in fig. 3.9. Results have been compared using 
One way ANOVA: * P<0.05, ** P<0.01. 
 
 
In order to subtract the background level of DNA damage that was present in Hela cells 
independent of the inflicted DNA damage, all results from Hela cells were summarised 
by considering only cells that contained more than 20 damage foci as shown in figure 
3.10.   
In comparison between mito-hTERT, nucl-hTERT and non-transfected cells, the results 
demonstrate a significant lower amount of high damage cells (>20 foci) in mito-hTERT 
shooter compared to the nuclear shooter and non transfected cells.  
Under basal condition, mito-hTERT transfected Hela showed significantly lower 
damage compared to nucl-hTERT shooter. However, both shooter transfected cells 
contained a significant higher amount of damage foci compared to the non transfected 
cells. The reason for that is not clear and it occurred exclusively in Hela cells. 
After H2O2 treatment, Hela cells with mito-hTERT shooter showed a significantly lower 
percentage of damage cells compared to both nucl-hTERT and non transfected cells 
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(P<0.01). As shown before in the whole damage analysis in nucl-hTERT Hela (see fig 
3.9 C), we saw a significantly higher number of damage before and after H2O2 
treatment. This data suggests that Hela cells transfected with nuclear hTERT shooter did 
already contain damage foci in untreated cells when hTERT localised in the nucleus and 
the damage increased significantly after stress conditions.  
This result was summarised from 3 independent experiments which confirmed each 
other well. Thus, in conclusion, mitochondrial localisation of hTERT in Hela showed 
significant decrease in the percentage of highly damaged cells after H2O2 treatment 
while nuclear hTERT localisation showed a high DNA damage and even significantly 
increase after H2O2 treatment. This result shows an indirect effect of the protection 
capacity of mitochondrial hTERT localisation to nuclear DNA. 
 
3.3.3.2  Localisation of exogenous hTERT affects nuclear DNA damage in 
MCF7 after H2O2 treatment 
 Because of the background problem of DNA damage in Hela, we decided to repeat the 
analysis with MCF7 cells since these have a functional p53 status in contrast to Hela 
cells. We were also interested whether this experiment could suggest any potential 
influence of the p53 status to mitochondrial protective function of hTERT and nuclear 
DNA damage. MCF7 cells were transfected with both shooters as described for Hela 
above under 3.3.2. Transfected MCF7 were double stained with H2A.X and myc-tag in 
order to determine whether there are differences in nuclear DNA damage due to a 
different TERT localisation of the exogenous TERT from the two shooter vectors. 
MCF7 damage foci were determined under normal and stress condition as in Hela and 
cells were separated into the same 4 categories as in Hela. Representative images for 
shooter transfection are shown in figure 3.11 and 3.12 while quantitative results are 
summarised in fig. 3.13 and 3.14 
Unlike Hela cells, only few MCF7 cells showed damage foci before treatment (figure 
3.13 A). Thus, this cell line seems more suitable than Hela for the analysis of DNA after 
H2O2 treatment.  
.  
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Figure 3.11  Double staining of MCF7 transfected with mito-hTERT shooter. Cells 
were double stained with H2A.X and myc-tag. Red colour represents DNA damage 
foci and green colour represents hTERT localisation. Nuclei were stained with DAPI 
(blue). White arrows indicate transfected cells. A is a representative image of MCF7 
cells transfected with mito-hTERT under basal condition and B is a representative 
image of MCF7 cells transfected with mito-hTERT after treatment with 200 M H2O2 
for1 hr.  
 
 
 
 
Figure 3.12  Double staining of MCF7 transfected with nucl-hTERT shooter. Cells 
were double staining with H2A.X and myc-tag. Red colour represents DNA damage 
foci and green colour represents hTERT localisation. Nuclei were stained with DAPI 
(blue). White arrows indicate transfected cells. A is a representative image of MCF7 
cells transfected with nuclTERT under basal condition and B is a representative image 
of MCF7 cells transfected with nuclTERT after treatment with 200 M H2O2 for1 hr.  
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Figure 3.13 DNA damage foci of MCF7 transfected with mito-hTERT, nucl-
hTERT and non-transfected under normal and stress conditions. Cells were treated 
with 200 M H2O2 for 1 hr, then fixed and double stained with H2A.X and myc-tag 
(for TERT identification) and damage foci number counted. A: non-transfected MCF7. 
B: MCF7 transfected with mito-hTERT. C: MCF7 transfected with nucl-hTERT. Bars 
indicate mean and standard error from three independent experiments. Results have 
been compared using ANOVA-single factor: * P<0.05, ** P<0.01, ns = non-significant 
difference.  
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In non-transfected cells, there is a significant difference between treated and untreated 
cells in the group of zero, low (1 to 20), low to medium (21 to 50) and high damage 
(more than50 foci). However, no significant difference was found in the group of higher 
than 50 damage foci before and after treatment. However, this group only contained a 
very low cell fraction suggesting that the whole extend of DNA damage is slightly 
lower in MCF7 cells compared to Hela cells (figure 3.13A). A similar result was found 
in mito-hTERT MCF7 under basal and treated conditions. Cells which contained more 
than 50 damage foci did not show a significant difference before and after treatment 
(figure 3.13B).  However, we found a significant difference between treated and non-
treated cells in the group of higher than 50 damage foci in nucl-hTERT transfected 
MCF7 (figure 3.13C). However, comparison between nucl-hTERT and the non-
transfected did not show a significant difference (figure 3.14). The comparison between 
mito-hTERT, nucl-hTERT and the non-transfected group before and after H2O2 
treatment is summarised in figure 3.14.  The result from MCF7 was also summarised 
from 3 independent experiments.  
Under basal condition, no significant difference has been observed between mito-
hTERT, nucl-hTERT and non-transfected MCF7. This result is different from Hela 
which showed a significantly higher damage when hTERT localised in the nucleus 
compared to mito-hTERT and the non-transfected group and increased pronouncedly 
after H2O2 treatment.  
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Figure 3.14 Comparison of damage foci number in MCF7 transfected with both 
TERT shooter vectors under different conditions. The graph represents the 
percentage of cells which showed more than 20 damage foci. Bars indicate mean and 
standard error from 3 independent experiments. Results have been compared using One 
way ANOVA * P<0.05, ** P<0.01, ns = non-significant difference.  
 
 
After H2O2 treatment, MCF7 showed a tendency for more resistance to the nuclear 
DNA damage in the mito-hTERT transfected group compared with nucl-hTERT and 
non transfected cells. This result might suggest a protective capacity of mitochondrial 
hTERT to nuclear DNA. Mitochondrial localisation of hTERT might help to prevent 
nuclear DNA damage after oxidative stress. However, there was no significant 
difference between nucl-hTERT and non-transfected MCF7 cells as found in Hela. We 
hypothesise that the different p53 status might be the reason of the higher of DNA 
damage of Hela when hTERT is localised in the nucleus compared to MCF7. An 
experiment to assess a possible correlation between p53 status and nuclear localisation 
of hTERT will be shown in Chapter 5.  
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3.3.3.3  Localisation of exogenous hTERT affects nuclear DNA damage in 
U87 after H2O2 treatment 
We have used U87 as a third cancer cell line to investigate the effect of exogenous 
hTERT to nuclear DNA damage. U87 contains a functional p53 as in MCF7, hence, we 
can investigate the influence of the p53 status to mitochondrial protective function of 
hTERT and nuclear DNA damage. U87 cells were transfected with both shooters as 
described for Hela and MCF7. Transfected U87 was double stained with H2A.X and 
myc-tag as described in materials and methods. U87 damage foci were determined 
under normal and stress condition and separated into 3 categories as: non damage (non 
foci damage detected), medium damage (contains 1-10 damage foci) and high damage 
(>10 damage foci). DNA damage quantitative results of U87 are summarised in fig. 
3.15 and 3.16. 
However, the results in U87 were different from those in MCF7. U87 showed high 
background damage as in Hela before treatment. 70-80% of U87 contained at least 1 
damage foci before treatment (figure 3.15). This is similar to results from another group 
which found background DNA damage in U87 (Short et al., 2007) and might suggest 
that background DNA damage is dependent on cell types. In non-transfected U87, there 
is a significant difference between treated and untreated cells in the group of medium (1 
to 10) and high damage (more than 10 foci) similar to U87 transfected with nucl-
hTERT. However, in U87 transfected with mito-hTERT, no significant difference was 
found in the group of medium damage (1 to 10 damage foci before) between before and 
after treatment. The comparison between U87 transfected with mito-hTERT, nucl-
hTERT and non-transfected U87 after H2O2 treatment is summarised in figure 3.16.  
The result of U87 is summarised from 3 independent experiments.  
Under basal condition, no significant difference has been observed between mito-
hTERT, nucl-hTERT and non-transfected U87 as in MCF7 suggest that high nuclear 
DNA damage in nucl-hTERT Hela under basal condition compared to mito-hTERT and 
the non-transfected group might be because the correlation between nuclear localisation 
of hTERT and inactive p53.  
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Figure 3.15 DNA damage foci of U87 transfected with mito-hTERT, nucl-hTERT 
and non-transfected under normal and stress conditions. Cells were treated with 200 
M H2O2 for 1 hr, then fixed and double stained with H2A.X and myc-tag (for TERT 
identification) and damage foci number counted. A: non-transfected U87. B: U87 
transfected with mito-hTERT. C: U87 transfected with nucl-hTERT. Bars indicate 
mean and standard error from three independent experiments. Results have been 
compared using ANOVA-single factor * P<0.05, ** P<0.01, ns = non-significant 
difference.  
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Figure 3.16 Comparison of DNA damage foci number in U87 transfected with both 
TERT shooter vectors under different conditions. The graph represents the 
percentage of cells which showed more than 10 damage foci. Bars indicate mean and 
standard error from 3 independent experiments. Results have been compared using One 
way ANOVA * P<0.05, ** P<0.01, ns = non-significant difference.  
 
 
After H2O2 treatment, U87 showed a tendency for more resistance to nuclear DNA 
damage in the mito-hTERT transfected group as found in Hela and MCF7. U87 cells 
transfected with mito-hTERT showed significantly lower damage compared to nucl-
hTERT and non-transfected cells. This result confirms a protective capacity of 
mitochondrial hTERT to nuclear DNA. U87 transfected nucl-hTERT showed no 
significant difference compared to non-transfected U87 as in MCF7. This result is 
different from Hela which support our hypothesis that a different p53 status might be 
the reason for the higher DNA damage of Hela cells when hTERT is localised in the 
nucleus.  
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3.3.3.4   Control experiments 
In order to confirm that the damage in the nucleus of nucl-hTERT shooter transfected in 
Hela was not the result of the shooter vector transfection itself, a control experiment 
using GFP shooter vectors was performed.  pCMV-GFP mito and nuclear shooter 
vectors were transfected into Hela cells. Cells were treated with 200 M H2O2 for 
1hour, then fixed and stained with a H2A.X antibody. A representative image of the 
mito/nucl GFP shooter transfection is shown in figure 3.17 and the quantitative 
comparison between mito/nucl GFP shooter and the non transfected cells is shown in 
figure 3.18.  The result did not show any significant difference between any of the GFP 
vectors and non-transfected cells. Thus the damage in the nuclear hTERT transfected 
cells was not a direct result from transfection of the shooter or the ectopic protein 
expression.  
 
 
 
Figure 3.17 Control experiment using GFP shooter vectors for DNA damage 
analysis.  Hela cells were transfected with pCMV-myc-mito/nucl-GFP and compared 
between untreated and treated conditions. A is Hela transfected with mito-GFP under 
basal condition. B is Hela transfected with mito-GFP and treated with 200 M H2O2 for 
1h, C is Hela transfected with nucl-GFP under basal condition and D is Hela transfected 
with nucl-GFP and treated with 200 M H2O2 for 1h .  
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Figure 3.18 Comparison between mito-GFP, nucl-GFP and non-transfected Hela 
cells under basal and stress conditions. Bars indicated means and standard deviation 
from at least 50 individual cells.  
 
 
3.3.4. Mitochondrial localisation of hTERT prevents DNA damage after x-
irradiation 
Hela, MCF7 and U87 were treated with irradiation in order to confirm the protective 
capacity of mitochondrial hTERT localisation onto DNA damage. However, we found 
that under 20Gy radiation that in Hela cells the over-expressed nucl-hTERT protein 
seemed to be rapidly excluded from the nucleus and performed similar to mito-hTERT 
(data shown in chapter 4). Thus, we were able to investigate the effect of mito-hTERT 
and nucl-hTERT only in MCF7 and U87 cells after irradiation.  
 
3.3.4.1  Localisation of exogenous hTERT affects nuclear DNA damage in MCF7 
after irradiation 
MCF7 was transfected with mito-hTERT or nucl-hTERT shooter and was treated with 
20 Gy irradiation, then double stained with H2A.X and myc-tag as described before. 
The representative images of MCF7 transfected with mito-hTERT of nucl-hTERT and 
irradiated with 20 Gy irradiation are shown in figure 3.19 and 3.20. 
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Figure 3.19 Double staining of MCF7 cells transfected with mito-hTERT shooter 
under untreated condition and x-irradiation. Cells were double stained with H2A.X 
and myc-tag. Red colour represents DNA damage foci and green colour represents 
hTERT localisation. Blue is DAPI for nuclear stain. White arrows indicate transfected 
cells. A is a representative image of MCF7 cells transfected with  mito-hTERT under 
basal condition and B is a representative image of MCF7 cells transfected with   mito-
hTERT after 20 Gy irradiation treatment. 
 
 
 
Figure 3.20  Double staining of MCF7 cells transfected with nucl-hTERT shooter 
under untreated condition and x-irradiation. Cells were double stained with H2A.X 
and myc-tag. Red colour represents DNA damage foci and green colour represents 
hTERT localisation. Blue is DAPI for nuclear stain. White arrows indicate transfected 
cells. A is a representative image of cells transfected with nucl-hTERT under basal 
condition and B is a representative image of cells transfected with nucl-hTERT after 20 
Gy irradiation treatment. 
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Figure 3.21 Damage foci of MCF7 transfected with mito-hTERT, nucl-hTERT and 
non- transfected under untreated condition and after X-irradiation. Cells were 
double stained with H2A.X and myc-tag and damage foci number counted. Bars 
indicate means and standard error from three independent experiments. A: non-
transfected MCF7. B: MCF7 transfected with mito-hTERT. C: MCF7 transfected with 
nucl-hTERT. Results have been compared using ANOVA-single factor * P<0.05, ** 
P<0.01, ns = non-significant difference. 
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Figure 3.22 Comparison of damage foci number in MCF7 under untreated 
condition and after x-irradiation. The graph represents the percentage of cells which 
showed more than 20 damage foci. For irradiation cells were treated with 20 Gy X-ray 
and fixed within 15 minutes after treatment. Bars indicate means and standard error. 
Results have been compared using One way ANOVA * P<0.05, ** P<0.01, ns = non-
significant difference.  
 
 
Figure 3.21 shows a number of DNA damage foci in untreated MCF7 and after 20 Gy 
irradiation. Cells were separated into 4 categories which were, zero (0), 1 to 20, 21 to 50 
and more than 50 damage foci.  
We found a significant increase of DNA damage in MCF7 after irradiation compared to 
the non-irradiated cells. However, this increasing of DNA damage was different in 
MCF7 transfected with mito-hTERT compared to nucl-hTERT and non-transfected 
MCF7. There was no significant difference between untreated and 20 Gy irradiated cells 
in the group of more than 50 damage foci in all non-transfected, mito-hTERT and nucl-
hTERT transfected cells. We found no significant difference between untreated and 
irradiation in the group of 21 to 50 in mito-hTERT while nucl-hTERT and non-
transfected cells showed a significantly higher amount of DNA damage after irradiation.  
Thus, in figure 3.22 we grouped the higher DNA damage groups together and compared 
only the group of more than 20 foci in MCF7 transfected with mito-hTERT, nucl-
hTERT and non-transfected cells as we did before in MCF7 after H2O2 treatment. We 
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found no significant difference between the 3 transfection groups before treatment. 
However, after 20 Gy irradiation, there was a significantly lower number of cells with 
more than 20 DNA damage foci in cells transfected with mito-hTERT compared to non-
transfected or cells transfected with nucl-hTERT. We found no difference between nucl-
hTERT and the non-transfected group after 20 Gy irradiation. Thus, this result from 
irradiation confirms our previous H2O2 experiment regarding the ability of 
mitochondrial localisation of hTERT to prevent DNA damage under an independent 
stress condition.  
 
3.3.4.2  Localisation of exogenous hTERT affects nuclear DNA damage in U87 
after irradiation 
U87 was transfected with mito-hTERT or nucl-hTERT shooter and was treated with 20 
Gy irradiation and then double stained with H2A.X and myc-tag as described before. 
U87 damage foci were determined under normal and stress condition and separated into 
3 categories as described for the H2O2 experiment. The quantitative results of DNA 
damage of U87 after irradiation are summarised in fig. 3.23 and 3.24.  
As shown in figure 3.23, we found no significant difference between untreated and 20 
Gy irradiated cells in the group of more than 10 damage foci in U87 transfected with 
mito-hTERT while U87 transfected with nucl-hTERT and non-transfected cells showed 
significant difference. This result indicates no increase of DNA damage after 20 Gy 
irradiation in U87 transfected with mito-hTERT while U87 transfected with nucl-
hTERT and non-transfected cell showed significant increased of nuclear DNA damage 
after 20 Gy irradiation. In figure 3.24 we grouped the high DNA damage groups (>10 
damage foci) together as we did before in U87 after H2O2 treatment. We found no 
significant difference between the 3 transfection groups before treatment which is 
similar to MCF7. After 20 Gy irradiation, there was a significantly lower number of 
cells with more than 10 damage foci in U87 transfected with mito-hTERT compared to 
non-transfected or U87 transfected with nucl-hTERT. We found no difference between 
nucl-hTERT and the non-transfected group after 20 Gy irradiation as in MCF7. This 
result in U87 transfected with mito-hTERT confirms the lower DNA damage when 
hTERT is localized in mitochondria as MCF7 transfected with mito-hTERT after 
irradiation and the previous results in H2O2 experiment.  
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Figure 3.23 DNA damage foci of U87 transfected with mito-hTERT, nucl-hTERT 
and non transfected under normal and stress condition. Cells were treated with 20 
Gy irradiation, then fixed and double stained with H2A.X and myc-tag (for TERT 
identification) and damage foci number counted. A: non-transfected U87. B: U87 
transfected with mito-hTERT. C: U87 transfected with nucl-hTERT. Bars indicate 
mean and standard error from three independent experiments. Results have been 
compared using ANOVA-single factor * P<0.05, ** P<0.01, ns = non-significant 
difference.  
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Figure 3.24 Comparison of DNA damage foci number in U87 transfected with both 
TERT shooter vectors under different conditions after x-irradiation. The graph 
represents the percentage of cells which showed more than 10 damage foci. Bars 
indicate mean and standard error from 3 independent experiments. Results have been 
compared using One way ANOVA * P<0.05, ** P<0.01, ns = non-significant 
difference.  
 
 
 
 3.3.5 Effect of mitochondrial localisation of hTERT on nuclear DNA damage in 
MRC5/SV40 
To confirm our results of hTERT shooter experiments which have been done in cancer 
cell lines we proceeded to use cells without endogenous telomerase expression and 
chose MRC5/SV40. We were trying to use normal MRC5 fibroblast before, however, 
we have not succeeded in the transfection of mito-hTERT or nucl-hTERT to MRC5 
using lipofectamine
TM
 2000 (2.2.2 in Chapter 2). Although we have tried other 
transfection agents such as FuGENE for the transfection we still got very few 
transfected cells. Thus we decided to use MRC5/SV40 instead of normal MRC5. This 
cell line is derived from normal MRC-5 fibroblasts transfected with a replication origin-
defective early region of SV40 containing the gene of large T antigen (Huschtscha and 
Holliday, 1983). This MRC5/SV40 does not express endogenous hTERT which might 
influence the effect of our exogenous shooter.  
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Figure 3.25  Double staining of MRC5/SV40 transfected with mito-hTERT shooter 
after 0, 5 and 10 Gy irradiation. Cells were double stained with H2A.X and myc-tag. 
Red colour represents DNA damage foci and green colour represents hTERT 
localisation. Blue is DAPI staining for visualisation of nuclei. White arrows indicate 
transfected cells. A represents SV40MRC5 cells transfected with mito-hTERT under 
basal condition. B represents SV40MRC5 cells transfected with mito-hTERT after 5 Gy 
irradiation treatment and C represents SV40MRC5 cells transfected with mito-hTERT 
after 10 Gy irradiation. 
 
 
 
Figure 3.26  Double staining of MRC5/SV40 transfected with nuclTERT shooter 
after 0, 5 and 10 Gy irradiation. Cells were double stained with H2A.X and myc-tag. 
Red colour represents DNA damage foci and green colour represents hTERT 
localisation. Blue is DAPI staining for visualisation of nuclei. White arrows indicate 
transfected cells. A represents MRC5/SV40 cells transfected with nucl-hTERT under 
basal condition. B represents MRC5/SV40 cells transfected with nucl-hTERT after 5 
Gy irradiation treatment and C represents MRC5/SV40 cells transfected with nucl-
hTERT after 10 Gy irradiation. 
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In MRC5/SV40, p53 is inactivated by SV40 large T-antigen (Lin and Simmons, 1991) 
similar to Hela cells where it is inactivated by HPV (papillomavirus). In this 
experiment, MRC5/SV40 was transfected with mito-hTERT or nucl-hTERT shooter 
vector as described in “Materials and Methods” and treated with different doses of x-
irradiation.  
Initially we irradiated MRC5/SV40 with a 20 Gy dose as in MCF7. However the cells 
displayed extremely high levels of DNA damage. Thus, we reduced the x-ray dose to 5 
and 10 Gy. We categorised the number of damage foci into 3 groups in this experiment 
which were 0, 1 to 10 and more than 10 damage foci. Results of MRC5/SV40 before 
and after irradiation are shown in figure 3.25-3.28. 
As shown in figure 3.27, there were no significant differences in the group of 0 damage 
foci in all MRC5/SV40 transfected with mito-hTERT, nucl-hTERT and non-transfected 
before and after irradiation. MRC5/SV40 already contained a large amount of damage 
in almost all of the cells before treatment which is similar to the situation in Hela. This 
suggests that acertain background damage in these two cell types might be due to a non-
functional p53.  
When we compared the group of 1 to 10 and more than 10 damage foci between 
untreated MRC5/SV40,  5 Gy and and 10 Gy irradiation in all mito-hTERT, nucl-
hTERT and non-transfected cells, we found a significant increase of DNA damage foci 
of the 5 and 10 Gy irradiation group compared with non treated group in MRC5/SV40 
transfected with nucl-hTERT and non-transfected. However, we have not found any 
significant difference between 5 Gy and 10 Gy irradiation when compared to the 
untreated group in MRC5/SV40 transfected with mito-hTERT. Moreover, we have not 
found a significant difference between DNA damage of MRC5/SV40 irradiated with 5 
Gy and 10 Gy between non-transfected, mito-hTERT and nucl-hTERT. Thus, we 
summarised the results of MRC5/SV40 under basal condition compared with cells 
which were irradiated with 10 Gy. We subtracted the damage background by 
considering only cells which contained more than 10 damage foci.  
Under basal condition, it seemed that nucl-hTERT promotes high amount of DNA 
damage foci. The nucl-hTERT group contained a significantly higher amount of DNA 
damage compared to non transfected group. However, we have not found a significant 
difference between mito-hTERT and nucl-hTERT before irradiation. There was also no 
significant difference between non-transfected and mito-hTERT before irradiation. This 
might be because of the high standard error in the mito-hTERT group.  
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Figure 3.27  DNA damage foci of MRC5/SV40 transfected with mito-hTERT, nucl-
hTERT and non-transfected cells untreated and after x-irradiation. Cells were 
double stained with H2A.X and myc-tag and damage foci number counted. A: non-
transfected MRC5/SV40. B: MRC5/SV40 transfected with mito-hTERT. C: 
MRC5/SV40 transfected with nucl-hTERT. Results have been compared using 
ANOVA-single factor * P<0.05, ** P<0.01. Bars indicate mean and standard error from 
three independent experiments.  
 
 
 
 
87 
 
 
Figure 3.28 Comparison of damage foci number in MRC5/SV40 under basal 
conditions and after x-irradiation. The graph represents the percentage of cells which 
showed more than 10 damage foci. For irradiation cells were treated with 10 Gy X-ray 
and fixed within 15 minutes after treatment. * P<0.05, ** P<0.01, ns = non-significant 
difference. Bars indicate means and  standard error from 3 independent experiments.  
 
 
After 10 Gy irradiation, MRC5/SV40 transfected with mito-hTERT shooter showed a 
significantly lower percentage of damage cells compared to both nucl-hTERT and non 
transfected cells. We have not found a significant difference between the non-
transfected group and nucl-hTERT group after irradiation. Thus, this result clearly 
showed the protection of nuclear DNA was cause by the exogenous mitochondrially 
localised hTERT. Overall, the results in this chapter indicate a correlation between 
mitochondrial hTERT and nuclear DNA protection function.  
 
3.3.6 Apoptosis induction in Hela, MRC5/SV40 and U87 transfected with mito-
hTERT and nucl-hTERT 
Since we found a significant decrease of DNA damage foci when hTERT is localised in 
the mitochondria we were interested whether this low DNA damage might related to 
lower apoptosis in cell transfected with mito-hTERT. Hela, MRC5/SV40 and U87  were 
transfected with nucl-hTERT and mito-hTERT and treated with 400 M H2O2 or 20 
Gy irradiation then washed with regular culture medium. MRC5/SV40 and U87 were 
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left one day for apoptosis induction while Hela was left 2 days before fixation due to a 
known delay in apoptosis induction of these cells. Cells were double stained for 
apoptosis (Activated Caspase 3) and exogenous hTERT localisation (c-myc staining). 
Results have been determined from 30-150 transfected cells per cell line and condition. 
A representative image and the analysis of apoptosis are shown in figures 3.29- 3.31. 
 
Figure 3.29 Mitochondrial TERT protects from apoptosis induction after H2O2 
treatment and x-irradiation compared to cells transfected with nuclear TERT. 
Representative images of activated caspase 3 (red colour) in A: Hela, B: MRC5/SV40, 
C: U87 cells transfected with mito-hTERT and nuclear-hTERT (myc-tag staining as 
shown in green colour) after 400 H2O2 treatment for 3h and irradiation with 20Gy 
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Figure 3.30 Quantification of the percentage of apoptotic cells of Hela, 
MRC5/SV40 and U87 transfected with mito-hTERT or nucl-hTERT after H2O2 or 
irradiation. 
A: quantification of the percentage of apoptotic cells of the 3 cell lines after 400 mM 
H2O2 treatment. B: Quantification of the percentage of apoptotic cells of the 3 cell lines 
after x-irradiation (20Gy). Bars present mean and standard error from around 45 
transfected cells per condition and cell line. * p<0.05 
 
From figure 3.30, we have not found any single cell of Hela, U87 and MRC5/SV40 
transfected with mito-hTERT showed any sign of apoptosis. The result was different in 
both 3 cell lines transfected with nucl-hTERT and untransfected cells. We found around 
20% of untransfected cells and between 40-60% of cells transfected with nucl-hTERT 
were apoptotic. These results indicate a correlation between the localisation of hTERT, 
the induction of DNA damage and apoptosis. The damage found in cells with nucl-
hTERT impacts directly on cell survival while mitochondrial TERT efficiently protects 
cells against apoptosis. 
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3.4   Discussion 
 
In this chapter, we showed that endogenous hTERT shuttles from nucleus to 
mitochondria upon oxidative stress in a heterogeneous manner in three different cell 
lines. Two cancer cell lines in our experiments (Hela and MCF7) showed about 20% of 
hTERT already localised in the cytoplasm/mitochondria under basal conditions. This 
finding is consistent with published data from other groups (Sharma et al., 2011; 
Kovalenko et al., 2010; Ahmed et al., 2008; Haendeler et al., 2009). Under oxidative 
stress, the kinetic exclusion of hTERT is different between Hela, MCF7 and MRC5-
hTERT. MRC5-hTERT cells showed a faster exclusion of endogenous hTERT to the 
cytoplasm with a maximum of hTERT exclusion at three hours post oxidative stress 
while it took longer time for Hela and MCF7 to exclude TERT from the nucleus. Both 
cancer cell lines took up to one day to reach the maximum hTERT exclusion.  
Interestingly, hTERT remained outside of the nucleus up to five days of follow-up in 
Hela and MCF7. Thus, nuclear TERT exclusion seems to be a persistent process which 
can last up to several days after a single treatment.  The long persistence of hTERT 
protein outside the nucleus might be an important contributor to an increased resistance 
against DNA damage and decreased apoptosis of these cells.  
However, cytoplasmic localisation of hTERT in MRC5-hTERT and MCF7 seems to 
gradually reduce after 24 hours after treatment while the cytoplasmic hTERT of Hela 
seems stable upon 5 days of our experiment. Both MRC5-hTERT and MCF7 habour an 
activated p53 while Hela contains an inactivated p53 because of the HPV subtype 18 
(Human papillomaviruses) viral proteins E6 and E7 functionally inactivate the check 
point of p53 (Hopper-Seyler and Butz, 1993). Thus, we hypothesised that this different 
p53 status could play a role for the  different kinetics of hTERT exclusion after 
oxidative stress.  
Moreover, our result indicates a correlation between localisation of telomerase and the 
DNA damage pattern. We quantified the amount of DNA damage foci correlated with 
the localisation of endogenous hTERT and found that if endogenous hTERT was 
excluded from nucleus to cytoplasm/mitochondria under oxidative stress, all three cell 
lines in our experiment displayed no or very low amount of DNA damage. In contrast, if 
endogenous hTERT was localised in the nucleus and not exclude while cells were under 
oxidative stress, all three cell lines displayed high amount of DNA damage. Kovalenko 
and co-workers speculate in their paper that the high level of DNA damage when 
hTERT is localised in the nucleus might play a role in cell cycle delay in order to repair 
the damage site (Kovalenko et al., 2010a )After DNA damage, activated p53 will induce 
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p21 and Hzf, a human zinc-finger-containing p53 target gene to arrest the cell cycle. 
This process will allow time for DNA repair (Zhang et al., 2012). However, if the 
damage is beyond repair, Hzf will be degraded, and activates E2F1 will induce the 
process which triggers apoptosis. Therefore, the cellular outcome is closely associated 
with p53 levels. Thus lack of an active p53 in Hela might be a reason of higher DNA 
damage. Further experiments regarding the effect of p53 are described in Chapter 5.   
To prove directly whether the different localisations of hTERT in the mitochondria or 
nucleus have indeed a direct influence to nuclear DNA damage, we used a model of 
specific hTERT shooter vectors to deliver TERT protein specifically to mitochondria or 
nucleus in Hela and MCF7. In addition, we used MRC5/SV40 which does not express 
an endogenous hTERT to confirm our model. We used two different exogenous stress 
treatments which were hydrogen peroxide and irradiation.  
Un-transfected Hela cells under basal condition already presented a number of damage 
foci in the nucleus (figure 3.7). This suggests a certain background damage in this 
cancer cell type which is probably due to the functionally inactive p53 as found in other 
p53 negative cancer cells (Kovalenko et al., 2010a ). In order to subtract the background 
level of DNA damage in Hela cells were summarised the damage data by considering 
only cells that contained more than 20 damage foci (figure 3.10).  The results 
demonstrated a significant lower amount of DNA damage in mito-hTERT shooter 
compared to the nuclear shooter and non-transfected cells in both basal and treated 
condition. However, it was a surprising result to find a higher damage level before 
treatment in Hela cells transfected with nucl-hTERT when compared with both the 
mito-hTERT and the non-transfected group.  After cells were treated with H2O2, the 
increase of the high damage group of nucl-hTERT was even more pronounced. This 
result supports the surprising suggestion that nuclear hTERT might even further 
increase the DNA damage foci in the nucleus. Kovalenko and colleagues   found that 
over-expression of a hTERT with a mutation of the TERT nuclear export signal (NES-
hTERT) which prevents the translocation of hTERT from the nucleus can significantly 
decrease the proliferation rate and the ability to form colonies in soft agar in LNCaP, 
SQ20B and Hela cells. The cancer cells also showed an increase of DNA damage at 
telomeric and extra-telomeric sites (Kovalenko et al., 2010 b). This result is in excellent 
accordance to our finding that nuclear hTERT transfection in Hela cells showed also a 
high DNA damage before treatment.  
To exclude that the high DNA damage of nucl-hTERT cells was the result of the 
shooter vector itself, a GFP experiment was performed. The results from mito-GFP and 
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nucl- GFP shooter did not show any difference between GFP vector transfected and 
non-transfected cells regarding with the DNA damage (figure 3.18). Thus the damage in 
the nucl-hTERT group was not a direct result from the shooter transfection or the 
ectopic protein expression, but rather specific for nuclearly localised TERT protein.  
Next, we investigated the effect of specific hTERT localisation in MCF7 and U87 cells. 
As shown in figure 3.14 and 3.16, no significant difference had been observed between 
mito-hTERT, nucl-hTERT and non-transfected cells in MCF7 and U87 under basal 
conditions. One possibility which could explain this difference might be the fact that 
Hela has a different p53 activity from MCF7 and U87. After H2O2 treatment, MCF7 and 
U87 showed a tendency for more resistance to the nuclear DNA damage in the mito-
hTERT transfected group. Both U87 and MCF7 transfected with mito-hTERT showed 
significantly lower damage compared to nucl-hTERT and non transfected cells. This 
result is similar to that in Hela and confirms the protective capacity of hTERT to 
nuclear DNA. Mitochondrial localisation of hTERT might help to prevent nuclear DNA 
damage after oxidative stress.  
We confirmed results obtained by using H2O2 by using irradiation as a different stress 
treatment. We found that under 20Gy radiation, Hela nucl-hTERT seemed to be rapidly 
excluded from the nucleus and performed as mito-hTERT (data shown in chapter 4). 
Thus, we were able to investigate the effect of mito-hTERT and nucl-hTERT only in 
MCF7 and U87 cells. The results conclude in figure 3.22 and 3.24 showed similar 
results as in hydrogen peroxide experiment. After 20Gy irradiation, a significantly 
lower number of cells with more than 20 DNA damage foci in MCF7 and more than 10 
damage foci in U87 have been found in cells transfected with mito-hTERT compared to 
non-transfected and nucl-hTERT. This result in both cancer cell types confirm that 
mitochondria localisation of hTERT could prevent DNA damage under an independent 
stress condition.  
We confirmed our results from cancer cells by transfecting mito-hTERT and nucl-
hTERT to a telomerase negative cell type. MRC5/SV40 which does not contain 
endogenous telomerase has been used to avoid the effect of endogenous telomerase 
which might influence the results in cancer cells. Under basal condition, nucl-hTERT 
transfected cells showed significant higher DNA damage compared to the non-
transfected group. However, there was no significant difference between mito-hTERT 
and non transfected cells (figure 3.28). After irradiation, no significant difference has 
been found between nucl-hTERT and non transfected group. However, mitoTERT 
transfected MRC5/SV40 showed a significantly lower DNA damage level than both 
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nucl-hTERT and non transfected cell. This result confirms that localisation of an 
exogenous hTERT in mitochondria reduces nuclear DNA damage.  
Finally, we analyse the apoptosis induction after exogenous stress (400 M H2O2 
treatment and 20Gy irradiation) in Hela, MRC5/SV40 and U87 in order to investigate 
the effect of hTERT localisation to cellular apoptosis. Intriguingly, we have not found 
any sign of apoptosis (active Caspase 3) in cell transfected with mitochondrial TERT.  
However, we found around 20% of untransfected cells and between 40-60% of cells 
expressing the nuclear shooter were apoptotic. This result confirms that indeed the 
induced DNA damage found in cells with nuclear TERT localisation impacts directly on 
cell survival while mitochondrial TERT efficiently protects against apoptosis. 
Thus, from the overall results we can conclude that mitochondrial localisation of 
hTERT provides a novel mechanism of protection from nuclear DNA damage. The 
mechanism of this protection will be analysed in the next chapter. 
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Chapter 4 
Mitochondrial localisation of hTERT protects against mitochondrial 
ROS generation after exogenous stress  
 
 4.1 Introduction 
Telomerase plays an important role for the proliferative capacity of the cell and cell 
survival. As described in Chapter 1, the main function of telomerase is to maintain 
telomere length and protect linear chromosomes from end-to-end fusions. However, 
recent evidence shows additional functions of telomerase independently from telomere 
maintenance.  It has previously been shown that telomerase catalytic subunit is excluded 
from the nucleus of various cell types upon oxidative stress (Haendeler et al., 2003, 
Santos et al., 2004, Ahmed et al., 2008, Indran et al., 2011) which is correlated to a 
protective effect of telomerase within mitochondria (Ahmed et al.,2008, Haendeler et 
al., 2009, Kovalenko et al., 2010a,b, Indran et al., 2011), including in cancer cells 
(Kovalenko et al., 2010b, Indran et al., 2011).  
To analyse whether there exists a direct correlation between physical location of hTERT 
in the mitochondria and its protective function, we used specific shooter vectors that 
deliver proteins specifically to various cell locations. Cells were transfected with 
hTERT-expressing shooter vectors which included the localisation signals specific for 
mitochondria or the nucleus (further on called mito-hTERT and nucl-hTERT).  We 
transfected cancer cells with these hTERT expressing vectors and compared their 
mitochondrial superoxide level under normal conditions (unstressed) and exogenous 
stress (H2O2 and x-irradiation) treatments. These experiments should uncover whether 
mitochondrial localisation of hTERT alone is sufficient and necessary to protect 
mitochondria effectively under normal and stress condition compared to the situation 
when only nuclear hTERT is present. Single cell staining experiments rather than FACS 
experiments for ROS measurement where used due to the relatively low (25-30%) 
transfection rate. We attempted to do FACS analysis but did not find any differences 
presumably due to the high background (around 70%) of un-transfected cells.   
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4.2 Results  
4.2.1 Quantitative determination of mitochondrial superoxide level in Hela and 
MCF7 cells under exogenous stress (H2O2) 
To prove whether there is a direct correlation between physical location of hTERT in 
the mitochondria and the level of mitochondrial ROS, Hela and MCF7 cells were 
transfected with mito-hTERT or nucl-hTERT and treated with 100 M H2O2 for 1 hour, 
left for 24 hours before staining and comparing their mitochondrial superoxide levels 
with cells cultured under untreated conditions. The reason for this long incubation 
period was because H2O2 treatment itself produced high ROS levels at earlier time 
points while after 1 day the effect of exogenous H2O2 was gone and only mitochondrial 
ROS generated after H2O2 treatment is measured. We have also tested the concentration 
of H2O2  at 100, 200, 400 and 800 M compared with untreated Hela cells and found 
that one day after treatment only 100  M H2O2 concentration showed equal ROS 
production as the untreated cells. We found a little higher level of ROS in Hela treated 
with 200 M H2O2 and even higher levels in 400 and 800 M (data not shown) which 
indicated the effect of H2O2 treatment was not completely gone and might interfere with 
our result. Thus we chose 100 M H2O2 concentration in our experiment. Results of the 
mitochondrial superoxide staining from both mito- and nucl-hTERT under basal and 
stress conditions are shown in figures 4.1-4.5. 
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Figure 4.1 Hela cells: double staining of mitochondrial superoxide and TERT 
under normal (untreated) condition. Hela cells were transfected with mitochondrial-
TERT (A) and nuclear TERT (B) shooter. Cells were double-stained with mitoSox for 
mitochondrial superoxide and myc-tag for TERT. White arrows indicate transfected 
cells.   
 
 
 
 
 
Figure 4.2 Hela cells: double staining of mitochondrial superoxide and TERT 
under stress condition. Hela cells were transfected with mitochondrial-TERT (A) and 
nuclear-TERT (B) shooter. Cells were treated with 100 M H2O2 before staining with 
mitoSox for mitochondrial superoxide and myc-tag for TERT. White arrows indicate 
transfected cells.   
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Figure 4.3 MCF7 cells: double staining of mitochondrial superoxide and TERT 
under normal condition. Cells were transfected with mitochondrial-TERT (A) and 
nuclear-TERT (B) shooter. Cells were double- stained with mitoSox for mitochondrial 
superoxide and Myc-tag for TERT. White arrows indicate transfected cells.   
 
 
 
 
 
Figure 4.4 MCF7 cells:  double staining of mitochondrial superoxide and TERT 
under stress condition. Cells were transfected with mitochondrial-TERT (A) and 
nuclear-TERT (B) shooter. Cells were treated with 100 mM H2O2 before staining with 
mitoSox for mitochondrial superoxide and myc-tag for TERT. White arrows indicate 
transfected cells.   
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Figure 4.5 Comparison of mitochondrial superoxide levels in mito-hTERT and 
nucl-hTERT transfected as well as non-transfected cells in Hela and MCF7 under 
basal conditions and H2O2 stress treatment. A: Hela under basal condition and after 
H2O2‎ treated condition. B: MCF7 under basal condition and after H2O2‎ treated 
condition. Bars show mean and standard error from 3 independent experiments.  One 
way Anova was used to test for significant differences between groups.  
 
 
The results from figure 4.5 indicated lower levels of mitochondrial superoxide in cells 
transfected with mitochondrial hTERT after H2O2 treatment compared to nuclear 
hTERT. Under basal condition both Hela and MCF7 did not show a significant 
difference of ROS levels between mitochondrial hTERT expression and nuclear 
hTERT. Surprisingly, the level of ROS in nuclear-hTERT transfected MCF7 under 
basal condition was higher than in non-transfected cells (P<0.05). This result was 
different for Hela cells where both mito-hTERT and nuclear-hTERT showed 
statistically significant lower ROS levels under basal condition compared to non-
99 
transfected cells (P<0.01) which might indicate a protective effect of hTERT before 
treatment. Under oxidative stress, Hela and MCF7 cells were treated with 100 M H2O2 
then left for 1 day before mitoSox staining and immuno-fluorescence staining. Mito-
hTERT expression in both Hela and MCF7 showed significantly lower ROS level 
compared to nucl-hTERT (P<0.01). ROS levels in mito-hTERT Hela were lower than in 
non-transfected cells (P<0.01). However, the nuclear hTERT and non-transfected cells 
did not show significant differences. In MCF7, ROS level of mito-hTERT transfected 
cells was significantly lower than in cells transfected with nuclear hTERT (P<0.01) but 
it is interesting that the level of ROS in nuclear-hTERT transfected MCF7 was higher 
than in non-transfected cells (P<0.05).  When compare between treated and non-treated 
condition of Hela and MCF7, the significant difference of non-transfected and nucl-
hTERT transfected Hela between before and after treatment has been found. However, 
mito-hTERT transfected Hela did not show a significant increase of ROS level after 
H2O2 treatment compared with before treatment. In MCF7, no significant difference 
have been found when compare between before and after treatment in non-transfected 
and nucl-hTERT MCF7. It is interesting that mito-hTERT transfected MCF7 showed 
significant lower ROS level after H2O2 treatment. Thus these experiments showed that 
mitochondrial localisation of hTERT is necessary to protect mitochondria effectively 
under stress condition. This low level of ROS expression might be the reason for less 
nuclear DNA damage under exogenous stress under conditions when TERT is localised 
within mitochondria.  
 
4.2.2 Control experiments (H2O2) 
To confirm that the reduction of mitochondrial superoxide was indeed a specific effect 
of mitochondrial hTERT, three control experiments were performed to exclude the 
possibility that decreased mitoSox staining in cells harbouring mitochondrial TERT 
protein was due to a methodological artefact.   
The first control is shown in figure 4.6. Hela and MCF7 were transfected with a control 
vector (pCDNA3.1), treated with 100 M H2O2 and stained with mitoSox and myc-tag. 
Double staining with mitoSox and myc tag in pCDNA 3.1 transfected Hela and MCF7 
did not show any change in mitosox due to the transfection per se. This data confirms 
that ROS expression does not influenced by the vector. 
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Figure 4.6 Hela and MCF7 transfected with pCDNA 3.1 (MOCK transfection) and 
stained with mitoSox and myc tag antibody. A-D:  are respresentative  images of A: 
Hela transfected with pCDNA3.1 and treated with 100 M H2O2 for 1 hr. B: Hela non-
transfected and treated with 100 M H2O2 for 1 hr. C: MCF7 transfected with 
pCDNA3.1 and treated with 100 M H2O2 for 1 hr. and D: MCF7 non transfected and 
treated with 100 M H2O2 for 1 hr. E: The graph indicates the level of mitoSox 
measured by ImageJ. Bars indicate means and standard error from at least 50 cells for 
each group. 
 
  
Figure 4.7 Hela transfected with mito-hTERT shooter and double staining with 
mitoSox and COX II. Hela was transfected with mito- and nucl-hTERT shooter 
plasmids, treated with 100 M H2O2 for 1 hr and double stained with MitoSOX and 
COXII antibody. A and B are respresentative images of A: Hela transfected with mito-
hTERT. Arrows indicate the speculated transfected cells which showed lower 
mitochondrial superoxide levels in A. B:  Hela transfected with nucl-hTERT. C: is a 
respresentative image of Hela transfected with empty plasmid (pCDNA 3.1) used as a 
control. D: graph indicates the level of mitoSox in cells transfected with mito-hTERT 
and nucl-hTERT compared to non-transfected cells and cells transfected with 
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pCDNA3.1 vector. Bars indicate means and standard error from at least 50 cells for 
each group. 
 
 
The second control is shown in figure 4.7. Hela and MCF7 cells were transfected with 
hTERT shooter (pCMV-myc-mito/nucl-hTERT) and then stained with mitoSox and 
COXII antibody in order to exclude that the myc antibody staining is responsible for a 
decrease in mitoSox. The COXII protein is a mitochondrial protein that is expressed in 
all mitochondria independent of a transfection event. If antibody staining would be 
responsible for the decrease in ROS it should be observed for all cells (transfected or 
not) in this experiment. Figure 4.7a shows the double staining of mitoSox and COXII 
which is a mitochondrial protein instead of the myc-tagged hTERT after mito-shooter 
transfection in Hela. We found that only 20-30% of all COXII stained cells showed low 
ROS level. This result indicated that the decreased of ROS level is not because of the 
antibody accumulated in mitochondria. We have not found a significant difference of 
ROS level between Hela non-transfected, Hela transfected with nucl-hTERT and Hela 
transfected with pCDNA3.1. This data suggests that the decreased mitochondrial 
superoxide levels in Hela and MCF7 transfected with mito-hTERT are not an artefact 
from the myc/TERT antibody staining.  
In the third control, Hela and MCF7 were transfected with GFP shooter vectors 
(pCMV-myc-mito/nucl-GFP) in order to see whether it is the shooter transfection or an 
unspecific effect of the shooter expressed protein in the mitochondria that is responsible 
for the decrease in mito ROS.  The images in figure 4.8 suggest a similar mitochondrial 
superoxide expression in cells with and without GFP expression. None of them showed 
any differences in mitoSox staining. This data suggests that the decreased mitochondrial 
superoxide levels in Hela and MCF7 are not an artefact from the shooter expressed 
protein. Thus the conclusion is that reduction of mitochondrial superoxide levels in Hela 
and MCF7 is a direct effect from the mitochondrial localisation of hTERT. 
 
4.2.3 Quantitative determination of mitochondrial superoxide levels in U87 
under exogenous stress (H2O2) 
We used U87 as a third cancer cells to confirm the effect of hTERT in different 
subcellular locations. The results from figure 4.9 indicated lower levels of 
mitochondrial superoxide in cells transfected with mitochondrial hTERT after H2O2 
treatment compared with nuclear hTERT and non-transfected cells. Under basal 
condition U87 showed a significantly lower  
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Figure 4.8 GFP control experiment, A-H are respresentative image of A Hela cells 
transfected with pCMV-myc-mito-GFP and treated with 100 M H2O2, B Hela 
transfected with pCMV-myc-nucl-GFP and treated with 100 M H2O2, C Hela 
transfected with pCMV-myc-mito-GFP and basal condition, D Hela transfected with 
pCMV-myc-nucl-GFP under basal condition, E MCF7 transfected with pCMV-myc-
mito-GFP and treated with 100 M H2O2, F  MCF7 transfected with pCMV-myc-nucl-
GFP and treated with 100 M H2O2, G  MCF7 transfected with pCMV-myc-mito-GFP 
under basal condition and H MCF7 transfected with pCMV-myc-nucl-GFP under basal 
condition.  
 
 
ROS levels in mitochondrial hTERT expression compared with nuclear hTERT and 
non-transfected cells (P<0.01). Under oxidative stress, U87 was treated with 100 M 
H2O2 as in Hela and MCF7 then left for 1 day before mitoSox and immuno-
fluorescence staining. Mito-hTERT expression in U87 showed significantly lower ROS 
level compared to nucl-hTERT (P<0.05) and non-transfected cells (P<0.01). We found 
that after stress treatment, the ROS level in mito-hTERT, nucl-hTERT and non-
transfected U87 were not significant increased compared with the untreated group. This 
low level of ROS expression under untreated and exogenous stress confirms the 
protective effect of hTERT to mitochondria. However, ROS measurement one day after 
100 M H2O2 treatment or only 100 M H2O2 concentration might not suitable to 
showed the real increase of ROS level in U87.  
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Figure 4.9 Comparison of mitochondrial superoxide levels in mito-hTERT and 
nucl-hTERT transfected as well as non-transfected cells in U87 under basal 
conditions and H2O2 stress treatment. Results were summarised from 3 independent 
experiments. Bars show mean and standard error. One way Anova was used to test for 
significant differences between groups.  
 
 
4.2.4 Quantitative determination of mitochondrial superoxide levels in Hela and 
MCF7 after x-irradiation 
Since the measurements of mitochondrial ROS in the H2O2 experiments was always 
done 1 day after treatment (since earlier time points showed a non-specific effect of the 
H2O2 treatment) we explored other DNA damage treatments and chose x-irradiation. 
Again, we tested whether there exists a direct correlation between physical location of 
hTERT in the mitochondria to the level of mitochondrial superoxide under a different 
stress condition. In addition, we performed a more kinetic approach in order to see 
whether there is any dynamics involved in the protection and to get an idea how long it 
lasts under our experimental conditions.  
Mito-hTERT and nucl-hTERT were transfected into Hela and MCF7 cells which were 
then treated with x-rays at a dose of 20 Gy. All cells were double stained with mitoSox 
and myc-tag at day 0 (cells were fixed within 30 minute after irradiation), day 1 and day 
2 compared with untreated cells. Results in Hela and MCF7 cells are shown in figures 
4.10-4.15.  
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Figure 4.10 Kinetic levels of ROS after mito- and nucl-hTERT transfection in Hela 
(with irradiation). Cells were double stained with mitoSox (red) and myc-tag antibody 
(green) within 30 minute (day0), 1 day and 2 days after 20 Gy irradiation treatment. 
Arrows indicate transfected cells. A are respresentative images of Hela cells transfected 
with mito-hTERT shooter and B are respresentative images of Hela transfected with 
nucl-hTERT shooter.  
 
 
Figure 4.11 Kinetic levels of ROS after mito- and nucl-hTERT transfection in Hela 
(without irradiation). Cells were double stained with mitoSox (red) and myc-tag 
antibody (green) at day 0, 1 day and 2 days at the same time as cells after irradiation. 
Arrows indicate transfected cells. A  are respresentative images of Hela cells transfected 
with mito-hTERT shooter and B are respresentative images of Hela transfected with 
nucl-hTERT shooter. 
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Figure 4.12 Kinetic levels of ROS after mito- and nucl-hTERT transfection in 
MCF7 (with irradiation).Cells were double stained with mitoSox (red) and myc-tag 
antibody (green) with in 30 minute (day 0), 1 day and 2 days after 20 Gy irradiation. 
Arrows indicate transfected cells. A are respresentative images of MCF7 transfected 
with mito-hTERT shooter and B are respresentative images of MCF7 transfected with 
nucl-hTERT shooter.  
 
Figure 4.13 Kinetic levels of ROS after mito- and nucl-hTERT transfection in 
MCF7 (without irradiation). Cells were double stained with mitoSox (red) and myc-
tag antibody (green) at day 0, 1 day and 2 days at the same time as cells after irradiation. 
Arrows indicate transfected cells. A are respresentative images of MCF7 cells 
transfected with mito-hTERT shooter and B are respresentive images of MCF7 
transfected with nucl-hTERT shooter.  
 
 
106 
In figure 4.14 A, results indicated lower mitochondrial ROS level of Hela transfected 
with mito-hTERT shooter compared to the non-transfected cells before and after 20 Gy 
irradiation while no-significant difference between mito-hTERT Hela before and after 
treatment and nucl-hTERT Hela before and after treatment have been found (figure 
4.14, blue line). This result indicates the protective effect of hTERT when it localised in 
mitochondria and nucleus in Hela before treatment. When compared untreated Hela 
group with Hela after 20 Gy irradiated group (figure 4.14 A), ROS level of all Hela 
showed no-significantly increased within 30 minute after irradiation compared with 
Hela before treatment. In the kinetic experiment, Hela transfected with mito-hTERT and 
nucl-hTERT shooter at day 0 and day 2 showed no significant differences in mitoSox 
levels (figure 4.15 A). Only the expression of mito-hTERT at day 1 correlated to 
significantly lower levels of mitoSox than nucl-hTERT (P< 0.05). The lack of 
significance at day 1 could be due to the large variation in mitoSox levels in the nuclear 
shooter transfected cells. Thus this result indicates a protective effect of both mito-
hTERT and nucl-hTERT to ROS production in Hela after irradiation.  
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Figure 4.14 Comparison of mitochondrial superoxide levels in mito-hTERT,  nucl-
hTERT and non-transfected cells in Hela and MCF7 cells  following X-irradiation. 
A: Hela under basal condition and treated with 20 Gy x-irradiation. B: MCF7 under 
basal condition and treated with 20 Gy x-irradiation. Both cell types were fixed within 
30 minutes after irradiation. Results were summarised from 3 independent experiments 
for each cell line. One way Anova was used to test for significance between groups.  
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Figure 4.15 Kinetics of mitochondrial superoxide levels in mito-hTERT, nucl-
hTERT and non-transfected cells in Hela and MCF7 after X-irradiation. A is ROS 
kinetics in Hela cells stained and measured within 30 minute after irradiation (day 0), 1 
day and 2 days after 20 Gy irradiation treatment and B is ROS kinetics in MCF7 stained 
and measured within 30 minute after irradiation (day0), 1 day and 2 days after 20 Gy 
irradiation treatment. Results were summarised from 3 independent experiments for 
each cell line. Bars show mean and standard error. One way Anova was used to test for 
significance between groups.  
 
 
The results of MCF7 under basal condition and irradiation are shown in figures 4.14 B. 
Within 30 minute after irradiation we saw a significant difference between the 
mitochondrial and the nuclear hTERT shooter transfected MCF7 (P<0.05) while there is 
no statistical difference in untreated and at day 1 and day 2 after irradiation as showed 
in figure 4.15 B. The comparison between MCF7 before and after 20 Gy irradiation 
indicates no significant difference of mito-hTERT MCF7 between before and after 
irradiation and nucl-hTERT MCF7 before and after irradiation while we found a 
significant increased of ROS level in non-transfected MCF7 after irradiation compared 
with non-transfected MCF7 before irradiation (figure 4.14 B). The latter results in 
figure 4.14 B and 4.15 B confirm the earlier results on MCF7 under untreated 
conditions from the H2O2 experiment. The kinetics of a disappearance of the difference 
between mito-hTERT and nucl-hTERT shooter regarding mitoSox levels at later time 
points is most likely the result of the nuclear TERT protein being excluded due to the 
applied DNA damage stress. Therefore these results might confirm our previous 
observations on endogenous and over-expressed general TERT that the exclusion of 
TERT takes time and is also dependent on the level of DNA damage inflicted by the 
irradiation.  
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4.2.5 Control experiments (x-irradiation) 
Similar to those control experiments performed for H2O2 treatment, GFP control 
experiments have been done to confirm that the reduction of mitochondrial ROS was 
not an effect of the shooter vector transfection itself. Figures 4.16 and 4.17 show a GFP 
experiment performed under irradiation in order to confirm that the decrease of 
mitochondrial superoxide is due to the TERT protein and not the shooter transfection 
itself. Hela and MCF7 were transfected with GFP shooter (pCMV-myc-mito/nucl-GFP) 
and irradiated with 20 Gy dose. Results indicated similar mitochondrial superoxide 
levels in cells with or without GFP expression. All of the transfected and non-
transfected cells did not show any differences in mitoSox staining. This data suggests 
that the decreased mitochondrial superoxide levels in Hela and MCF7 are not an artefact 
from the shooter vectors but indeed due to mitochondrially localised TERT protein.  
 
 
Figure 4.16 Control experiment: Hela transfected with GFP shooter.  
A-D:  respresentative images of Hela transfected with A: pCMV-myc-mito-GFP and 
irradiated with x-rays (20Gy), B: pCMV-myc-mito-GFP under normal condition, C: 
pCMV-myc-nucl-GFP and radiated with x-rays (20Gy) and D: pCMV-myc-nucl-GFP 
under normal condition. E: Hela non-transfected after 20 Gy irradiation. F: Hela non-
transfected under normal condition. G: The graph demonstrates that the levels of 
mitoSox measured by ImageJ are similar for all cells transfected with either hTERT 
shooter vector. Bars indicate means and standard error from at least 50 cells for each 
group. 
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Figure 4.17 Control experiment: MCF7 transfected with GFP shooter. 
A-D are respresentative  images of MCF7 transfected with A: pCMV-myc-mito-GFP 
and irradiated with x-rays (20Gy), B: pCMV-myc-mito-GFP under normal condition, 
C:pCMV-myc-nucl-GFP and irradiated with x-rays (20Gy) and D: pCMV-myc-nucl-
GFPunder normal condition (un-irradiated). E: Hela non-transfected after 20 Gy 
irradiation. F: Hela non-transfected under normal condition. G: the graph demonstrates 
that the level of mitoSox measured by ImageJ is similar for all cells transfected with 
either hTERT shooter vectors. Bars indicate means and standard error from at least 50 
cells for each group. 
 
 
 
4.2.6 Quantitative determination of mitochondrial superoxide levels in U87 after 
x-irradiation 
Similar to the H2O2 experiment, we used U87 as a third cancer cell line to confirm the 
effect of hTERT in different subcellular locations after x-irradiation. Under basal 
condition U87 showed a significant lower of ROS levels in mitochondrial hTERT 
compared with nuclear hTERT and non-transfected cells (P<0.01 and P<0.05, 
respectively). U87 cells transfected with mito-hTERT and nucl-hTERT were treated 
with 20 Gy irradiation and stained for mitoSox and myc-tag antibody using immuno-
fluorescence. After irradiation, mito-hTERT expression in U87 showed significantly 
lower ROS levels compared to nucl-hTERT and non-transfected cells (P<0.01 and 
P<0.05, respectively). No significant difference between nucl-hTERT U87 and non-
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transfected cells has been found. When compare all U87 before and after treatment, 
similar results as in mito- and nucl- hTERT transfected U87 with H2O2 treatment have 
been found. No significant difference in mito-hTERT, nucl-hTERT and non-transfected 
U87 compare between before and after treatment has shown. It seems that mito-hTERT 
showed protective function even under basal condition in U87. Moreover, ROS level 
did not increased after irradiation. It is interesting that we haven’t found a significant 
increase of ROS level in U87 in both after 100 M H2O2 treatment (ROS measured 1 
day after treatment) and 20 Gy irradiation (cells were fixed within 30 minute after 
irradiation) compared with the group of non-treated U87. However, the result of the 
lower level of ROS expression under untreated and exogenous stress still confirms the 
protective effect of hTERT to mitochondria as in a third independent cancer cell line.  
 
 
Figure 4.18 Comparison of mitochondrial superoxide levels in mito-hTERT and 
nucl-hTERT transfected as well as non-transfected cells in U87 under basal 
conditions and irradiation treatment. A: U87 under basal condition. B: U87 after 20 
Gy irradiation. Results were summarised from 3 independent experiments. Bars show 
mean and standard error. One way Anova was used to test for significant differences 
between groups.  
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4.2.7 Quantitative determination of mitochondrial superoxide levels of cells 
without endogenous telomerase effect under basal condition (un-irradiated) and 
after irradiation. 
As described in chapter 3 MRC5/SV40 is a cell line which contains an inactivated p53 
due to expression of the T-antigen of the SV40 virus and does not express endogenous 
hTERT which potentially could interfere with the exogenous shooter. MRC5/SV40 cells 
were transfected with mito-hTERT or nucl-hTERT shooter vectors as described before 
and treated with different oxidative stress treatments.  
And as mentioned in Chapter 3, we have not found a different effect between 5 Gy and 
10 Gy irradiation. Thus in this experiment we have treated cells only with 10 Gy.  
Mito-hTERT or nucl-hTERT were transfected into MRC5/SV40 and then treated with 
X-irradiation as described previously in chapter 3. All cells were fixed within 30 
minutes after irradiation and double stained with mitoSox (live cell staining) and myc-
tag (immunofluorescent). Representative images are shown in fig. 4.19 and 
quantification of the results is shown in figure 4.20.  
Under basal conditions, there is no significant difference between mito-hTERT or nucl-
hTERT transfected cells and the non-transfected group. In the comparison between 
untreated and after 10 Gy irradiation, ROS level of mito-hTERT, nucl-hTERT and non-
transfected MRC5/SV40 did not showed any significant increase after irradiation  
compared with the untreated group. However, after irradiation, ROS in mito-hTERT 
transfected cells showed significant lower ROS level compared with nucl-hTERT and 
non-transfected MRC5/SV (P<0.01). Moreover, ROS in nucl-hTERT transfected cells 
after irradiation also showed significant lower level (P<0.01) than non-transfected cells 
after irradiation which might indicate a protection of nucl-hTERT to the ROS 
production.  
This result after irradiation suggests the effect of exogenous hTERT onto the decrease 
of ROS production. Interestingly, variations between the 3 different experiments were 
much larger in untreated cells than after irradiation. 
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Figure 4.19 Double staining of ROS and TERT in MRC5/ SV40 cells transfected 
with mito-hTERT and nucl-hTERT shooter under basal (un-irradiated) condition 
and after 10 Gy irradiation. Cells were double stained with mitoSox and myc-tag. Red 
colour represents mitochondrial superoxide and green colour represents hTERT 
localisation. Arrows indicate transfected cells. A shows MRC5/ SV40 cells with mito-
hTERT under basal condition. B shows MRC5/SV40 with mito-hTERT after 10 Gy 
irradiation. C shows MRC5/ SV40 with nucl-hTERT under basal condition D shows 
MRC5/ SV40 cells with nucl-hTERT after 10 Gy irradiation. 
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Figure 4.20 Comparison of mitochondrial superoxide levels in mito-hTERT, nucl-
hTERT and non-transfected cells in MRC5/SV40 after X-irradiation. Cells were 
treated with 10 Gy doses and fixed immediately after irradiation. Bars show mean and 
standard error from 3 independent experiments. One way Anova was used to test for 
significance between groups. 
 
 
4.2.8 Control experiment (MRC5/SV40 after x-irradiation) 
To confirm that the reduction of ROS in MRC5/ SV40 is because of the localisation of 
the exogenous hTERT protein and not the shooter transfection itself MRC5/ SV40 had 
also been transfected with GFP shooter (pCMV-myc-mito/nucl-GFP) and irradiated 
with the same 10 Gy doses. Results from figure 4.21 indicate a similar mitochondrial 
superoxide expression in cells with or without GFP expression. None of the transfected 
cells under any condition showed any significant differences in mitoSox staining. Thus 
this data confirms that the decrease of mitochondrial superoxide levels in MRC5/ SV40 
is not an artefact from the shooter vectors but indeed due to mitochondrially localised 
TERT protein.  
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Figure 4.21 Control experiment: MRC5/SV40 transfected with GFP shooter. A-D 
are representative images of MRC5/SV40 cells transfected with A: pCMV-myc-mito-
GFP under basal condition. B: pCMV-myc-mito-GFP and irradiated with X-rays 
(10Gy). C: pCMV-myc-nucl-GFP under basal condition. D: pCMV-myc-nucl-GFP and 
irradiated with X-rays (10Gy). E: The graph shows levels of mitoSox measured by 
ImageJ. Bars indicate means and standard error from at least 50 cells for each group. 
 
 
 
 
4.3 Discussion 
Previously published results of our group have shown that under oxidative stress 
hTERT is excluded from the nucleus and protects mitochondria in hTERT over-
expressing fibroblasts (Ahmed et al., 2008). These cells show a lower production of 
oxidative stress, less mitochondrial DNA damage, lower mitochondrial mass and 
mtDNA copy number as well as higher mitochondrial membrane potential compared to 
telomerase negative parental fibroblasts. However, in the generally over-expressed 
system, it was hard to say whether it was rather the nuclear TERT which protected 
telomeres or the fraction of mitochondrial TERT that was responsible for the decrease 
in ROS. In order to separate both localisations properly we used organelle-specific 
TERT shooter vectors. Here we show that the specific location of hTERT in 
mitochondria protects cells against oxidative stress. Hela, MCF7, U87 and MRC5/SV40 
were transfected using mitochondrial (mito-hTERT) and nuclear (nucl-hTERT) specific 
hTERT shooter vectors. In hydrogen peroxide treatment experiment, Hela, MCF7 and 
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U87 cells were transfected using mito-hTERT or nucl-hTERT shooter vectors and the 
mitochondrial ROS level measured one day after the treatment. The reason for this 
delay was to avoid the direct interference of the exogenous H2O2 which we used to treat 
cells onto the ROS measurement. One day delay after treatment was determined as the 
optimal time point for ROS measurement after H2O2 stress treatment. 
Under basal condition, both Hela and MCF7 did not show a significant difference of 
ROS levels in mito-hTERT expression and nucl-hTERT (figure 4.5). However, the level 
of ROS in nucl-hTERT transfected MCF7 under basal condition was higher than in non-
transfected cells (P<0.05).  Both mito-hTERT and nucl-hTERT transfected Hela cells 
under basal condition showed statistically lower ROS levels compared to non-
transfected cells (P<0.01).  However, mito-hTERT and nucl-hTERT transfected Hela 
did not show a statistical difference between mitochondrial hTERT expression and 
nuclear hTERT. This result suggests a difference between the Hela and MCF7 cellular 
models and might indicate a protective effect of nucl-hTERT to ROS production. After 
H2O2 stress treatment, mito-hTERT expression in both Hela and MCF7 showed 
significantly lower ROS levels compared to nucl-hTERT (P<0.01) (figure 4.5). The 
control experiment also suggests that this reduction of mitochondrial superoxide levels 
was a direct effect from the mitochondrial localisation of hTERT. However, when both 
mito-hTERT and nucl-hTERT transfected cells were compared with the non-transfected 
groups, a slight difference in mitochondrial superoxide expression between Hela and 
MCF7 were detected. Nucl-hTERT Hela showed significant lower ROS level than non-
transfected cells while nucl-hTERT MCF7 showed significant higher ROS level than 
non-transfected cells.  
We used U87 as a third cancer cell line to investigate the effect hTERT in different sub-
cellular location. U87 showed significant lower ROS level when transfected with mito-
hTERT compared with nucl-hTERT and un-transfected cells in both before and after 
H2O2 stress treatment. The significant lower ROS production in U87 cells transfected 
with mito-hTERT compared with nucl-hTERT and non-transfected cells after H2O2 
stress treatment confirms the results in Hela and MCF7 after stress treatment.  However, 
the ROS level in nucl-hTERT U87 before treatment is similar with nucl-hTERT Hela 
before treatment which showed a significant lower ROS level than non-transfected cells. 
Both results might indicate a protective effect of nucl-hTERT in U87 before treatment. 
The reason for this protection is still unclear. 
Since the measurement of mitochondrial ROS in the H2O2 experiments was done 1 day 
after treatment we explored other treatments and chose x-irradiation. This experiment 
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should confirm whether there exists a direct correlation between physical location of 
hTERT in the mitochondria and the level of mitochondrial superoxide under a different 
stress condition. Hela and MCF7 were transfected with mito-hTERT or nucl-hTERT 
and underwent irradiation (X-Rays at a dose of 20 Gy). In addition, we performed a 
kinetic approach at day 0 (cells were fixed within 30 minutes after irradiation) 
compared to non-irradiated and one day and two day post irradiation in order to see 
whether there is any dynamics involved in the protection.  
Hela cells transfected with mito-hTERT and nucl-hTERT after 20 Gy irradiation 
showed slightly different results in ROS levels compared to Hela transfected with mito-
hTERT and nucl-hTERT after H2O2 treatment (figure 4.5 to figure 4.14). After 20Gy 
radiation Hela transfected with mito-hTERT and nucl-hTERT showed no significant 
differences in mitoSox levels immediately after irradiation. For the kinetic approach 
(figure 4.15), Hela transfected with mito-hTERT and nucl-hTERT showed no 
significant differences at day 2 post treatment. However, only a slightly significant 
difference between mito-hTERT and nucl-hTERT has been found at day 1 (P< 0.05). 
The reason for this result could be due to the large variation in mitoSox levels in the 
nuclear shooter transfected cells or the protective effect of nucl-hTERT to 
mitochondrial ROS production. In irradiated MCF7, ROS levels of mito-hTERT and 
nucl-hTERT transfected cells has shown a slightly significant difference only 
immediately after irradiation (P<0.05). No statistical difference was detected at day1 
and day 2 post irradiation. This low level of ROS in nucl-hTERT transfected in both 
Hela and MCF7 might be due to the nuclear shooter being excluded over time due to the 
applied stress (irradiation) and acts as a mito-hTERT.   
Again, we used U87 as a third cancer cell line after x-irradiation. Under basal condition, 
U87 showed a significant lower ROS level in the mito-hTERT group compared with 
nucl-hTERT and un-transfected cells while no significant difference was found between 
nucl-hTERT U87 and non-transfected cells. After irradiation, mito-hTERT U87 showed 
significant lower ROS production compared with nucl-hTERT and non-transfected 
cells. In general, these results with irradiation confirm our previous observations on 
endogenous and over-expressed general TERT that the exclusion of TERT takes time 
and is also dependent on the level of DNA damage inflicted by the irradiation as shown 
in   Chapter 3.  
To confirm that the mitochondrial protection was due to the mitochondrial shooter 
vector and not because of endogenous telomerase, we tested the correlation between 
physical localisation of hTERT in the mitochondria or nucleus to the expression of ROS 
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in MRC5/SV40.  This cell line does not express endogenous hTERT which might 
influence the effect of the transfected exogenous mito-hTERT shooter.  Thus the 
protective function in this cell type could be atributed exclusively to  the transfected 
hTERT. Under basal conditions, there was no significant difference between mito-
hTERT, nucl-hTERT and the non-transfected group. However, after irradiation, ROS in 
the mito-hTERT transfected group was significantly lower than both nucl-hTERT and 
non transfected cells (figure 4.19). This result confirms the effect of exogenous hTERT 
to the lower ROS production when it was localised in mitochondria. However, ROS 
levels of nucl-hTERT in MRC5/SV40 after irradiation were also significantly lower 
than the non-transfected group which confirm the previous result of the protective 
capacity of nucl-hTERT to mitochondrial ROS production. Although MRC5/SV40 also 
contains an inactive p53 similar to Hela cells they did not show a similar result after 
irradiation. Thus the influence of p53 on the protective capacity of hTERT and the 
protective effect of nucl-hTERT to mitochondrial ROS production is unclear. Further 
experiments to investigate whether p53 status affects the protective function of 
telomerase will be described in chapter 5. To exclude the possibility that the reduction 
of ROS due to hTERT localised in mitochondria was the result of the shooter vector 
transfection itself, experiments using GFP containing shooter vectors were performed in 
all cell lines: Hela, MCF7 and MRC5/SV40 (figure 4.9, 4.16-17 and 4.20). The 
experiments using mito/nucl-GFP shooter vectors did not show any difference among 
GFP transfected and non-transfected cells. Thus this reduction of ROS expression was 
not a direct result from the shooter transfection or general ectopic protein expression. 
Taken together, all results confirm that mitochondrial localisation of telomerase protects 
against mitochondrial ROS generation after exogenous stress treatment. 
It has to be concern that in some cells such as U87 and MRC5/SV40 and some 
condition such as Hela after 20 Gy irradiation, ROS level did not increased after stress 
treatment compared with the same cell types under basal condition. The reason for this 
probably be that the stress treatment condition might not high or suitable enough to 
show a real H2O2 effect. Thus the treatment condition should vary depend on cell type.  
ROS is known to be responsible for nuclear DNA damage (Passos et al., 2010) the 
reduction of ROS when hTERT is localised in mitochondria cause the protection of 
DNA which we have found in Chapter 3. Passos and colleagues reported a feedback 
loop of ROS production through CDKN1A (p21), MAPK14 (p38MAPK) and TGF 
linked to DNA damage response in senescent fibroblasts (Passos et al., 2010).  Nitta and 
colleagues reported that although p21 does not influence the protection of TERT in 
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ATM-deficient hematopoietic stem cells in aged mice (37 weeks old) however, TERT 
can partially protect the hematopoietic stem cells from ROS-induced apoptosis via 
inactivation of p38MAPK in mice (Nitta et al., 2011). Therefore this mechanism might 
be partially involved in the protective mechanism of mitochondrial localised telomerase. 
Further experiments correlating apoptosis induction and mitochondrial localisation of 
hTERT could explain the influence of mitochondrial telomerase to the cellular ageing 
process in telomerase positive cells.  
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Chapter 5 
The influence of p53 status on the protective function of telomerase 
 
5.1 Introduction  
We have found some differences in mitochondrial superoxide expression and nuclear 
DNA damage between Hela and MCF7 as described in Chapters 3 and 4. One possible 
explanation for this difference could be that Hela and MCF7 display a different  p53 
status . Hela harbours an inactivation of p53 because of the HPV (Human 
papillomaviruses) subtype 18 viral proteins E6 and E7 that functionally inactivate the 
check point of p53 and p16 protein, respectively. Therefore p53 is compromised and 
non-functional in these cells (Hopper-Seyler and Butz, 1993). This is different from 
MCF7 which expresses a strange cytoplasmic localization of p53 and is also p16 
negative (Valenzuela et a., 1997). Thus, we hypothesised that this different p53 status 
could play a role for the differences in mitochondrial superoxide and DNA damage 
between Hela and MCF7.  
The tumour suppressor gene known as p53 is a DNA-binding protein which acts as a 
transcription factor to control the expression of proteins involved in the cell cycle.  In 
response to DNA damage, p53 accumulates in the cell nucleus, which causes cells to 
undergo cell cycle arrest and DNA repair or apoptosis. It is believed that cancer cells 
defective in p53 have lost the ability to undergo cell cycle arrest.  P53 is mutated in 
around 60% of all tumours and might contribute to better cancer cell survival because 
the cells don‘t arrest even with a high load of DNA damage. 
The p53 gene is located on human chromosome 17p13.1. This gene is 20 kb long  (Pei 
et al., 2012).  Transcription of this gene produces a pre mRNA with eleven exons, 
which can then be spliced to an mRNA between 2 and 2.5 kb in length and containing 
two promoters (Roemer and Friedmann, 1994).  Subsequent to translation and 
tetramerization, the p53 tumour suppressor goes on to regulate cell growth by 
controlling cell cycle progression at the G1/S and G2/M transitions, or by inducing 
apoptosis.   
The p53 protein is activated upon DNA damage in the cell, which can be caused by 
ionising radiation, UV radiation, genotoxic stress, or extreme hypoxia (<1%).  The up 
regulation of p53 occurs at the post-translational level (phosphorylation, 
tetramerisation), and is achieved through stabilisation of the protein (Choisy-Rossi et 
al., 1999). Upon induction, the main outcome of p53 activation is growth suppression, 
growth arrest at the G1, G2, and M checkpoints. The p53 protein also plays an 
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important role in cell death through the apoptotic pathway.  Bax, a pro-apoptotic 
protein, is up-regulated by p53, while Bcl-2, an antiapoptotic protein, is down regulated 
by p53 (Zeimet et al., 2000).  In addition to these transactivation pathways toward 
apoptosis, it has also been suggested that p53 may regulate apoptosis through a 
transcription-independent pathway p53 that can be induced by ROS. The cellular 
response to oxidative stress can embrace changes in nucleus, mitochondria and other 
cellular organelles.  
Many groups have implicated ROS generation in the post translational modifications of 
p53. During cisplatin-induced apoptosis, ROS are involved in phosphorylation of p53 
that leads to p53-mediated MAPK activation (Bragado et al. 2007). ROS are also 
implicated in the phosphorylation and activation of p53 via oxidative-stress-induced 
activity of platelet-derived growth-factor-β and ATM kinase which phosphorylates p53 
in response to DNA damage under H2O2 stress condition in Human umbilical vein 
endothelial cells (Chen et al. 2003(b)). 
P53 is a key effector in response to oxidative injury and DNA damage to a cell fate 
decisions. P53 has also been reported to translocate to the outer mitochondrial 
membrane to interact with both pro- and anti-apoptotic proteins and influence the 
induction of both apoptosis and autophagy. However, the physiological relevance of 
these non-transcriptional mechanisms are not clear (Chipuk & Green 2003). 
Various mutations at hot spots have been described to inactivate it in many cancer types 
( Liu et al., 2009; Ye et al., 2009; Campitelli et al., 2012). The physiological expression 
of point-mutated p53 can strongly limit overall cellular p53 function (de Vries et al., 
2002). The presence of a heterozygous point-mutated p53 allele resulted in delayed 
transcriptional activation of several p53 downstream target genes after irradiation in 
mouse embryonic stem cells (de Vries et al., 2002). Presence of mutated p53 reduced 
the ability of wild-type p53 in inducing p21, MDM2 and PIG3 (Willis et al., 2004). 
Thus mutant p53 exerts its dominant negative activity by abrogating functional wile-
type p53. 
In order to address our research question about the influence of p53 status on the 
protective function of telomerase we used an isogenic cell pair of the glioblastoma cell 
line U87 to analyse whether the p53 status might play any role for the correlation 
between mitochondrial protection of hTERT and nuclear DNA damage.  
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5.2 Experimental procedure 
5.2.1 Cell lines and transfection efficiency  
An isogenic pair of glioblastoma cells was used in this experiment. U87 and its isogenic 
clone which will be described as UP96 (U87 transfected with a mutant p53 vector that 
contained point mutation p53 at codon 143 were generated previously in our group, 
Saretzki et al., 1999). UP96 cells were maintained in the p53 mutated status by selection 
with G-418 sulfate. This method ensured that only cells which contained the vector 
pC53-SCX3 which expresses a p53 cDNA point-mutated at codon 143 were 
maintained. The phosphorylation of p53 in U87 and UP96 were analysed before and 
after 400 M H2O2 treatment for 3 hours. For that a phospho-specific antibody, 
Phospho- p53 against Ser 15 (Cell Signalling) was used. The westernblot of U87 and 
UP96 after 400 M H2O2 treatment were stripped with Western blot stripping buffer 
and then re-blotted with total p53 antibody and tubulin. Western blot analysis of U87 
and UP96 is shown in figure 5.1. We found a positive band of phosphorylated p53 in 
U87, U87 mito-hTERT and U87 nucl-hTERT after H2O2 treatment while no 
phosphorylated p53 in UP96, UP96-mito-hTERT and UP96 nucl-hTERT have been 
found after H2O2 treatment. This result indicated an active p53 in U87 while no p53 
activated in UP96.  
        
 
Figure 5.1 Westernblot of p53 and phosphorylated p53 in U87 and its isogenic 
form. Lane M is a western blot marker lane 1: U87, lane 2: U87 transfected with mito-
hTERT shooter, lane 3: U87 transfected with nucl-hTERT, lane 4: UP96, lane 5: UP96 
transfected with mito-hTERT shooter, lane 3: UP96 transfected with nucl-hTERT 
shooter 
 
 
U87 and UP96 cells were transfected with hTERT shooter vector as described in 
Chapter 2. Figure 5.2 represents the transfection efficiencies for U87 and UP96 with 
lipofectamine 2000.  
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Figure 5.2  Transfection efficiencies of mito-hTERT and  nucl-hTERT into U87 
and UP96 cells. pShooter vectors were transfected to U87 and UP96 by 
lipofectamine
TM
 2000. 2 days after transfection, cells were fixed and the transfection 
efficiency was determined using immuno-fluorescence against the myc-tag.  
 
 
 
5.3 Results 
5.3.1 The effect of p53 expression onto the kinetic exclusion of TERT  
We started this experiment with the comparison of the kinetic exclusion of endogenous 
hTERT after oxidative stress. U87 and UP96 were treated with 400μM H2O2 for 3 
hours. Cells were fixed every 15 minutes until 1 hour and then at 2 and 3 hours. 
Representative images and results are shown in figures 5.3-5.5. 
As shown in figure 5.5, there was no major difference found between U87 and UP96 
cells in the short-term kinetic exclusion of endogenous hTERT after 400μM H2O2 
treatment. The only difference was a slightly faster exclusion in U87 at 45 min 
compared to UP96 cells where the exclusion started only at 1 hour. However, there were 
some differences when compared to the previously analysed exclusion kinetics in other 
cancer cell lines. Firstly, before treatment (under basal condition) both U87 and UP96 
already showed about 30% of hTERT localised in the cytoplasm. This is higher than 
Hela and MCF7 where we had found only 20% of hTERT already localised in the 
cytoplasm under untreated condition. Secondly, the maximum exclusion was reached 
after 2 hours with around 60% hTERT in the cytoplasm in both U87 and UP96. Thirdly, 
the nuclear hTERT exclusion reverted already back after 2 hours and was reduced to 
40% while both Hela and MCF7 maintained a stable exclusion for several days (figure 
3.6 in chapter 3). Therefore, considering the already high initial exclusion rate of 30% 
in U87 and its derivative the general exclusion levels seems small (not more that 20% 
(30-50%) additional) and it did not last for much longer than an hour. In general, except 
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a slight delay in the start of hTERT exclusion from the nucleus, p53 activity does not 
seem to play any major role in telomerase exclusion from nucleus to cytoplasm in this 
experimental system.  
 
 
 
Figure 5.3 Endogenous hTERT localisation before and after H2O2 treatment in 
U87 cells. U87 cells were treated with 400 M H2O2 for 3 hours and hTERT 
localisation within or outside the nucleus evaluated as described under 2.2.11 in Chapter 
2. A is a representative image of U87 under basal condition. B is a representative image 
of U87 after 3 hours of 400 M H2O2 treatment. 
 
Figure 5.4 Endogenous hTERT localisation before and after H2O2 treatment in 
UP96 cells. UP96 cells were treated with 400 M H2O2 for 3 hours and hTERT 
localisation evaluated within or outside the nucleus as described under 2.2.11in Chapter 
2 . A is a representative image of UP96 under basal condition. B is a representative 
image of UP96 after 3 hours of 400 M H2O2 treatment. 
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Figure 5.5 Short-term kinetic exclusion of endogenous hTERT in U87 and UP96. 
All cells were treated with 400μM H2O2 for 3 hours. A: U87 treated with H2O2. B: 
UP96 treated with H2O2. Cells were fixed at the indicated time points. The localisation 
of hTERT was measured in each individual cell using ImageJ. At least 30 cells per time 
point have been evaluated in each experiment. Bars indicate means and standard error 
from 3 independent experiments. 
 
 
5.3.2 The effect of p53 status on nuclear DNA damage when hTERT is localised 
in different cell compartments 
Since we found a difference in DNA damage and ROS levels when hTERT was 
localised in different cellular compartments in Hela and MCF7 we now used an isogenic 
cell pair in order to avoid any additional genetic differences between unrelated cancer 
cell lines. U87 and UP96 were transfected with mito-hTERT or nucl-hTERT, treated 
with 2, 5 10 and 20 Gy irradiation and then double stained with myc-tag andH2A.X 
for DNA damage determination. Representative images of U87 and UP96 after different 
irradiation dosages are shown in figures 5.6 and 5.7.  DNA damage foci of U87 and 
UP96 after different irradiation dosages are shown in figure 5.8 and summarised in 
figure 5.9.    
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Figure 5.6 Double staining of U87 and UP96 cells transfected with mito-hTERT 
shooter under different dosages of x-irradiation. Cells were double stained with 
H2A.X and myc-tag. Red colour represents DNA damage foci and green colour 
represents hTERT localisation. Blue is DAPI for nuclear staining. White arrows indicate 
transfected cells. 
 
 
 
Figure 5.7 Double staining of U87 and UP96 cells transfected with nucl-hTERT 
shooter under different dosages of x-irradiation. Cells were double stained with 
H2A.X and myc-tag. Red colour represents DNA damage foci and green colour 
represents hTERT localisation. Blue is DAPI for nuclear staining. White arrows indicate 
transfected cells. 
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Figure 5.8  DNA damage foci in U87 and UP96 cells transfected with mito-hTERT, 
nucl-hTERT and non transfected after different dosages of x-irradiation. Cells 
were double stained with H2A.X and myc-tag and DNA damage foci number were 
counted from each cell. At least 20 cells were analysed per experiment. Bars indicate 
means and standard error from 2-3 independent experiments. * P<0.05, ** P<0.01, ns = 
non-significant difference.  
 
 
As shown in figure 5.8 cells which contained DNA damage foci were categorised into 2 
groups: the group which contained none or less than 10 damage foci and the group 
which contained more than 10 damage foci inside the nucleus. We found some 
background damage in both cell lines and chose the categories accordingly.  
Under untreated condition, U87 and UP96 showed no significant difference for cells 
which contained more than 10 damage foci. Likewise, there were no differences 
between mito-hTERT, nucl-hTERT and non-transfected cells in U87 or any UP96.  
Initially, we used low dose irradiation to treat the cells. After 2 Gy and 5 Gy irradiation 
treatments, no significant differences had been found between mito-hTERT, nucl-
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hTERT and non transfected cells in U87. However, at 5 Gy irradiation UP96 cells 
transfected with nucl-hTERT were starting to show a significantly higher damage than 
mito-hTERT and non transfected group, while no significant difference has been found 
between non-transfected cells and cell with nucl-hTERT (see fig. 5.7). 
Therefore, we increased the dosis of irradiation to 10 and 20 Gy. Under 10 Gy, 
mitochondrial localisation of hTERT started to express its protective function. Both 
U87 and UP96 transfected with mito-hTERT showed significantly lower damage in the 
group of more than 10 foci compared to both nucl-hTERT and non-transfected cells 
while no significant difference was found between nucl-hTERT and non-transfected 
U87. For UP96, on the other hand, a difference between non transfected and nucl-
hTERT transfected cells appeared in the group of 10 Gy irradiation (p<0.05), but nucl-
hTERT UP96 became significantly different (p<0.01) when we increased the irradiation 
dosage to 20 Gy. Here, we found a significant higher DNA damage in UP96 transfected 
with nucl-hTERT transfected cells compared to non transfected and mito-hTERT 
transfected cells while no significant difference was found between non transfected cells 
and nucl-hTERT transfected cells in U87 after 20 Gy irradiation. Thus, it seems that the 
specific increase of DNA damage in UP96 cells transfected with nucl-hTERT could be 
caused by the different p53 status of these cells compared to U87. Although for cells 
transfected with mito-hTERT under 20 Gy, both U87 and UP96 showed significant 
lower DNA damage compared to nucl-hTERT and non transfected cells, the decrease in 
DNA damage was much more pronounced in U87 cells. Thus, although p53 status does 
not influence the protective function of telomerase when it is localised in mitochondria 
per se, it seems to be more efficient when cells have a functioning p53 checkpoint. 
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Figure 5.9  Comparison of damage foci number in U87 and UP97 transfected with 
mito-hTERT, nucl-hTERT and non transfected under basal conditions and after x-
irradaition. The graph represents the percentage of cells with more than 10 damage 
foci. Cells were treated with different x-ray doses and fixed within 15 minutes after 
treatment. A: U87 after x-irradiation. B: UP96 after x-irradiation. * P<0.05, ** P<0.01, 
ns = non-significant difference. The graph is the summary of 2-3 independent 
experiments per condition and cell type. 
 
 
In figure 5.9, the results presented in figure 5.8 are shown as a kinetic expression with 
increasing irradiation doses and contains only cells with more than 10 foci. U87 and 
UP96 showed a different kinetics of DNA damage under increasing irradiation dosage. 
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When hTERT was localised in mitochondria, the damage of U87 which contains p53 
wild type was reduced and significant lower when the dosage of irradiation increased. 
However, no significant difference has been found between the DNA damage level of 
nucl-hTERT and non-transfected U87 when we increased the irradiation dosage upto 20 
Gy.  
Interestingly, in nucl-hTERT transfected UP96, the DNA damage was increasing when 
irradiation dosage has increased. We found pronounced increase of the DNA damage 
after nucl-hTERT UP96 was irradiated at 20 Gy. However, mitochondrial hTERT 
localisation in UP96 was still expressing their protective capacity and helps to reduce 
nuclear DNA damage. Significantly lower DNA damage has been found in mito-
hTERT UP96 compared with nucl-hTERT and non–transfected UP96. This experiment 
confirms the previous results in Hela and MCF7 regarding to the DNA damage after 
hydrogen peroxide treatment (figure 3.9 and 3.10). Thus, p53 status does influence the 
amount of protection of telomerase when it is localised in the mitochondria and 
exacerbates nuclear DNA damage when it is localised in the nucleus. 
 
The comparison between U87 and UP96 after 20 Gy irradiation is shown in figure 5.10. 
Two results are striking: Firstly, although mitochondrial localisation of hTERT showed 
a protective capacity to DNA damage in both U87 and UP96 the protective effect was 
significantly (P<0.01) larger in U87 than in UP96 cells. Secondly, the level of DNA 
damage in UP96 transfected with nuclear shooter was significantly higher than U87 
transfected with the same vector. Both mito-hTERT and nucl-hTERT transfected UP96 
showed significant higher DNA damage than U87 after a high irradiation doses. There 
was no difference between U87 and UP96 in non-transfected cells. Therefore, the 
localisation of hTERT to the different cell compartments: nucleus or mitochondria, has 
a pivotal influence on the sensitivity of the respective cell against DNA damaging 
genotoxic stress. Thus, there might be a possible interaction between telomerase and 
mutated/inactive p53 of UP96 when a cell is under stress condition.  
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Figure 5.10 Comparison of DNA damage foci number in U87 and UP96 cells 
transfected with mito-hTERT, nucl-hTERT and non-transfected after 20Gy 
irradiation. The graph represents the percentage of cells which showed more than 10 
damage foci.           * P<0.05, ** P<0.01, ns = non-significant difference. Bars indicate 
means and standard error from three independent experiments. 
 
 
5.3.3 Quantitative determination of mitochondrial superoxide levels in U87 and 
UP96 after irradiation  
As our previous experiment in Chapter 4 showed a correlation between mitochondrial 
ROS generation with different hTERT localisation.   In order to characterise the effect 
of p53 to this protective function of telomerase, we compared the levels of 
mitochondrial superoxide in mito-hTERT, nucl-hTERT and non-transfected cells in 
U87 and UP96 under basal and stress conditions (irradiation treatment).  Transfected 
and non–transfected U87 and UP96 were treated with X-irradiation at a dose of 2 Gy 
and 20Gy and compared with non-irradiated cells. All cells were double stained with 
mitoSox immediately within 15 minutes after irradiation, then fixed and stained with an 
antibody against myc-tag.  
Figure 5.11 represent a comparison of mitochondrial superoxide levels in mito-hTERT,  
nucl-hTERT and non-transfected cells in U87 and UP96 between basal conditions and 
cells after 2 Gy irradiation. Interestingly, both cell lines transfected with mito-hTERT 
shooter demonstrated already a protective effect of lower ROS levels compared to nucl-
hTERT and non-transfected cells before treatment. We found a significant difference 
between non-transfected U87 and nucl-hTERT transfected U87 which might indicate 
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the protective effect of nucl-hTERT to ROS production before treatment. However, no 
significant difference was found between non-transfected UP96 and UP96 transfected 
with nucl-hTERT.  
After 2 Gy irradiation we found lower mitochondrial ROS levels in both U87 and UP96 
cells transfected with mito-hTERT shooter compared to those transfected and nucl-
hTERTshooter. We have not found a significant difference between U87 transfected 
with nucl-hTERT and the non-transfected group after 2 Gy irradiation. However, a 
significant difference has been found between non-transfected UP96 and nucl-hTERT 
UP96 after 2 Gy irradiation. Both mito-hTERT and nucl-hTERT transfected UP96 
showed a significant lower (P<0.01and P<0.05, respectively) ROS level than non-
transfected cells which indicate the protective effect of hTERT to ROS production.  
Comparison of mitochondrial superoxide levels in mito-hTERT,  nucl-hTERT and non-
transfected U87 and UP96 between basal condition and 20 Gy irradiation is shown in 
figure 5.12. We found a similar significant lower mitochondrial ROS levels in both U87 
and UP96 cells transfected with mito-hTERT shooter after 20Gy irradiation compared 
to those non-transfected and nucl-hTERT transfected cells. It is interesting that there are 
no significant difference between ROS level of mito-hTERT transfected group before 
and after 20Gy irradiation which indicated a protective function of hTERT in 
mitochondria. However, we found non-significant difference between both U87 and 
UP96 transfected with nucl-hTERT compared with the non-transfected group after 20 
Gy irradiation. Both of them also showed significant higher of ROS level compared 
with the similar cells under basal condition.  
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Figure 5.11 Comparison of mitochondrial superoxide levels in mito-hTERT,  nucl-
hTERT and non- transfected cells in U87 and UP96 under basal conditions and 2 
Gy x-irradiation. A: U87 before (black) and after 2 Gy irradiation (red). B: UP96 
before (black) and after 2 Gy irradiation (red). Bars show mean and standard error from 
3 independent experiments. * P<0.05 ** P<0.01, ns = non-significant difference. One 
way Anova was used to test for significant differences between groups.  
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Figure 5.12 Comparison of mitochondrial superoxide levels in mito-hTERT,  nucl-
hTERT and non- transfected cells in U87 and UP96 under basal conditions and 20 
Gy x-irradiation. A: U87 before (black) and after 20 Gy irradiation (red). B: UP96 
before (black) and after 20 Gy irradiation (red). Bars show mean and standard error.      
* P<0.05 ** P<0.01, ns = non-significant difference. One way Anova was used to test 
for significant differences between groups.  
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5.3.4 Where is the nuclear DNA damage generated due to nuclear TERT shooter 
localised in U87 and UP96?  
Since we found a significant increase of DNA damage when hTERT is localised in the 
nucleus and nuclear telomerase is closely related to telomere maintenance we were 
interested whether the DNA damage  is located on or outside the telomere. U87 and 
UP96 were transfected with nucl-hTERT and treated with 20 Gy irradiation. Cells were 
fixed within 15 minutes after irradiation and then triple stained for combined immuno-
fluorescence staining and telomere –FISH. The protocol for Telo-Fish and co-
localisation analysis was described in 2.2.17 in Chapter 2. A representative image and 
the analysis of the co-localisation are shown in figures 5.13- 5.14. 
 
 
 
Figure 5.13  Representative image of telo-FISH in UP96 cells transfected with nucl-
hTERT shooter. UP 96 was transfected with nuclTERT shooter and irradiated with 20 
Gy. Cells were triple labelled with Alexa
®
 Fluor 488 (green) for H2A.X and Alexa® 
Fluor 633 (far red) for myc-tag staining and PNA probe (Cy3, red) for telomere 
hybridisation. Cells were stained with To-pro3 to show the nucleus. A: Merged image 
of 3 colour channels. The white square indicates the cell which was enlarged as shown 
in B- E. B: telomere signals from hybridisation with PNA probe (Cy3, red). C: DNA 
damage foci stained with gamma H2A.X. D: Merged picture between telomere signal 
and DNA damage foci. Yellow arrows indicate the colocalisation between PNA probe 
and DNA damage which appeared in yellow. E: Merged picture between Myc-tag and 
To-pro3. 
 
136 
 
Figure 5.14  Levels of H2A.X foci in U87 and UP96 under basal and 20 Gy 
irradiation. A: average number of H2A.X foci in U87 and UP96 cells (all transfected 
with nuclear TERT shooter vector) under basal (untreated) condition and 20 Gy 
irradiation. Black bars represent an average of total number of H2A.X foci 
colocalisation with telomeres (TAF). Red bars represent the average number of H2A.X 
foci  not colocalised with telomere. Data was averaged from 3 independent cell groups. 
B: percentage of H2A.X foci colocalising with telomere (%TAF per cell) in U87 and 
UP96 under basal condition and after 20 Gy irradiation.  
 
 
 We found before that transfected of nucl-hTERT to UP96 showed significantly higher 
amount of DNA damage compared to non-transfected cells after 20 Gy irradiation. 
Thus, we analysed here only cells which contained high DNA damage (>10 foci per 
nucleus) in both U87 and UP96 to analyse the co-localisation between H2A.X and 
telomere after 20 Gy irradiation.  
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The average amount of DNA damage in U87 and UP96 under basal and 20 Gy 
irradiation is shown in figure 5.15. We found a significant increase of non-telomeric 
DNA damage in UP96 after 20 Gy irradiation compared to U87 after irradiation. (red 
bar in figure 5.15A). However, we did not find any difference between telomeric 
H2A.X foci (TAF, black bar in figure 5.15A) compared between U87 and UP96 under 
basal condition and U87 and UP96 after 20 Gy irradiation. The co-localisation 
percentage of H2A.X to telomere ranged between 4 to 10% before irradiation and 
increased to about 12 to 15% after irradiation in both U87 and UP96. We have analysed 
at least 10 cells per group by using Z-stack images.  
 
5.4  Discussion 
We hypothesised from our previous results in chapter 3 that the difference in DNA 
damage between Hela and MCF7 transfected with nucl-hTERT shooter vectors could be 
due to their different p53 status. P53 in Hela is non-functional while MCF7 contains 
active p53. In order to clarify the role of p53 for mitochondrial protection of hTERT and 
DNA damage we used an isogenic cell pair of glioblastoma cells: U87 which contains 
wild type p53 and UP96 which contains a dominant negative mutated p53. 
Unfortunately, we have not compared the apoptosis data between U87 and UP96 which 
should be done in order to compare the effect of hTERT localisation after stress 
treatment to the apoptosis induction. Thus this experiment should be performed in order 
to investigate the effect of different p53 status to apoptosis induction in our cell system. 
For the influence of p53 status on the protective function of telomerase, first, we tested 
the localisation of hTERT in both cell lines. We found that U87 and UP96 have already 
about 30% of hTERT localised in the cytoplasm under basal condition. The cytoplasmic 
accumulation of hTERT in U87 and UP96 under untreated condition is slightly higher 
than in Hela and MCF7 which show only 20%. This high initial exclusion rate could 
possibly be a result from high stress experienced already under basal conditions which 
might be due to inadequate culture conditions. In addition, it is also possible that the 
high initial exclusion rate could be connected to the low additional hTERT exclusion 
under increased stress. Since we are the first to have analysed the hTERT exclusion 
systematically the reasons for this different kinetics in the 3 cancer cell lines remain 
elusive. We would speculate that additional genetic changes in each of the cancer cell 
lines might influence the hTERT exclusion behaviour. 
In general, we have not found a major difference in the exclusion kinetics between un-
transfected U87 and UP96 cells. However, U87 cells excluded hTERT slightly faster 
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(45 minutes) while the exclusion only started at 1h for UP96. In general, the exclusion 
reached a maximum after 2 hours and already decreased at 3 hours. This is in striking 
contrast to the other analysed cell lines. Thus, we could not detect any major influence 
of p53 activity on telomerase exclusion from nucleus to cytoplasm. However, a more 
careful analysis of different stress types and more time points could probably help to 
address that question in more detail. 
For DNA damage, we found that under basal conditions U87 and UP96 showed no 
significant difference between mito-hTERT, nucl-hTERT and non-transfected cells. It is 
also interesting to note that UP96 cells which contain a mutated p53 similar to the 
functionally inactivated one in Hela cells did not show a significantly higher damage 
under basal conditions when transfected with nucl-hTERT. U87 and UP96 also did not 
show a significant difference between mito-hTERT, nucl-hTERT and non-transfected 
cells under low dose of irradiation. Thus, p53 activity does not correlate to the DNA 
damage level directly in this manner.  
However, at 5 Gy irradiation UP96 cells transfected with nucl-hTERT were starting to 
show a significantly higher DNA damage. When we increased irradiation dosages even 
further the protective capacity of mitochondrial hTERT became increasingly 
pronounced. Both U87 and UP96 cells transfected with mito-hTERT showed 
significantly lower DNA damage compared to those containing nuclear hTERT and non 
–transfected cells. However, at 20 Gy there was a very clear effect of much better 
protection of mito-hTERT in U87 than in UP96 cells (figure 5.8).  
Most importantly, when hTERT was localised in the nucleus, we discovered differences 
in the level of DNA damage in U87 and UP96 cells. The level of DNA damage in UP96 
cells was significantly higher than in U87 cells transfected with mito-hTERT. We have 
not found a similar effect in non-transfected cells. This result means that the p53 status 
is clearly important for the outcome of irradiation or other stress treatments in cancer 
cells. In the context of p53 and apoptosis, cells which contain active p53 might apoptose 
easier than that cells contain mutated p53 but this process takes time to induce. In our 
experimental which we fixed cells within 15 minutes after irradiation, apoptosis 
induction is not relevant to our experimental system and effect our results. However, the 
fact that apoptosis is induced in non-transfected or transfected with nucl-hTERT cells 
corresponds to those having high ROS as well as high DNA damage levels. The 
mechanism which related to the higher DNA damage after irradiation when active 
hTERT is localised in nucleus in p53- cell is still unclear. We hypothesis that 
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telomerase localisation might possibly interact with p53 when a cancer cell is under 
stress condition.  
Kovalenko and co-workers suggested that the high level of DNA damage when hTERT 
is localised in the nucleus might play a role in cell cycle delay in order to repair the 
damage site (Kovalenko et al., 2010b). Activated p53 will arrest the cell cycle to allow 
time for DNA repair (Zhang et al., 2012). My results demonstrate that nuclear 
localisation of hTERT could not reduce ROS generation under stress conditions 
compared to mitochondrial localisation of hTERT resulting in higher nuclear DNA 
damage. One could speculate that this higher level of ROS generation might activate 
p53 to arrest the cell cycle to allow time for DNA repair. Nuclear hTERT might help to 
delay cell cycle progression in cells which contains functional p53 but could not display 
this function when cell contains inactive p53. More detailed analysis of the relationship 
between hTERT and p53 along with other p53 related genes might help to explain the 
discovered correlation between nuclear localisation of telomerase and induction of DNA 
damage.   
Regarding the influence of p53 on ROS levels described in chapter 4, we found that 
U87 and UP96 have lower mitochondrial ROS levels when transfected with mito-
hTERT shooter compared with nucl-hTERT and non-transfected cells. This result 
confirms our previous findings on Hela and MCF7. It is interesting that we have found a 
significant induction of ROS generation in both U87 and UP96 transfected with nuclear 
hTERT and non-transfected cells after 20 Gy irradiation while no-significant increase of 
ROS production in both U89 and UP96 transfected with mito-hTERT. These results 
indicate that p53 protein does not influence the mitochondrial protective function of 
hTERT when it localised in mitochondria.   
In co-localisation analysis between telomeric and non-telomeric DNA damage, we 
found a significant higher non-telomeric nuclear DNA damage level in UP96 
transfected with nucl-hTERT shooter after 20 Gy irradiation compared to U87 
transfected with nuclear hTERT after 20 Gy irradiation as we have found before. 
Unfortunately, due to technical difficulties we could not confirm that all analysed cells 
contained the nuclear hTERT shooter vector.  In order to address the question whether 
there was a change in the amount of TAFs due to different 53 status we analysed the 
percentage of colocalisation of H2A.X foci telomeres (%TAF). We have not found a 
significant difference in the localisation of the DNA damage between U87 and UP96 
transfected with nucl-hTERT before and after 20 Gy irradiation. Thus the higher 
number of nuclear DNA damage when hTERT was localised in nucleus in cells 
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containing inactive p53 did not increase the percentage of co-localisation between DNA 
damage and telomere. Our experiment has found about 12-15% of TAFs in U87 and 
UP96 which is different from experiments of another group which reported about 40-
50% co-localised between DNA damage and telomere in SQ20B and LNCaP 
transfected with hTERT harbouring a mutated the nuclear exclusion signal (Kovalenko 
et al., 2010b). Moreover, we have not found a significant increase of the percentage of 
co-localisation between DNA damage and telomere as reported in Kovalenko’s 
experiment. So far, we are the second group which confirms that the localisation of 
hTERT in the nucleus correlates to nuclear DNA damage. However, our experiment 
used a different method which over-expressed the fully functional wild type hTERT in 
the nucleus and showed a correlation between nuclear localisation of hTERT and DNA 
damage in cells which contain different p53 activity under stress condition. The 
expression of telomerase is related to the activation of many genes (Baross et al, 2004; 
Ahmed et al., 2008; Daniels et al., 2010). Thus more detailed experiments on the 
correlation between hTERT and gene expression while p53 is inactive might help to 
better understand the pathway responsible for this DNA damage induction.  
In conclusion, results in this chapter confirmed the protective function of mitochondrial 
telomerase regarding the reduction of ROS production after exogenous stress treatment 
while the influence of the p53 status was variable. The most dramatic influence has 
mutated p53 on DNA damage induction on cells with nuclear TERT localisation. It 
seems possible that telomerase interacts functionally with p53 in the nucleus. This 
experiment might open a novel link between telomerase and p53 activity while a cell is 
under stress condition.   
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Chapter 6 
Mitochondrial localisation of telomerase reduces mitochondrial ROS 
and nuclear DNA damage after endogenous stress 
 
6.1 Introduction  
In previous chapters we have used hydrogen peroxide and irradiation to activate cellular 
oxidative stress. However, both of them are an exogenous stress inducers. In a further 
experiment we o used an endogenous stress inducer to investigate the protective 
function of telomerase when it is localised in the mitochondria. Thus we used paraquat 
which is a chemical which can directly activate mitochondrial ROS production (Ali et 
al., 1996; Castello et. al., 2007; Shibata et. al., 2010).  
Paraquat (PQ
2+
) is a bipyridyl compound (1,1‘ –dimethyl-4,4‘ –bipyridylium), the 
prototype toxin know to exert injurious effect through oxidative stress and bears a 
structural similarity to the Parkinson’s disease toxicant, 1-methyl-4-pheynlpyridinium 
(Mohammadi-Bardbori and Ghazi-Khansari, 2008). Paraquat has been originally 
developed as a herbicide. However, it is also widely used as a source of oxidative stress 
to cells. Paraquat-induced cytotoxicity is preceded by the increase in ROS production 
and mitochondria are a major source of paraquat-induced oxidative stress (McCarthy et 
al., 2004; Castello et al., 2007; Mohammadi-Bardbori and Ghazi-Khansari, 2008). 
Paraquat can penetrate the outer mitochondrial membrane and enter inter-membrane 
space and matrix (Castello et al., 2007). Cocheme and Murphy reported that paraquat 
causes mitochondrial oxidative damage in mammalian systems following its inner 
mitochondrial transmembrane potential (Δψm) dependent. Paraquat can entry and 
accumulate into the mitochondrial matrix and the mitochondrial complex I (NADH-
ubiquinone oxidoreductase) is a major mitochondrial site for paraquat interference 
(Cocheme and Murphy, 2008). However, Castello and her team reported that the major 
site of paraquat interference is complex III (ubiquinol-cytochrome-c reductase) in the 
respiratory chain. Electrons from Complex II and complex III in the electron transport 
chain can be transfered to the PQ
2+ 
molecule and are proposed to participate in 
mechanisms of superoxide production by PQ
2+
( Castello et. al., 2007). Moreover, Yang 
and Tiffani-Castiglioni reported that paraquat might decrease the activity of 
mitochondrial complex V by abducting an electron (Yang and Tiffani-Castiglioni, 
2007). Thus, impairment of mitochondrial complexes by paraquat results in inhibition 
of electron transport with subsequent increased production of superoxide anion 
(Boelsterli and Lim, 2007). 
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Based on these findings we decided to use paraquat as a mitochondrial ROS inducer to 
investigate the protective function of telomerase when localised in the mitochondria. 
This chapter should clarify whether the protective capacity of telomerase works not only 
from the exogenous stress but also protects a cell from endogenous, directly 
mitochondrially derived stress.  
 
6.2 Results 
6.2.1 Endogenous telomerase exclusion after paraquat treatment 
We have previously shown that the exclusion level and localisation of telomerase is 
correlated to mitochondrial ROS generation as well as to nuclear DNA damage. 
However, we had used H2O2 and irradiation treatment in the previous experiments 
which are an exogenous stress induction. We were now interested in addressing the 
question whether telomerase is also protective when mitochondrial ROS are induced 
endogenously. Therefore, in this chapter we investigated the protective function of 
telomerase when cellular stress is induced by endogenous stress treatment by using 
paraquat. MRC5 and MRC5/hTERT cells were used in this experiment in order to 
investigate the protective effect to telomerase compared with cells without endogenous 
telomerase expression.  
First, we investigated the kinetic hTERT exclusion after paraquat treatment. 
MRC5/hTERT cells were treated with 400 M paraquat and the sub-cellular shuttling of 
hTERT protein at 1, 3, 6 and 24 hours after treatment were investigated. Representative 
images of MRC5/hTERT after paraquat treatment are shown in figure 6.1. The kinetic 
exclusion of hTERT in MRC5/hTERT after paraquat treatment is shown in figure 6.2. 
In figure 6.2 we do not show the exclusion results at early time points as for the 
exogenous stress treatment (H2O2) because we have not found a significant hTERT 
exclusion in the first 3 hours. Moreover, we have treated the cells for longer than 24 
hours. However, no cells survived after 24 hours of paraquat treatment. We found that 
most cells were apoptotic at 48 hours paraquat treatment (data not shown). 
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Figure 6.1 Representative images of the kinetic exclusion of endogenous hTERT in 
MRC5/hTERT cells after paraquat treatment. All cells were treated with 400μM 
paraquat. Green colour represents hTERT localisation. Nuclei were stained with DAPI 
(blue). Red signal indicates H2A.X. Red arrow indicates cells which showed nuclear 
localisation of hTERT correlated to DNA damage. Cells were treated for the indicated 
time points up to 24 hours, then fixed immediately. The localisation of hTERT was 
measured in each individual cell by ImageJ.  
 
 
Results in figure 6.2 represent a kinetic exclusion of endogenous hTERT in 
MRC5/hTERT cells after 400μM paraquat treatment (figure 6.2A) in parallel with 
400μM H2O2 treatment (figure 6.2B). We have found that after paraquat treatment, 
hTERT starts to exclude slower than after H2O2 treatment where the exclusion started 
around 1 hour post treatment and reached a maximum of 50% exclusion already after 3 
hours. At 1 and 3 hours (180 min) only 20% of hTERT was excluded from the nucleus 
to the cytoplasm after paraquat treatment while about 50-60% had been already 
excluded in MRC5/hTERT treated with H2O2 at 3 hours. The level of telomerase 
exclusion reached a maximum of around 50% in paraquat treatment at 6 hours post 
treatment. Thus, TERT seems to exclude slower in an endogenous stress treatment. No 
cells survived beyond 48 hours of paraquat treatment and telomerase exclusion already 
reversed back into the nucleus at 24 hours of treatment. A similar phenomenon has been 
found in MRC5/hTERT cells treated with H2O2, however, TERT predominantly 
locating in the nucleus was much slower (figure 6.2B). This experiment suggests a 
different exclusion behaviour of endogenous hTERT after paraquat treatment compared 
to H2O2 treatment.  
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Figure 6.2 Comparison between paraquat and H2O2 treatment for the kinetic 
exclusion of endogenous hTERT in MRC5/hTERT cells. A: Kinetic exclusion of 
endogenous hTERT after 400μM paraquat treatment. B: Kinetic exclusion of 
endogenous hTERT after 400μM H2O2 treatment. Bars indicate means and standard 
error from at least 30 individual cells for every timepoint. 
 
 
6.2.2 DNA damage in MRC5 and MRC5/hTERT cells after 400 M paraquat 
treatment  
To analyse whether the physical location of hTERT after paraquat treatment correlates 
to ROS generation and DNA damage, MRC5 and MRC5/hTERT cells were treated with 
400μM paraquat and DNA damage examined at 1, 3, 6 and 24 hours after treatment. 
Representative images of MRC5 and MRC5/hTERT are shown in figure 6.3 and 6.4. A 
summary of DNA damage foci numbesr in MRC5 and MRC5/hTERT is shown in 6.5. 
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Figure 6.3 Formation of DNA damage under 400μM paraquat treatment in MRC5. 
Cells were treated with 400μM paraquat up to 24 hours and stained for H2A.X. Red 
colour represents H2A.X and blue colour represents nuclei. 
 
 
Figure 6.4 Formation of DNA damage after 400μM paraquat treatment in 
MRC5/hTERT. MRC5/hTERT were treated with 400μM paraquat up to 24 hours and 
stained for H2A.X. Red colour represents H2A.X and blue colour represents nuclei. 
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Figure 6.5 DNA damage foci in MRC and MRC5/hTERT under 400 M paraquat 
treatment for the indicated time points. Cells were stained with H2A.X and damage 
foci number counted. A: MRC5 under 400 M paraquat treatment. B: MRC5/hTERT 
under 400 M paraquat treatment. The bars represent means and standard error from 
three independent experiments.  
 
 
Figure 6.5 shows the percentage of cells that contain DNA damage foci. The damage 
foci number of MRC5 and MRC5/hTERT were categorised into three groups which 
were: no DNA damage, 1-10 DNA damage foci and more than 10 DNA damage foci.  
Before paraquat treatment both cell types showed the same very low amount of 
damaged cells while around 90% had no damage at all. After paraquat treatment we 
found a different kinetics of increase in DNA damage between MRC5 and 
MRC5/hTERT. DNA damage response occurs much faster in MRC5 while it is 
significantly slower and there is also less DNA damage in MRC5/hTERT cells.  After 1 
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hour of treatment, almost all MRC5 cells already showed a low amount of DNA 
damage (more than 80% of cells had 1-10 damage foci) while no difference to untreated 
cells was found in MRC5/hTERT cells.  
With increasing treatment time, the amount of highly damaged cells (with more than 10 
foci) increased continuously in MRC5 cells while MRC5/ hTERT cells accumulated 
significantly lower damage, mainly in the category of 1-10 damage foci. After 24 hours 
more than 90% of cells in MRC5 showed more than 10 damage foci while only 20-25% 
of cells in MRC5/hTERT had more than 10 damage foci. This result was summarised 
from three independent experiments which confirmed each other.  
 
 
Figure 6.6  Comparison of DNA damage foci between MRC and MRC5hTERT 
after 400 M paraquat treatment for the indicated time points. % of cells contained 
damage foci were summarised from the group of high damage (more than 10 foci) for 
each indicated time point. The bars represent means and standard error from three 
independent experiments.     Ns = non-significant difference, ** p<0.01, ***p<0.001.   
 
 
 
 
 
 
 
 
148 
Figure 6.6 represents a comparison between percentages of cells that contained more 
than 10 damage foci of MRC5 and MRC5 at each indicated time point. We found a 
significant increased of DNA damage in MRC5 compared with MRC5/hTERT starting 
at 1 hour of paraquat treatment. Moreover, we found a highly significant difference 
between MRC5 and MRC5/hTERT at 3, 6 and 24 hours of paraquat treatment.  
Thus, this experiment indicates that cells which contain endogenous telomerase show a 
protective capacity not only regarding mitochondrial DNA as had been demonstrated 
earlier (Ahmed et al., 2008) but, rather surprisingly, also regarding nuclear DNA 
damage. This result of a protective capacity of nuclearly excluded telomerase to protect 
from nuclear DNA damage confirms our previous experiments with exogenous stress 
treatments.  
 
6.2.3 Quantitative determination of mitochondrial superoxide and peroxide levels 
after   400 M paraquat treatment  
To confirm the protective capacity of telomerase after endogenous stress we 
investigated whether expression of telomerase can reduce mitochondrial ROS 
generation by flow-cytometer (FACS) analysis. MRC5 and MRC5/hTERT were treated 
with 400 M paraquat for 6 and 24 hours and the mitochondrial superoxide levels were 
investigated by mitosox staining and peroxide levels by dihydrorhodamine 123 (DHR) 
staining. The experiments were repeated more than 4 times for each staining at each 
time point. Results of mitosox at 6 hours after paraquat treatment and DHR at 6 and 24 
hours after paraquat treatment were represented by absolute (arbitrary) units. However, 
since there was high variation of the level of mitosox of each single analysis at 24 hours 
after paraquat treatment, we summarised the data in percentage by adjust MRC5 and 
MRC5/hTERT before treatment as 100% and summarised the data of mitosox of MRC5 
and MRC5/hTERT after paraquat treatment as an increase in percentage of mitosox 
compared with cells before paraquat treatment. All results are shown in figure 6.7.   
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Figure 6.7 Mitochondrial superoxide and dihydrorhodamine 123 in MRC-5 and 
MRC5/hTERT after 6 and 24 hours paraquat treatment. A: represents FL1/FL3 
from DHR staining after 6 hours of paraquat treatment.  B: represents FL3 from 
mitosox staining after 6 hours of paraquat treatment. C: represents represent FL1/FL3 
from DHR staining after 24 hour paraquat treatment.. D: represents FL3 from mitosox 
staining after 24 hour paraquat treatment. The graph represents percentage of untreated 
cells. Bars indicates means and standard error from at least 4 independent experiments. 
* p<0.05, **p<0.01.   
 
As shown in figure 6.7 MRC5 showed a significant difference for cells before and after 
paraquat treatment in both 6 and 24 hours time periods. We found a significant increase 
of FL1 and FL3 on MRC5 treated with paraquat (6 and 24 hours, figure 6.7 A and C) 
compared with MRC 5 before paraquat treatment which indicated a significant 
increased of peroxide level in MRC5. However, we have not found a significant 
difference between FL1 and FL3 in MRC5/hTERT before and after paraquat treatment 
(6 and 24 hours, figure 6.7 A and C). Similar results have been found in the 
mitochondrial superoxide level. Mitosox of MRC5 was significantly increased after 
paraquat treatment (6 and 24 hour, figure 6.7 B and C) compared with untreated cells. 
However, no significant difference was found in MRC5/hTERT before and after 
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paraquat treatment (6 and 24 hours) indicating a lower level of mitochondrial 
superoxide in MRC5/hTERT compared to MRC5 at 6 and 24 hours paraquat treatment. 
These results confirm our previous experiment which had shown that when telomerase 
is localised within mitochondria it expresses a protective capacity by reducing 
mitochondrial ROS production under cellular stress condition. Consequently, 
telomerase can protect mitochondria and reduce ROS generation under both endogenous 
and exogenous stress treatments. These results correspond well with the highest hTERT 
exclusion after 6 hours, while afterwards it already decreased again. 
This reduction of ROS generation correlates to the DNA damage in MRC5 and 
MRC5/hTERT (see fig 6.5). MRC5 cells which do not have telomerase showed higher 
ROS generation and higher DNA damage after paraquat treatment while MRC5/hTERT 
which contains endogenous (over-expressed) telomerase showed lower ROS generation 
and lower DNA damage. Thus, from all these results, we can conclude that telomerase 
can reduce ROS generation which seems to correlate to lower nuclear DNA damage.  
 
6.2.4 Confirmation of the mitochondrial protective capacity and lower DNA 
damage after paraquat treatment by using hTERT shooter vectors 
To prove whether the protective function of telomerase to ROS generation and DNA 
damage was indeed because of the localisation of telomerase in mitochondria, in the 
next experiment we used the hTERT shooter vectors to deliver hTERT protein 
specifically to the nucleus or mitochondria. Because of the  connection to Parkinson’s 
disease we decided to use again the brain derived glioblastoma cell line U87.  U87 was 
transfected with mito-hTERT or nucl-hTERT as described before. Transfected cells 
were then treated with 400μM paraquat for 1, 3, 6 and 24 hours similar to the fibroblasts 
used before. The results are shown in figures 6.8-6.9. 
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Figure 6.8 Determination of mitochondrial superoxide levels in U87 cells 
transfected with hTERT shooter vectors after paraquat treatment. Red colour 
represents mitochondrial superoxide. Myc-tag is represented in green colour. Nuclei 
were stained with DAPI (blue). White arrows indicate transfected cells. A: U87 cells 
were transfected with mito-hTERT shooter and treated with 400 M paraquat for the 
indicated time. B: U87 cells were transfected with nucl-hTERT shooter and treated with 
400 M paraquat for the indicated time.   
 
 
Figure 6.9 Kinetics of ROS levels in U87 for different time points after 400 M 
paraquat treatment. All cells were treated with 400μM paraquat up to 24 hours. ROS 
level in each individual cell was measured using ImageJ. At least 30 cells per group 
have been evaluated. The graphs represent the average from 3 independent experiments. 
Bars indicate means and standard error. Ns = non-significant difference, * p<0.05, 
**p<0.01.   
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As shown in figure 6.9, we have found a significantly lower ROS level in U87 
transfected with mito-hTERT already before treatment demonstrated compared with 
nucl-hTERT and non-transfected U87. After treatment with 400μM paraquat, ROS level 
seems to increase vigorously until 24 hours under paraquat treatment in cells transfected 
with nucl-hTERT as well as in non-transfected cells. However, ROS levels in mito-
hTERT and nucl-hTERT were not significantly different at 3 hours under paraquat 
treatment and no significant difference of ROS level have been found between nucl-
hTERT and non-transfected cells at 24 hours. The reason for this is unclear , however, 
this result  indicates the protective function of both mitochondria and nuclear hTERT to 
ROS production after paraquat treatment. But in all other time points, we found a 
significant lower ROS level when hTERT was localised in mitochondria under paraquat 
treatment. This result confirms our findings of previous experiments demonstrating the 
protective function of mitochondrial telomerase. ROS production was suppressed in 
cells transfected with mito-hTERT while increased in cells transfected with nucl-
hTERT and the non transfected controls.  
Thus, these results confirm again that mitochondrial localisation of hTERT can reduce 
mitochondrial ROS production from both exogenous and endogenous stress. 
To prove whether this reduction of ROS generation due to mitochondrial localisation of 
hTERT can reduce nuclear DNA damage, U87 has been transfected with mito-hTERT 
or nucl-hTERT, treated with 400μM paraquat and then the DNA damage was examined 
at 1, 3, 6 and 24 hours after treatment. The results of this experiment are shown in 
figures 6.10-6.13. 
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Figure 6.10 Representative images of the accumulation of DNA damage foci in U87 
cells transfected with mito-hTERT and nucl-hTERT after paraquat treatment. 
Cells were treated with 400 M paraquat up to 24 hours and stained for H2A.X.  Red 
colour represents DNA damage foci and green colour represents hTERT localisation. 
Blue is nuclear DAPI stain. White arrows indicate transfected cells. A: U87 transfected 
with mito-hTERT. B: U87 transfected with nucl-hTERT. 
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Figure 6.11 Kinetics of accumulation of DNA damage foci in U87 cells transfected 
with mito-hTERT and nucl-hTERT. A: non-transfected U87. B: nucl-hTERT 
transfected U87. C: mito-hTERT transfected U87. Cells were treated with 400 M 
paraquat up to 24 hours. Cells were stained with H2A.X and DNA damage foci 
numbers counted. Bars represent means and S.E. from three independent experiments. 
Ns = non-significant difference,* p<0.05, **p<0.01.    
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Figure 6.11 shows the percentage of cells containing DNA damage foci. U87 was 
treated with 400μM paraquat as in the previous experiments and then stained with 
H2A.X to examine the DNA damage foci number. Cells were categorised into three 
groups which were: no damage, 1-10 damage foci and more than 10 damage foci as in 
the experiment using MRC5 and MRC5/hTERT cells.  
Again, a different kinetic increase of DNA damage between cells transfected with mito-
hTERT and nucl-hTERT has been found. DNA damage occurs faster in U87 cells 
transfected with nucl-hTERT while it stays low and there was no significant difference 
between the groups which showed no damage and more than 10 damage foci at all time 
points in mito-hTERT U87 after paraquat treatment.  The DNA damage in non-
transfected cells and those transfected with nucl-hTERT seemed to increases 
continuously until 24 hours of paraquat treatment. At 24 hours paraquat treatment, 
about 50% of U87 transfected with nucl-hTERT showed more than 10 damage foci 
while only 15-20% of U87 transfected with mito-hTERT have more than 10 damage 
foci. This result demonstrates that localisation of hTERT in mitochondria can prevent or 
reduce DNA damage under endogenous stress treatment. Thus mitochondrial 
localisation of hTERT can protect nuclear DNA from damage in both endogenous and 
exogenous stress inducers. 
 
Figure 6.12 Kinetics of accumulation of DNA damage foci in the group of more 
than 10 damage foci in U87 cells transfected with mito-hTERT and nucl-hTERT. 
Cells were treated with 400 M paraquat up to 24 hours. Cells which contained more 
than 10 damage foci were summarised for each time point. Bars represent means and 
S.E. from three independent experiments. Ns = non-significant difference, * p<0.05, 
**p<0.01.   
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Next, we compared the group of high DNA damage (displaying more than 10 foci) of 
U87 transfected with mito-hTERT, nucl-hTERT or non-transfected cells. As the result 
in figure 6.12 shows, we have not found a significant difference between high DNA 
damage between mito-hTERT, nucl-hTERT and non-transfected U87 before 3-6 hours 
of paraquat treatment. However, after 3-6 hours of paraquat treatment, mito-hTERT 
U87 showed significant lower of high DNA damage compared with nucl-hTERT and 
the non- transfected group. We have not found a significant difference between U87 
transfected with nucl-hTERT and the non-transfected group which correlated with the 
result of U87 after irradiation (figure 5.9 in  Chapter 5).  
Furthermore, results from Chapter 3 and 4 and previous results in this chapter showed 
that ROS levels positively correlated to the amount of nuclear DNA damage. Thus in 
this experiment we correlated ROS levels using mitosox staining to the occuring of 
DNA damage on parallel coverslips when U87 was transfected with different shooter 
vectors as shown in figure 6.13.  
We found a very interesting correlation between ROS level and the amount of DNA 
damage foci. Under basal condition, although ROS level was already low in cells 
transfected with mito-hTERT we have not found a significantly lower level of DNA 
damage foci compared to U87 transfected with nucl-hTERT under basal condition. 
However, after the start of the treatment U87 with paraquat, ROS levels of U87 
transfected with mito-hTERT did not increase with the time of treatment which 
correlates to a stably low DNA damage in the nucleus (figure 6.12 A, B, blue line). In 
contrast in U87 transfected with nucl-hTERT, the ROS level was increased 
continuously which could be the cause for the  induction of nuclear DNA damage 
(figure 6.12 A, B, red line). Overall this experiment seems to suggest that localisation of 
hTERT within mitochondria could directly cause the reduction of ROS production 
which in turn could prevent nuclear DNA damage under endogenous stress treatment.  
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Figure 6.13  ROS levels and DNA damage foci in U87 cells transfected with mito-
hTERT and nucl-hTERT after paraquat treatment. A: ROS level of U87 
transfected with mito-hTERT or nucl-hTERT shooter. B: DNA damage foci in the 
group of more than 10 damage foci in U87 cells transfected with mito-hTERT or nucl-
hTERT. Cells were treated with 400 M paraquat up to 24 hours. Bars indicate means 
and standard error from three independent experiments. * p<0.05, **p<0.01.   
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6.3 Discussion 
In our initial experiments we have used hydrogen peroxide and irradiation to activate 
cellular oxidative stress. H2O2 can oxidise transition metals in many cellular 
components. H2O2 directly damages the iron-sulfur clusters of key enzymes and can 
inactivate enzymes that use single iron atoms to bind substrates, such as ribulose-5-
phosphate epimerase. H2O2 also reacts with the intracellular pool of unincorporated 
ferrous iron and thereby generates hydroxyl radicals (Sawyer et. al., 1985). Ionising 
radiation can directly induce DNA double-strand breaks (DSBs) which are the most 
dangerous lesions (Firsanov et al., 2011).  Irradiation of tumor tissues and the use of 
drugs that directly produce DSBs or induce replication stress are widely applied for 
cancer therapy (Redon et al., 2010). However, both of these are exogenous stress 
inducers. In our last experiment we sought to induce endogenous stress in order to 
investigate the protective function of telomerase when it is localised in the 
mitochondria. Thus we used paraquat which is a chemical which can directly activate 
mitochondrial ROS production.  
We found that under 400μM paraquat treatment the maximum hTERT exclusion from 
the nucleus to the cytoplasm occurred at 6 hours and and reduced at 24 hours in 
MRC5/hTERT. This maximum exclusion point is slower than another treatment (H2O2). 
Cocheme and Murphy reported that paraquat caused mitochondrial oxidative damage in 
mammalian systems following its Δψm-dependent accumulation into the mitochondrial 
matrix (Cocheme et al., 2008).   Castello and her colleagues found that mitochondria 
can uptake paraquat in different ways. In their experiment, the level of paraquat uptake 
into extracted mitochondria was different depending on the respiration substrates 
(Castello et al., 2007). Thus, the uptake level of paraquat even into whole cells might be 
affected by the culture medium or culture condition which might relate to the time 
required for paraquat uptake to reach the effective level. Moreover, we have not found 
MRC5/hTERT (and also other cells treated with paraquat) that survived after 48 hours 
paraquat treatment. The continuous treatment of paraquat in our experiment might cause 
continuously uptake paraquat into mitochondria that might have detrimental effects for 
cellular survival at such high concentrations.  
We found a different kinetics increase in DNA damage after paraquat treatment between 
MRC5 and MRC5/hTERT cells. The occurence of DNA damage was faster in MRC5 
cells while significantly slower in MRC5/hTERT. After 24 hours treatment, 80% of 
cells in MRC5 had a high amount (>10) of DNA damage foci while only 20-25% of 
cells in MRC5/hTERT displayed high amount of damage DNA foci.  
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MRC5/hTERT cells also showed lower ROS production and peroxide levels than 
MRC5 after paraquat treatment which confirm previous results from our group that 
MRC5/hTERT showed lower mitochondrial superoxide generation compared with 
MRC5 after hyperoxic (40% oxygen in the incubator) treatment (Ahmed et al., 2008). 
We found a significant difference between ROS levels and peroxide levels of MRC5 
cells compared between untreated and 6 hours paraquat treatment and untreated with 24 
hours paraquat treatment. In contrast, MRC5/hTERT cells indicated no-significant 
difference between before treatment and after 6 and 24 hour paraquat treatment in both 
ROS and peroxide.   
These results confirm the protective function of telomerase under both endogenous and 
exogenous stress treatment in cells with over-expressed hTERT (MRC5/hTERT) 
compared with the same background cell type (MRC5) without hTERT. MRC5 does not 
express telomerase which indicated that the reduction of ROS production and protection 
of nuclear DNA damage under stress condition was the effect of overexpression of 
telomerase in MRC5/hTERT. Moreover, we have found only 20% of hTERT excluded 
from nucleus to cytoplasm at 1 and 3 hours after paraquat treatment in MRC5/hTERT. 
And the exclusion has reached the highest exclusion level (40-50%) at 6 hours of 
paraquat treatment. This exclusion level of hTERT is different from the exclusion of 
hTERT in MRC5/hTERT after H2O2 treatment. It is interesting that even the small 
amount of hTERT which was excluded from the nucleus under stress condition could be 
enough for the mitochondrial protection compared to cells without endogenous hTERT 
(MRC5).  However, our group has also shown that a stable hTERT over-expression in 
MRC-5 fibroblasts can lead to changes in gene expression (Daniels et al., 2010). 
Therefore it is not clear whether hTERT shuttling is the only parameters that influences 
a decrease in mitochondrial ROS. Indran et al., (2011) have demonstrated a higher level 
of MnSOD as well as more cellular glutathione in Hela cells overexpressing hTERT. 
Although we have not found a higher antioxidant expression in our system (data not 
shown) we cannot exclude the influence of additional factors. 
Next, we aimed to analyse more directly whether localisation of hTERT in 
mitochondria could be the reason for mitochondrial protection after endogenously 
induced stress. We have used mito-hTERT and nucl-hTERT shooter vectors transfected 
into U87 as in the previous experiment. We found a decrease in ROS production in U87 
transfected with mito-hTERT after paraquat treatment. We also found a lower amount 
of DNA damage in U87 transfected with mito-hTERT compared with nucl-hTERT and 
non-transfected U87 after paraquat treatment.  
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As concluded in figure 6.13, different localisations of hTERT display a differential 
effect on ROS generation as we have found before: mitochondrial localisation of 
hTERT promotes lower ROS production and lower nuclear DNA damage while nuclear 
localisation of hTERT does not show this protection.  
Thus, mitochondrial localisation of hTERT is the reason for lower ROS production and 
indirectly protects nuclear DNA from damage induction after endogenous stress 
treatment.  Haendeler and colleagues reported that TERT increased respiratory chain 
activity which is most pronounced at complex I (Haendeler et al., 2009). Interestingly, 
mitochondrial complex I (NADH-ubiquinone oxidoreductase) is a major mitochondrial 
site for superoxide production by paraquat (Cocheme and Murphy, 2008). Thus the 
protection of complex I of the respiratory chain might be a reason for lower ROS 
production after paraquat treatment in cells with either nuclear hTERT exclusion such 
as MRC5/hTERT cells or direct mitochondrial hTERT localisation using mito-hTERT 
shooter transfection.  
Finally, overall results from this chapter definitely indicate that mitochondrial 
localisation of hTERT protects mitochondria by reducing ROS production from the 
respiratory chain which might be a reason for the lower nuclear DNA damage after 
endogenous stress treatment.   
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Chapter 7 
General discussion 
 
7.1 Has different localisation of telomerase an effect on nuclear DNA damage? 
Various groups have reported the shuttling of telomerase catalytic subunit from the 
nucleus to mitochondria upon oxidative stress (Santos et al., 2004, 2006; Ahmed et al., 
2008; Haendeler et al., 2009; Indran et al., 2011). We found that localisation of hTERT 
is directly correlated to the different levels of DNA damage foci after various oxidative 
stress treatments such as hydrogen peroxide, paraquat treatment and irradiation. 
Endogenous telomerase is excluded from the nucleus in a time and stress dependent 
manner. However, there seems to be heterogeneity in hTERT exclusion within various 
cell populations (analysed in Hela, MCF7, and MRC5/hTERT cells). Importantly, in 
cells where hTERT still remains in the nucleus, cells accumulate high DNA damage 
after stress treatment (hydrogen peroxide and irradiation). In contrast, when hTERT is 
excluded from the nucleus and shuttles to mitochondria, cells show no or very low 
nuclear DNA damage. Cells which showed an intermediate exclusion pattern of hTERT 
exclusion (roughly 50% in the nucleus and cytoplasm) also showed an intermediate 
range of DNA damage (see fig 3.4 in Chapter 3).  
It seems surprising that the localisation of hTERT in the nucleus did not protect DNA 
from nuclear DNA damage and, even more intriguingly, seemed even to promote DNA 
damage while localisation of hTERT in mitochondria has an indirect effect to protect 
nuclear DNA from damage. This finding leads to the speculation that, although 
telomerase exerts its canonical, telomere maintaining function in the nucleus when a 
cell gets under stress, nuclear hTERT has a negative effect on DNA damage response 
which we measured using H2A.X. Consequently, in addition to lowering mitochondrial 
ROS when localised within the organelle there might be an additional biological 
function for hTERT exclusion from the nucleus. Both processes could be tightly 
connected. Moreover, this result also suggests that cells which contain endogenous 
telomerase show a protective capacity not only regarding mitochondrial DNA as had 
been demonstrated earlier (Ahmed et al., 2008) but, rather surprisingly, also regarding 
to nuclear DNA damage.  
Passos and colleagues have shown recently that there exists a positive feed-back loop 
between nuclear DNA damage resulting in mitochondrial dysfunction which in turn 
induces more nuclear DNA damage (Passos et al., 2010). Although this loop was found 
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in senescent fibroblasts and might take  much longer time to take effect one cannot 
exclude that a similar process takes place in our system (telomerase positive cells 
including various cancer cell lines) and occurs in a shorter time frame as well.  
To prove our findings of the effect of endogenous telomerase on nuclear DNA damage, 
we used a model of specific hTERT shooter vectors to deliver the protein to specific 
cellular organelles - mitochondria and nucleus.  
While in cells with endogenous telomerase the applied stress triggered nuclear 
exclusion, in our shooter vector system hTERT is already located in the respective 
compartment-nucleus or mitochondria- when the stress occurs. The TERT shooter 
plasmids carry a targeting protein sequences which leads hTERT into a specific location 
of a cell. Thus, cells containing exogenous hTERT shooters which stayed in there 
resemble those cancer cells where endogenous hTERT was not excluded within 3 hours, 
while in a longer time frame exogenous hTERT could still be excluded since for longer 
time points (up to 5 days) at least 40% of telomerase per cell were excluded from the 
nucleus (figure 3.6).  
From the hTERT shooter model, we have found that different localisations of 
exogenous hTERT showed a different protective effect to nuclear DNA after induced 
DNA damage in three cancer cell lines (Hela, MCF7 and U87). Mitochondrial 
localisation of hTERT after shuttling was correlated to much lower DNA damage while 
nuclear localisation of hTERT did not show this protection and in cells without an 
active p53 it seemed and even increase the level of nuclear DNA damage significantly.  
This result is in accordance with previous findings from  another group that 
confinement to the nucleus of hTERT that is unable to shuttle due to a mutated nuclear 
exclusion signal might correlates to an increase of nuclear and mitochondrial DNA 
damage (Kovalenko et al., 2010 a,b). Kovalenko and co-workers explain their findings 
by an activation of DNA damage response genes ATM, Chk2 and p53 when hTERT is 
locked inside the nucleus that might increase the amount of DNA damage (Kovalenko 
et al., 2010b).  We found that cells which harbour an activate p53 (MCF7, U87 and 
MRC5/hTERT) showed no significant difference of DNA damage level when hTERT is 
localised in the nucleus compared with the control group (non-transfected cells) while 
cells that harbour an inactivated p53 (Hela) showed a significantly higher DNA damage 
level even under basal condition when hTERT is localised in the nucleus compared with 
the control group (non-transfected cells). We hypothesise that p53 status might play a 
role with this higher DNA damage when hTERT is localised in the nucleus.  
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In addition, to confirm our results from cancer cells, we used MRC5/SV40 cells which 
do not contain endogenous telomerase as a model to avoid any potential interference of 
endogenous telomerase with the transfected TERT shooter vectors which might 
influence the results in cancer cells. We found a significantly lower DNA damage level 
in MRC5/SV40 which contained mitochondrial hTERT compared with MRC5/SV40 
containing nuclear hTERT and the control group (non-transfected MRC5/SV40) after 
irradiation. This result confirms that localisation of an exogenous hTERT in 
mitochondria reduces nuclear DNA damage independent of any endogenous telomerase 
expression.  Investigating the potential underlying mechanism for the lower DNA 
damage in mitochondrial TERT containing cells we were able to correlate it with a 
decrease of mitochondrial superoxide level.  
 
7.2  Is physical localisation of hTERT in mitochondria necessary and sufficient for 
a decrease of mitochondrial superoxide after stress treatment? 
Previous results from four groups, including ours, have shown that telomerase catalytic 
subunit is excluded from various cell types upon oxidative stress (Haendeler et al., 
2003, Santos et al., 2004, Ahmed et al.,2008, Indran et al., 2011) which is correlated to 
a protective effect of telomerase within mitochondria (Ahmed et al.,2008, Haendeler et 
al., 2009, Kovalenko et al., 2010a,b, Indran et al., 2011), including in cancer cells 
(Kovalenko et al., 2010b, Indran et al., 2011). Our experiments in Chapter 4 have 
shown that the specific location of hTERT in mitochondria protects cells against 
oxidative stress in cancer cell lines (Hela, MCF7 and U87) and fibroblasts 
(MRC5/SV40). Modelling TERT localisation using specific hTERT shooter vectors in 
Hela, MCF7 and U87 showed a significant lower mitochondrial superoxide production 
when hTERT was localised in mitochondria compared with nuclear localisation under 
H2O2 stress treatment. However, the detection of ROS had been performed one day after 
treatment to avoid the interfering with the exogenous H2O2 which was used to treat the 
cells onto the ROS measurement. Therefore, we used X-irradiation to stress cells and 
detected ROS production within 30 minutes after treatment. We found a reduction of 
mitochondrial superoxide levels as a direct effect from the mitochondrial localisation of 
hTERT in MCF7 and U87. However, no significant difference in ROS levels was found 
between Hela harbouring mitochondrial hTERT shooter and nuclear hTERT shooter. 
Even Nuclear hTERT transfected cells, somehow, showed a significant higher ROS 
level than mitochondrial hTERT transfected cells, but in some condition such as in Hela 
under basal condition (figure 4.5 and 4.14) or MRC5/SV40 after irradiation  (figure 
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4.20) the level of ROS production is significant lower than non transfected cells which 
might indicate a protective effect of nuclear hTERT to the ROS production.  The reason 
for this is still unclear. 
We have also performed a kinetics over time of ROS levels in Hela and MCF7 after 
irradiation with 20 Gy  and followed it up to 2 days post irradiation. We found no 
significant difference between mitochondrial hTERT transfected cells compared with 
nuclear hTERT transfected cells in both Hela and MCF7 at day 2 after irradiation. This 
result could also confirm the protective effect of nuclear hTERT to cellular ROS 
production.  One possibility to explain this phenomenon might be that nuclear hTERT 
might be excluded from the nucleus over the time after stress treatment.  
Next, we have used MRC5/SV40 cells which do not contain endogenous telomerase to 
exclude any potential interference of endogenous telomerase in cancer cells with the 
exogenous hTERT shooter to ROS production, We found a significant difference in the 
amount of mitochondrial superoxide production in MRC5/SV40 transfected with 
mitochondrial hTERT shooter compared with nuclear hTERT transfected and the 
control group (non-transfected MRC5/SV40). These results confirm that mitochondrial 
localisation of hTERT protects against mitochondrial superoxide production after 
exogenous stress treatment and that there was no interfereing influence of endogenous 
telomerase in the 3 cancer cell lines.   
Haendeler and coworkers reported that TERT is transported into the mitochondria via 
TIM/TOM complex, enters the mitochondrial matrix and binds to mitochondrial DNA 
coding regions for ND1 and ND2 and increases complex I respiratory efficiency 
(Haendeler et al., 2009). They also showed that binding of TERT to the mitochondrial 
DNA can protect the mitochondria against ethidium bromide and UV damage induction 
and increases overall respiratory chain activity which increases mitochondrial 
respiratory efficiency in HEK cells and mouse primary lung fibroblasts. Analysis of 
respiration in heart and liver mitochondria in TERT-/- mice indicated a particular 
importance of TERT in tissues with a high respiratory rate in vivo (Haendeler et al., 
2009).  Moreover, inhibition of endogenous hTERT expression using siRNA in 
endothelial cells (Ahmed et al., 2008) and shRNA in HEK293 (Haendelere et al., 2009) 
also shows increase of oxidative stress.  
Indran and co-workers reported that siRNA-mediated gene silencing in transiently 
hTERT over-expressing Hela cells increased the level of ROS generation (Indran et al., 
2011). Hela cells transfected with a vector containing hTERT displayed significantly 
lower mitochondrial ROS levels compared with wildtype Hela cells and Hela cells 
165 
transfected with the control vector after H2O2 treatment (Indran et al., 2011). However, 
they have not specified the exact hTERT localisation in their system since it is a general 
over-expression system in Hela-cells already highly expressing telomerase without 
transfection. Our experiments have shown here that mitochondrial localisation of 
telomerase protects against mitochondrial ROS generation and could indirectly protect 
nuclear DNA from damage under stress condition. As telomerase activity has been 
detected in 90% of all human malignancies (Shay and Bacchetti, 1997). It is possible 
that anti-cancer treatments such as chemotherapeutic drugs or irradiation could induce 
the mechanism of telomerase catalytic subunit shuttling to mitochondria, decreasing 
mitochondrial ROS generation and prevents nuclear DNA damage. Passos et al (2010) 
has demonstrated a positive feedback loop between mitochondrial ROS and nuclear 
DNA damage. The exogenous ROS generation by irradiation in fibroblasts damages 
mitochondria and accelerate nuclear DNA damage (Passos et al., 2010). We showed 
here an interaction between mitochondria and nucleus also exists in cancer cells. The 
results from our experiments might speculate that the exclusion of telomerase could 
contribute to mitochondria and nuclear DNA protection and might increased resistance 
of those cancer cells against various anti-cancer treatments. 
 
7.3  Has endogenously induced stress the same effect as exogenous induction of 
ROS? 
We have found that mitochondrial localisation of telomerase can protect mitochondria 
not only against exogenous stress activators (H2O2 and irradiation) but also against an 
endogenous stress inducer: paraquat. When we treated MRC5/hTERT with 400 M 
paraquat we found that the exclusion of hTERT occurred slower than in the same cell 
type treated with H2O2. However, no fibroblast could survive beyond 48 hours of 
paraquat treatment which was different from MRC5/hTERT treated with exogenous 
stress (H2O2). The reason for this might be the continuous uptake of paraquat into 
mitochondria over the whole time (up to 24h).  
We found significantly higher nuclear DNA damage in MRC5 compared with 
MRC5/hTERT after treatment with 400 M paraquat. This result correlates well with a 
significant lower level of ROS production in MRC5/hTERT compared with MRC5 after 
400 M paraquat (figure 6.13). To confirm our findings that protective function of 
telomerase to ROS generation and DNA damage was indeed caused by the localisation 
of telomerase in mitochondria, we used a model of specific hTERT shooter vectors in 
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U87. We decided to use this brain derived glioblastoma cell line because we want to 
connect our results for the further investigation in Parkinson’s disease. We found a 
decrease in ROS production and nuclear DNA damage in U87 cells transfected with 
mitochondrial hTERT compared with cells transfected with nuclear hTERT and the 
control group (non-transfected U87) after paraquat treatment. Thus, this result suggested 
that mitochondrial localisation of hTERT protects mitochondria by reducing ROS 
production which indirectly protected nuclear DNA under endogenous stress as we 
found in the exogenous stress condition.  
Paraquat is known to induce cellular cytotoxicity by increasing in mitochondrial ROS 
production (McCarthy et al., 2004; Castello et al., 2007; Mohammadi-Bardbori and 
Ghazi-Khansari, 2008).  Cocheme and murphy  reported that mitochondrial complex I 
(NADH-ubiquinone oxidoreductase) is a major mitochondrial site for superoxide 
production by paraquat (Cocheme and Murphy, 2008). Haendeler and co-workers found 
that telomerase can increase respiratory efficiency, in particular at complex I (Haendeler 
et al., 2009). Thus, the protection of complex I of the respiratory chain might be a 
reason for lower ROS production after paraquat treatment in cells with either nuclear 
hTERT exclusion such as MRC5/hTERT cells or direct mitochondrial hTERT 
localisation using shooter vector transfection. The reduction of mitochondrial ROS 
producation by telomerase catalytic subunit in cells such as U87 could suggest a 
protective role of telomerase in neuronal cells. Mitochondrial localisation of hTERT 
might play a role in mitochondria protection against mitochondrial dysfunction which is 
thought to be one of the major pathological mechanisms responsible for Parkinson's 
disease.  
 
 
7.4  Does p53 status influence the protective function of telomerase? 
Our results in Chapter 3 showed that there seems to be a correlation between p53 
activity and the effect of nuclear hTERT on the induction of nuclear DNA damage. We 
found that cancer cells which harbour an active p53 (MCF7, U87) showed no 
significant difference between DNA damage when hTERT is localised in the nucleus 
compared with the control group (non-transfected cells). However, cells that harbour an 
inactivated p53 (Hela) showed significantly higher DNA damage when hTERT was 
localised in the nucleus under basal and stress condition compared with the control 
group (non-transfected Hela). We hypothesised that the p53 status might play a role for 
this higher DNA damage while hTERT is localised in the nucleus. By using an isogenic 
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pair of glioblastoma cells (U87 and UP96) that only differed in their p53 status, we 
aimed to distinguish the effect of p53 on the protective function of telomerase.  
Firstly, we have analysed the kinetic hTERT exclusion of U87 and UP96. We did not 
find a major difference in the kinetic exclusion of the endogenous telomerase of U87 
and UP96 and most likely that there was no influenced by difference p53 activation.  
Regarding  DNA damage, U87 and UP96 cells transfected with mitochondrial hTERT 
showed significantly lower DNA damage compared to those containing nuclear hTERT 
and the control group (non-transfected cells) suggesting a protective function of 
mitochondrial telomerase to nuclear DNA in high dosages irradiation. Interestingly, 
UP96 which harbours mutated p53 showed a significantly higher DNA damage when 
transfected with nuclear hTERT shooter compared with mitochondrial hTERT shooter 
(figure 5.9).  
High levels of DNA damage when hTERT is localised in the nucleus might play a role 
in cell cycle delay in order to repair the damage site (Kovalenko et al., 2010a). 
Activated p53 arrests the cell cycle to allow time for DNA repair (Zhang et al., 2012). 
However, if the damage is beyond repair, p53 can induce a permanent cell cycle arrest 
(senescence) or a process which triggers apoptosis. However it is not clear what is the 
molecular mechanism for a potential interaction between inactive p53 status, higher 
nuclear DNA damage and nuclear localisation of hTERT under stress condition. 
Experiments which examine the correlation between hTERT and gene expression while 
p53 is inactive might help to better understand the pathway responsible for this DNA 
damage induction. 
We found significantly lower ROS levels in U87 and UP96 cells transfected with 
mitochondrial hTERT shooter compared with cells transfected with nuclear hTERT and 
the control group (non-transfected cells). This result confirms our previous result in 
Hela and MCF7 cells. Moreover, it is interesting that, in both U87 and UP96 treated 
with 20Gy irradiation, we have found a significant induction of ROS generation in both 
U87 and UP96 transfected with nuclear hTERT and non-transfected cells, however, no-
significant increase of ROS production in both U89 and UP96 transfected with mito-
hTERT. These results indicate that p53 protein does not influence the mitochondrial 
protective function of hTERT.   
We found a significantly higher non-telomeric DNA damage in UP96 transfected with 
nuclear hTERT compared with U87 transfected with nuclear hTERT after 20 Gy 
irradiation (figure 5.15 in Chapter 5). However, we have not found a significant 
difference of the non-telomeric DNA damage between UP96 transfected with nuclear 
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hTERT compared with U87 transfected with nuclear hTERT under basal. Moreover, no-
significant difference between telomeric DNA damage have been found between U87 
and UP96 under basal and after 20 Gy irradiation. This result suggests that different p53 
status does not increase the amount of telomeric DNA damage after stress treatment. 
This result is different from the result of another group (J Santos’s group) which has 
demonstrated a significant increase of the percentage of telomeric DNA damage 
between cells without transfection and cells contained mutated nuclear exclusion signal 
hTERT which locks the hTERT inside nucleus which is comparable to our nuclear 
shooter in LNCaP and SQ20B cells under basal condition (Kovalenko et al., 2010b). 
Our experiment used a slightly different experiment model which transfected the fully-
functional hTERT into the nucleus and evaluated the correlation between hTERT and 
DNA damage in cells which harbour different p53 under stress condition.  It is 
interesting that SQ20B in Kovalenko’s experiment harbours a mutated p53 while 
LNCaP contains aberrant methylation of p16 but still expresses wild type p53. Under 
basal condition both SQ20B and LNCaP showed a significant increase of the percentage 
of total DNA damage and  the percentage of telomeric DNA damage in cells containing 
mutated nuclear hTERT compared with cell without nuclear hTERT. Our experiment 
found that under basal condition cells contained mutated inactive p53 which contained 
nuclear hTERT did not show significant difference in % of total DNA damage and % 
Telomeric DNA damage compared with cell contained wild type active p53 and 
contained nuclear hTERT suggests that the increase of nuclear DNA damage in 
Kovalenko’s experiment was because of the effect of nuclear hTERT blocked inside the 
nucleus under basal condition. However, after the cells was stressed by irradiation (20 
Gy) we found a pronounced increasing of non-telomeric DNA damage while there was 
no significant difference between telomeric DNA damage between cells contained 
inactive p53 compared with cell contain active p53. This result suggests that nuclear 
hTERT may play more roles on nuclear DNA damage in cells which lack active p53 
under stress condition.  
 
7.5 Summary 
Our study has found different nuclear exclusion patterns of endogenous telomerase after 
hydrogen peroxide treatment in cancer cells and a telomerase over-expressing cell line 
and showed a significant correlation between localisation of telomerase catalytic subunit 
and DNA damage. Cells where hTERT remains in the nucleus displayed high DNA 
169 
damage while cells which excluded hTERT from the nucleus displayed no or very low 
DNA damage.  
Thus, we used organelle specific hTERT localisation vectors to specify the effect of 
telomerase in nucleus and mitochondria after exogenous and endogenous stress 
treatment. We found that mitochondrial localisation of hTERT protects nucleus from 
DNA damage while nuclear localisation of hTERT correlated with higher amounts of 
DNA damage. 
Since reactive oxygen species (ROS) are known to be responsible for nuclear DNA 
damage, we have tested the correlation between the localisation of hTERT and the 
expression of mitochondrial ROS. Our results indicated that mitochondrial localisation 
of hTERT decrease mitochondrial ROS generation level directly after both endogenous 
and exogenous stress which might be a reason of the prevention of nuclear DNA 
damage.  
We hypothesised that p53 status might influence the protective function of telomerase. 
Our results in an isogenic cell pair of glioblastoma cells showed that p53 status does not 
prominently influence the protective function of mitochondrial hTERT. However, 
nuclear hTERT of cells which contained inactive p53 displayed a significantly higher 
DNA damage than cells which contained an active p53. This effect became more 
pronounced when stress levels where increased. We hypothesise that hTERT 
localisation might possibly interact with p53 when a cancer cell is under stress 
condition. However, the molecular mechanism for that is unknown. 
In conclusion, our results demonstrate a novel link between mitochondrial localisation 
of hTERT, decrease of mitochondrial ROS and the protective capacity of telomerase to 
nuclear DNA from damage after stress treatments.    
 
7.6 Future directions 
The results and discussion presented in this thesis have improved the understanding that 
mitochondrial localisation of hTERT protects against nuclear DNA damage and 
mitochondrial ROS production after exogenous and exogenous stress. However, a 
number of questions remain outstanding: 
 Why does nuclear localisation of hTERT promote nuclear DNA damage when 
p53 is inactive? More experiments about the connection between nuclear hTERT 
localisation and genes related with the activation of p53 might be beneficial to 
answer this question. 
170 
 What factors influence the different exclusion kinetic of endogenous hTERT 
under stress treatment? Since we found different kinetic exclusion in different 
cancer cell types, understanding of the factors which influence telomerase 
kinetic exclusion would be important in order to block the exclusion of 
telomerase which could be developed for a cancer therapy in the future.  
 Why can a small amount of hTERT which is excluded from the nucleus be 
sufficient to reduce mitochondrial ROS production and protect the nucleus DNA 
from damage? It is intriguing that in paraquat treatment experiment, even the 
small amount of hTERT which was excluded from the nucleus before reaching 
highest exclusion rate at 6 hour in MRC5/hTERT was enough for the 
mitochondrial protection and protect nucleus DNA from damage compared with 
cells without endogenous hTERT (MRC5).  
 Does hTR localisation or the expression level correlate with the induction of 
DNA damage when hTERT is localised in the nucleus under stress condition? 
hTR is necessary for the canonical function of telomerase. However, there is a 
report by Ting and co-workers that hTR can stimulates the kinase activity of 
DNA Dependent Protein Kinase (DNA-PK) which is required for the repair of 
DSBs via the non-homologous end-joining (NHEJ) pathway (Ting et al., 2009). 
As we found a link between nuclear localisation of hTERT, inactive p53 and 
increase of DNA damage under stress condition, does hTR corroborate on this 
correlation?  
 Do cells such as cancer stem cells, adult stem cells or endothelial cells show a 
similar phenotype when hTERT is localised in different cellular compartments? 
It has been shown that cancer stem cells express high telomerase activity level 
(Joseph et al., 2010). However nothing is known about TERT shuttling or the 
effect of TERT when it is localised in different cellular compartments in these 
cell types. Thus experiments on other cell types would be interesting and 
enhance the understanding of telomerase in cellular ageing and longevity.  
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